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Phytochemicals 
The term phytochemicals refers to chemical compounds derived from plants, (phyto 
derives from ancient Greek meaning plant), able to exert a beneficial effect on human 
health.   
Phytochemical is a definition that was made up from pharmaceuticals and nutrition
1
 
because they are contained mainly in edible plants, thus they can also be defined as food or 
part of food that improves human health preventing or healing disease.
2
 Classes of 
phytochemicals include alkaloids, phenolic compounds, carbohydrates, organic acids and 
vitamins and they are used in the nutraceuticals industry as components in food 
supplements. 
They have gained an increasing amount of attention over the last few years given their 
recognised health benefits, their availability from sustainable sources and the fact that the 
food supplement market, in which they are largely employed, it is quickly growing because 
they are not classified as drugs and they do not need to undergo complex pattern for 
regulatory approval. 
This opens up an issue related to fraudulent products with a non-defined or fake 
composition.
3
 
In the work herein presented, two of the main classes of phytochemicals were considered:  
 Soluble fibre (carbohydrate polymers such as fructo-oligosaccharides) and their 
novel characterisation methods 
 Polyphenols derived from consumable sources: structure–activity relationship 
(SAR) studies of their semi-synthetic analogues 
The application and development of innovative methods for the characterisation of bio-
polymers (soluble fibre) is crucial, primarily for the food and nutraceutical industry given 
the lack of rapid and efficient analytical methods for the quality control of those 
phytochemicals in foodstuff. 
It is a compelling issue especially giving that the presence of soluble fibre is used to claim 
prebiotic activity for the food product. It is worth mentioning that the term soluble fibre is 
specific to certain structures classes e.g. inulins and fructo-oligosaccharides etc. 
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Characterisation of such materials, up until now, has been done by mass difference. 
However, it is clear that this cannot be sufficient to support their presence and the claims 
associated with it in nutraceuticals and foodstuff and so precise analytical methods and 
more precise characterisation is essential. 
Thus the first part of this work focuses on the application of a novel High Performance 
Thin Layer Chromatography (HPTLC) based method which was developed using samples 
of Adansonia digitata fruit pulp to demonstrate this approach given the reported prebiotic 
activity of this essential food. 
The second part of this thesis focuses instead on structure–activity relationship studies of 
food phytochemicals and their semisynthetic analogues on selected targets. Within that 
research line new polyphenol analogues were designed, synthesised and evaluated on 
different targets in order to determine their potential as multi-target compounds. 
Polyphenols have attracted great interest in the field of medicinal chemistry considering 
their reported anti-cancer, anti-inflammatory, anti-oxidant, anti-artherosclerotic properties, 
as well as neuro- and cardio-protective activities. They have been used in prebiotics, 
pharmaceuticals, cosmetics, nutraceuticals and can be extracted from renewable sources 
such as tea leafs, grapes, cocoa seeds and vegetables. Unfortunately, due to their poor 
solubility properties in aqueous media and rapid in vivo metabolic breakdown they are yet 
to be exploited to their full potential.  
The fact that they have not exploited to their full potential yet, make this class of 
phytochemicals interesting to work on, in order to try to solve the discussed issues related 
with them and to expand the project scope further. 
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1.  Introduction to Novel Characterisation Methods in Phytochemicals 
1.1.  History of Chromatography 
Until the 1930’s, adsorption chromatography technique conceived by Tswett (1872-1919), 
was the method commonly used in the analysis of natural extracts. The necessity of having 
a quick method to identify the different components of the mixture under analysis led to 
the invention, by Izmailov and Shraiber in 1938, of an “open” chromatographic method – 
thin layer chromatography (TLC). In 1944 Consden et al. changed the approach to partition 
chromatography using paper,
4
 which from that moment onwards quickly became 
universally used as stationary phase. In 1951, Kirchen and coworkers then introduced a 
fluorescent indicator in the stationary phase, which led to silica gel becoming the new 
preferred stationary phase for TLC. The term thin layer chromatography was created by 
Stahl in 1956 and from there Merck created other kind of thin layers to be used as 
stationary phase, such as aluminium oxide layers. It is at the end of the 1970’s that High 
Performance Thin Layer was commercialised and thus the technique HPTLC started to 
develop from 1987 when Geiss published the manual “Fundamentals of Thin-layer 
Chromatography” and in 1988 the Journal of Planar Chromatography was born. 
1.2.  Chromatography Theoretical Principles 
The first principle underlying chromatography is the “affinity” that the analytes contained 
in the samples move in the system in relation to their affinity towards the mobile and 
stationary phase. Each analyte in a given chromatographic system has a partition 
coefficient K (Equation 1.2.1Equation 1.2.1) that is the ratio between the substance 
concentration in the stationary phase (Cs) and the mobile phase (Cm). 
K= Cs/Cm 
Equation 1.2.1 Calculating the partition coefficient. 
Assuming that the sample provided is soluble in both phases, it would distribute itself 
between the two until reaching the partition equilibrium. Although it can appear that the 
substances move with a different speeds, in reality and in accordance with the solubility of 
each analyte in the mobile phase, some substances will leave the column faster than others 
(most soluble in the eluent are less retained by the stationary phase). This results in shorter 
retention times in High Performance Liquid Chromatography (HPLC) or advancing to 
Formattato: Tipo di carattere: 12
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higher retention factor, Rf,
*
 values on TLC plates. Substances which possess higher 
solubility in the eluent, migrate less often per unit time. 
In thin layer chromatography several factors contribute to determine the Rf such as:  
1. Dimension and model of the chamber 
2. Composition and dimension of the thin layer 
3. Flux direction of the mobile phase 
4. Volume and composition of eluent  
5. Humidity 
6. Sample preparation 
The most relevant mechanism in TLC are the following: 
1.2.1.  Adsorption 
The stationary phase is generally a solid (although it can occasionally be an immobilised 
layer of liquid) and on the surface the analyte interacts either specifically or non-
specifically. The degree of retention depends on the functional groups on each analyte and 
on their steric structure. In “normal phase chromatography” the mobile phase is less polar 
than the stationary. There are two models explaining the mechanism of adsorption 
chromatography. According to the model of Snyder
5
 and Soczewinskithe,
6
 the mobile 
phase competes with the analytes to be retained by the thin layer and the samples displace 
the eluent molecules from the adsorption site on the stationary phase. The model of Scott 
and Kucera,
7
 instead, shift the focus on the interaction between the mobile phase and the 
sample. Both models are valid mainly depending on the composition of the eluent. 
1.2.2.  Partition 
Partition chromatography is based on the different solubility of the substances in the 
samples in two immiscible liquid phases. The stationary liquid phase is immobilised on a 
solid usually porous support, either by absorption or chemical bonds. In the case of using 
polar bonded phase (PBP) such as a diol bonded phase (useful for carbohydrates) the 
mechanism is more complicated and adsorption must be considered as well. 
                                                          
*
 Rf is defined as the difference between the substance position on the TLC plate and the eluent front. 
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1.2.3.  Complex Formation 
The retention principle is another possible mechanism and it is based on the reversible 
formation of coordinated complexes between Lewis acids and bases. This system is 
particularly useful in separating compounds according to the degree of saturated bonds or 
steric effects (chiral compounds can also be separated through complex formation). In this 
type of chromatography, the stationary phase can be impregnated with Lewis acids, such as 
metal ions. Other separation mechanism include:  
 Ion-exchange chromatography 
 Size exclusion chromatography 
 Inclusion chromatography 
1.3.  Thin Layer Chromatography 
1.3.1.  Planar Chromatography 
High Performance Thin Layer Chromatography (HPTLC) is the most recent application of 
planar chromatography and together with column chromatography is a developing field. 
The stationary phase in TLC is a thin layer of solid material immobilised on a plain 
support. 
Is common to place the TLC plate vertically in the TLC closed chamber with the eluent – 
the mobile phase exploits the capillary forces to proceed on the stationary phase and move 
the analytes along it until the plate is removed from the chamber. Capillary forces are weak 
and generated by the eluents decrease in free energy when it starts interacting with the 
porous matrix of the TLC plate. 
The research on TLC has recently produced new technologies (Figure 1.3.1Figure 1.3.1) to 
enable the technique not only to become more reproducible and efficient but also to enable 
quantitative as well as qualitative analysis. The stationary phase, sample deposition, elution 
and detection are critical points and thus several tools to better control these steps have 
been introduced, such as: 
 High performance thin layer plates which have the same characteristic of stationary 
phase of HPLC columns 
 Automated tools for sample deposition 
 New elution systems 
Formattato: Tipo di carattere: 12
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 New techniques for plate analysis, such as densitometry (which also enables 
quantitative analysis)  
The main innovations in terms of elution phase has been AMD (Automated Multiple 
Development) in which the developing chamber is hermetically sealed and the 
environment is controlled under an atmosphere of nitrogen. This is in order to avoid the 
contact with oxygen which could induce the eventual oxidation of the analytes. 
Furthermore, this controlled atmosphere prevents the eventual adsorption of water on the 
thin layer (due to humidity) which could affect the separating ability of the thin layer. This 
technology also enables very high efficiency through the possibility of realising multi-step 
gradients as the one presented in this dissertation. 
Another innovation in modern TLC is given by the forced flow systems that enable the user 
to increase the speed of the flow or to keep it constant.  
OPLC (Over Pressured Layer Chromatography) was introduced in the 1980’s. In this 
technique, an inflatable cushion exerts an adjustable pressure on the TLC plate and a pump 
pushes the mobile phase through the stationary. This enables optimisation of the flow 
speed and removal of the vapour phase from the system. 
HPTLC (High Performance Thin Layer Chromatography) use the pressure to move the 
mobile phase. 
In RPC (Rotation Planar Chromatography), the plate of the stationary phase is round. The 
sample can also be applied inline with the mobile phase besides applying it before the 
development as in the other TLC technique. The development mode can proceed from the 
centre of the plate outwards or from the outside towards the centre.
8
  
Among the forced flow methods PEC (Planar Electro Chromatography) should be 
mentioned as another recent development. It is based on an electroosmotic flow technique 
generated applying an electric field along the chromatographic system. To date, this is used 
only in the characterisation of ideal mixture.
9
 
 7 
 
 
Figure 1.3.1 Planar  Chromatography techniques: TLC (Thin Layer Chromatography); HPTLC (High 
Performance Thin Layer Chromatography); AMD (Automated Multiple Development); RPC (Rotation 
Planar Chromatography); OPLC (Over Pressure Thin Layer Circular Chromatography); PEC (Planar Electro 
Chromatography); RPC (Rotation Planar Chromatography). 
1.3.2.  Chromatographic Parameters 
Some of the fundamental parameters in TLC, beside the retention factor Rf are: 
 Partition coefficient K 
 Retention factor k’ 
 Selectivity factor  
 Separation efficiency 
 Equivalent height of theoretical plates (HETP) 
 Number of theoretical plates (N) 
 Resolution Rs 
 Separation factor (S) 
 Optimisation parameter r 
 Velocity constant k 
The partition coefficient K is a thermodynamic constant which describes the partition 
equilibrium between the mobile phase and the stationary phase of a given analyte A 
(Equation 1.3.1Equation 1.3.1).  
CAPILLARY FLOW FORCED FLOW
TLC HPTLC RPC
OPLC HPTLC
PEC
AMD
Planar 
Chromatography
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K = [Astationary]/[Amobile] 
Equation 1.3.1 Equation for the partition coefficient. 
The retention time k’ is, instead, a kinetic constant, which can be experimentally 
determined. It describes the speed of analytes along a chromatographic system. It is 
defined as the ratio between the time that the solute spends in the mobile phase and the 
time it spends in the stationary phase. It can also be described as the ratio between the 
amounts of solute in the two phases in a precise moment. 
In planar chromatography, to efficiently separate two compounds, the chromatographic 
system must be selective and the compounds need to be retained to a different extent. This 
means that the partition coefficients of the species under analysis have to be sufficiently 
different to result in a selectivity factor higher than 1. 
The selectivity factor α is described as the ratio between the partition coefficient of the two 
species under analysis, and K1 > K2 (Equation 1.3.2Equation 1.3.2). Thus factor  is 
always > 1. 
K1 / K2 
Equation 1.3.2 Equation for the selectivity factor α. 
The separating efficiency in chromatography, also depends on the band widening – the 
wider the band the lower the separation efficiency. Band widening is a phenomenon 
dependent on several factors such as turbulent and molecular diffusion, mass transfer 
effects and retention mechanism of solute that is specific of any system mobile 
phase/solute/stationary phase. 
Each of the effects mentioned above are more or less determined according to the 
characteristic of the chromatographic system. 
The band widening in TLC means an increase of the surface area of the spots, in capillary 
flow conditions the determining factors are connected to the dimensional distribution and 
the average size of the stationary phase. If the particles have an average size around 12 µm 
and are characterised by irregular shape and distribution, the band widening depends on the 
packing quality, related to the turbulent movements and to the mass transfer process that 
are particularly slow. The efficiency in this case is limited by the entity of those effects. 
Formattato: Tipo di carattere: 12
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In stationary phases characterised by smaller particle size, with homogenous distribution 
and spheric shape (high performance thin layers) and short migration distances the 
phenomenon is regulated only by the particle size (optimal particle size are around 5-6 
µm). 
The development of high performance thin layers has enabled thin layer chromatography 
to discuss separation efficiency through the following concepts: HEPT the height of the 
theoretical plates
†
 and the number of theoretical plates (Equation 1.3.3Equation 1.3.3). 
𝐍 =
𝐿
H
 
Equation 1.3.3 Number of theoretical plates as ratio between migration distance of mobile phase L, and 
height of theoretical plates H. 
The theoretical plate number depends on the migration distance of the mobile phase, 
migration distance of solute and on the amplitude of the spot in the direction of the 
development. The packing and the particle size of the stationary phase are critical for band 
broadening during analysis. HEPT can also be seen as the ability of the system to reduce 
band broadening giving narrow bands. 
Fundamental in chromatography is the Van Deemeter Equation (Equation 1.3.4Equation 
1.3.4) as it links the different factors contributing to band broadening. 
𝐇 =
A + B
𝑢 + C
∙ 𝑢 
Equation 1.3.4 Van Deemeter equation. 
In the above equation, H is the height equivalent to a theoretical plate, A is constant term 
dependent on the average particle size and homogeneity of the stationary phase and C is 
constant and is related to longitudinal diffusion (it becomes less relevant with the increase 
of u which is the flow speed in cm/s). The term C instead is related to stationary phase 
mass transfer. 
Given that in HPTLC the particle size is reduced and homogeneity increased compared to a 
conventional TLC plate, the band broadening is reduced (Figure 1.3.2Figure 1.3.2). 
 
                                                          
†
 The height of theoretical plates (HETP) is the ability of a chromatographic system to generate sharp peaks 
Formattato: Tipo di carattere: 12
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Figure 1.3.2 Particle size distribution of the stationary phase in HPTLC and TLC. 
The flow also depends on the stationary phase as well as the characteristic of the mobile 
phase and for this reason, the effect of varying the mobile phase has on the eluent strength 
is studied in the optimisation of the gradient.
10
  
Another parameter to take into account is the resolution Rs between two peaks in the 
chromatogram, which express the separation between two compounds. 
It depends on selectivity factor α, plate number N and k’ capacity factor (Equation 
1.3.5Equation 1.3.5). In general, it is the combination of stationary and mobile phase to 
determine the system resolution. 
𝐑𝒔 =  
1
4⁄ (𝛼 − 1)𝑁
1
2⁄ (𝑘
′
1 + 𝑘′⁄ ) 
Equation 1.3.5 Equation for the resolution Rs. 
1.3.3.  Stationary Phase 
In thin layer chromatography, the stationary phase involves two principles: adsorption and 
partition. In adsorption chromatography, the two main factors determining the activity of 
the stationary phase are the dimension of the area of the activated surface and the surface 
energy for surface unit. The activated area affects the number of adsorption process that 
can happen, all together, and effect of the deactivators on separation. The wider the 
activated area the lower the deactivators. For hydrophilic stationary phase (as for silica gel 
or alumina), the main deactivator is water. 
0 2 4 6 8 10 12 14 16
mm 
TLC 
HPTLC 
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Variation in the activated surface area can affect: 
 Spots dimension 
 Rf values 
 Selectivity 
 Speed migration of eluent front 
 The position relative to multiple fronts that are often formed when the mobile phase 
is constituted of several solvents 
The surface energy affects the strength of the adsorption interaction and it is generally 
assumed that this value is independent from the surface activated area. However, its 
average value for surface unit decreases with increasing the deactivation’s effect. The 
surface energy reaches a stable value when 20 to 50% of the active sites have been 
deactivated. The highest energetic sites are the ones that are deactivated first. The Snyder 
equation relates the activities of stationary phase with characteristics of the analyte and 
solvent.
11
 
It shows that separation efficacy is strongly dependent on: 
 Particle size (µm) 
 Specific surface area (m2/g) 
 Diameter (Ǻ) and pores volume (mL/g) 
The most common adsorbing material used (~80% of cases) is silica gel. Its activated 
surface contains free silanol groups (-Si-OH), which are responsible for the polar 
characteristics of silica layer, and siloxanes groups (-Si-O-Si-). Silica 60 most widely used 
and has an average pore diameter of 60 Å. 
Alumina is another stationary phase commonly used (for acid sensitive compounds). It is 
highly polar and possesses characteristics of both cationic and anionic exchange. 
Stationary phase for partition chromatography are generally modified (Figure 1.3.3Figure 
1.3.3). 
 
    
 
– Si – OH + Cl – Si – R 
CH3
CH3
– Si – O – Si –R 
CH3
CH3
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Figure 1.3.3 Modified stationary phase. 
R can either be an alkyl group, for hydrophobically modified (reversed phase, RP) layers, 
or a substituted alkyl group in the case of hydrophilic thin layers. 
The main alkyl groups in reversed phase are methyl, octyl, dodecyl, octadecyl. The 
hydrophobic character of those phases depends on chain length and on substituent R, the 
longest the less polar, and from the degree of modification of the support (its degree of 
porosity affects the efficiency of substitution). 
The R of the hydrophilic modified thin layers instead are functional groups of different 
polarity, such as the ciano (– C2H4CN), the diol (– C3H6OCH2CHOHCH2OH) and the 
amino groups (– C3H6NH2 ).
12
 
1.4.  Development Solvent  
The characteristics that the development solvent should possess are purity grade, chemical 
stability, low viscosity and easy handling. During the solvent selection process, its strength 
and selectivity must be considered. Solvent strength is defined by three main parameters: 
Hildebrand solubility parameter (δ), power of absorption (ε°), and polarity parameter (P’). 
Hildebrand solubility parameter  constitutes a measure of the degree of molecular 
interaction (Van Der Waals) of the solvent. It represents the density of cohesive energy (c) 
of the solvent and is experimentally obtained through Equation 1.4.1Equation 1.4.1, in 
which H is the vaporisation heat, R the fundamental gas constant, T the boiling point of 
the solvent, Vm the molar volume of the solvent.
13
 
mV
RTΔH
cδ

  
Equation 1.4.1 Hildebrand solubility parameter. 
The power of absorption ε° is the main parameter to consider in adsorption 
chromatography. Snyder defined in Equation 1.4.2Equation 1.4.2, where ESa refers to the 
adsorption energy and As is the molecular surface occupied by the solvent. 
S
Sa
A
E
ε  
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Equation 1.4.2 Equation for the power of absorption factor εo. 
 
In Snyders definition it is assumed that the adsorbent surface is completely occupied with 
solvent (S) and solute (X) and compete with one another according to the equilibrium 
reported in Equation 1.4.3Equation 1.4.3. In Equation 1.4.3Equation 1.4.3, Xa and Sa refer 
to adsorbed molecules of solute and solvent respectively, whereas Xm and Sm refer to 
molecule that have not been adsorbed of solute and solvent respectively.  
n Sa + Xm  Xa + n Sm 
Equation 1.4.3 Adsorption equilibrium. 
The overall retention equation in adsorption chromatography is shown below (Equation 
1.4.4Equation 1.4.4). 
 





  XAX
Vm
Wa
VaRm log  
Equation 1.4.4 Retention equation used in adsorption chromatography. 
The highest interactions between the solute and the adsorbent will result in a higher Rm 
and consequently the constant k’, and lower Rf. The optimal value for k’ is between 2 and 
5 for a bi-component sample and between 0.5 and 20 for a multi-component sample. 
The parameter most widely used in partition chromatography (although it is also used in 
adsorption chromatography) is the polarity parameter P’, experimentally defined as the 
sum of the solubility’s in the solvent under examination of three standard molecules: 
ethylic alcohol (hydrogen donor), dioxane (hydrogen acceptor) and nitromethane (high 
dipole moment). It can range between -2 and 10.2 (which is water polarity). 
It is common practice to use a mixture of solvents in order to adjust the eluent strength for 
specific applications. P’ in a mixture of n components is defined according to Equation 
1.4.5Equation 1.4.5, where Φ is the volume fraction of the compounds and P’i is the mean 
of the polarity of the pure components. 
i
n
i
iP 
1
'  
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Equation 1.4.5 Equation for the mean polarity of pure components. 
It is worth mentioning that the solvent strength depends on the interactions with the 
stationary phase and it increases with its polarity in normal phase chromatography (instead 
in reverse phase it decreases).
14,15
 
Solvent selectivity is determined by molecular interactions and can affect the separating 
efficiency power through polarity and hydrogen bonds. The dispersion forces cause 
fluctuant polarisation constantly moving on the molecular surface, which induce weak 
attractive forces. These are the only components of the molecular interaction of polar 
solvents. The degree of polarity that the temporary dipoles confer to a molecule are related 
to the surface area, thus the bigger the molecule the bigger the interactions. 
Hydrogen bonds can instead be evaluated from the point of view of the interactions 
between electron-donors and electron-acceptors and the reactivity can be described of 
Lewis acid-base. A practical method to represent the total composition is the construction 
of a selectivity triangle.  
Assuming that the Hildebrand value δ is the same for all substances it can also be assumed 
that the solubility characteristic of compounds are determined not from the differences in 
the total value of  but from the contribution related to the three interactions forces that 
compose it. 
T = D + P + H  
Equation 1.4.6 Hildebrand total parameter. 
In Equation 1.4.6Equation 1.4.6, T is the Hildebrand total parameter, D is the dispersion 
component, P polar component and H hydrogen component. Based on this hypothesis, the 
fractional parameters f (Equation 1.4.7Equation 1.4.7) which represent the percentage 
contribution to the three components are reported on the side of a triangle.  
HPD
D
Df



          
HPD
P
Pf



        
HPD
H
Hf



   
Equation 1.4.7 Equations for the three components.  
In this way, it is possible to obtain a selectivity triangle in which each spot of the area 
represent a precise force composition. The Teas triangle (Figure 1.4.1Figure 1.4.1) has a 
theoretical meaning more than a practical one. This because solvents are not all equivalent 
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and so the solvents localisation in the triangle needs to be adjusted with experimental 
results. The triangle is mainly an empirical system. 
 
Figure 1.4.1 Teas triangle. 
Snyder has described a triangular selectivity of solvents as well. Its definition takes into 
account the dipolar interaction, proton-acceptor and proton-donor characteristics, which 
are the parameters that define the polarity parameter P’. Relating to these parameters the 
fractional values x that locate the solvents on the triangle are xd, xa and xn (Equation 
1.4.8Equation 1.4.8). 
P'
donor)-(H solubility ethanol
xd   
P'
acceptor)-(H solubility dioxane
x a   
P'
(dipol) methane-solubility-nitro
x n   
Equation 1.4.8 Synders equations for solvent selectivity. 
DISPERSION
DIPOLE
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Snyder also classified the solvents into eight selectivity classes (Figure 1.4.2Figure 1.4.2). 
TOLUENE
VII
DCM
V
VI
ACN
III
THF
MTBE
I
METHANOL
II
FORMAMIDE
IV
VIII
CHLOROFORM
DIPOLE
xn
H-ACCEPTOR
xa
H-DONOR
xd
 
Figure 1.4.2 Synders classification of solvents. 
 
In order to choose the correct solvent mixture for a separation, the optimal strength is 
detected and subsequently the selectivity of the solvents is considered. 
1.5.  Modern Planar Chromatography 
As previously mentioned, critical steps in Thin Layer Chromatography are: sample 
deposition, elution, derivatisation and detection. With modern planar chromatography 
techniques, these steps are automated which enables optimisation and reproducibility of the 
technique. 
Deposition happens by means of a microsyringe 
which enables the deposition of thin bands which are 
characterised by fixed length and homogenous 
distribution, small amount of sample (1-5 µL), thus 
avoiding overloading of the samples that would 
affect resolution and efficiency. This deposition 
method is a “spray-on” method (the solvent 
completely evaporates during the process) and 
deposition of samples through this automated method 
make the separation efficacy independent from the 
nature of the solvent. This also enables the operator 
Figure 1.5.1 Linomat 5 apparatus. 
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to deposit multiple times along the same band if needed, which is very useful especially if 
the standard’s addition method mast be used. 
Another advantage of using the automated depositor CAMAG Linomat 5 (Figure 1.5.1) is 
the opportunity to start from a single diluted solution and deposit different traces at 
different concentrations, generating multi-level calibrations with a noteworthy time saving. 
The sample deposited through the CAMAG Linomat 5 is nebulised in nitrogen flux. The 
dimension of the band, the volume of the deposited sample, the distance between the 
borders of the plate and the traces can be selected and saved to be reproduced iterative 
times. 
In the elution process, using the Automated Multiple Developer (Figure 1.5.2Figure 1.5.2) 
offers several advantages. The TLC plate is placed in an isolated and closed chamber under 
nitrogen atmosphere. This avoids the condensation of molecules of mobile phase on the 
thin layer affecting the development and it enables the speed of solvent front to become 
independent from the saturation degree of the vapour phase. Operating in controlled 
atmosphere also enables to avoid the deactivation effects exerted by water molecules due 
to humidity and it enables better separation efficiency and higher reproducibility. 
 
Figure 1.5.2 AMD apparatus. 
The main advantage of the AMD is the possibility of ameliorating the resolution through 
band concentration. It enables the automated development following a multi-step gradient, 
in which the solvent strength decrease increasing the number of elution and this decrease is 
combined with an increase of the development distance. 
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The separating ability of this technique is comparable with HPLC methods and separation 
can be refined for each segment of the chromatogram. In planar chromatography it is 
possible to perform mono and bi-dimensional separations. In the first case, the TLC plate is 
developed up to a chosen length for chosen times before the development is stopped and 
solvent removed (the elution process takes place 
several times). This strategy, used in the separation of 
complex matrices, allows the variation of 
experimental parameters such as plate length, mobile 
phase composition in each development and the 
number of developments. 
Weak eluents are necessary to separate substances that 
are less retained whereas components strongly 
retained are separated using stronger eluents. 
An important characteristic of the development process is 
the concentration mechanism of the bands, which increase 
the efficiency of the layer counteracting the diffusion process of the zone. Each time the 
stationary phase compress the spot in the direction of the development, the spots that are 
initially round in shape, gradually turns to oval and eventually turns to be a thin band. This 
happens because the mobile phase firstly interacts with the molecules in the bottom portion 
of the spot, starting moving them, when the eluent front surpass the concentrated spot, this 
migrates and enlarge according the same mechanism common to thin layer 
chromatography. 
The derivatisation of the plates is performed through Chromatogram Immersion Device III 
from CAMAG (Figure 1.5.3) which is an instrument composed of a dipping apparatus 
controlled by a timer which dips the TLC plate in a dipping chamber, enabling an 
homogenous and more reproducible method for derivatisation compared to the spray 
method normally used. 
As a detection system, modern chromatography utilises densitometry scanning, which is a 
technique that enables not only qualitative but also quantitative determination. The 
instrument used is a CAMAG TLC Scanner 3 (Figure 1.5.4Figure 1.5.4) interfaced with 
the software winCATS. According to the signals registered (absorbance or fluorescence) it 
produces a densitogram which is similar to a chromatogram where the peak maximum 
corresponds to the maximal density of the spot on the plate. 
Figure 1.5.3 Immersion device 
III. 
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Figure 1.5.4 Scheme of action mechanism of Scanner 3D. 
Taking into account that samples are adsorbed and dispersed in a solid matrix are able to 
cause light scattering, the instrument generally works by reflectance and not through 
transmittance. The Beer–Lambert linear expression is not usable. Normally the non-linear 
Kulbeka–Munk is used in HPTLC, (Equation 1.5.1Equation 1.5.1) where R   is the 
reflectance of an opaque layer infinitely thick, S is the scattering coefficient, ε is the molar 
adsorption coefficient of analyte and c is the analyte concentration.
16,17 
 
S
C
R
R 



 303.2
2
1
 
Equation 1.5.1 Kulbeka-Munk equation.  
The fluorescence measurement has a low background noise and the signal is a linear 
function of the quantity of sample in a concentration range between two and three orders of 
size. The equation in this case is shown in Equation 1.5.2Equation 1.5.2, where F is 
defined as the intensity of fluorescence,  is the quantum yield, I0 is the excitation source, 
ε is the adsorption coefficient, b is the TLC thickness and c is the sample quantity. 
Cb   oIF  
Formattato: Tipo di carattere: 12
pt, Non Grassetto
Formattato: Tipo di carattere: 12
pt, Non Grassetto
 20 
 
Equation 1.5.2 Equation for fluorescence measurement. 
1.6.  Adansonia Digitata and Prebiotics 
The African Baobab (A. digitata) is a tree that belongs to the Bombacaceae family, gender 
Adansonia, specie Digitata and it spontaneously grows in Africa (one species), in Australia 
(one species) and in Madagascar (six species). The various species differ in the 
morphological characteristics of the flower. The Adansonia digitata fruit pulp is mainly 
used as food due to its high nutritional properties, (energetic value 200 kcal/100g and 
836 kJ/100g). Baobab fruit pulp is 10-45 cm long and 8-15 cm large and it is covered by a 
hard shell (the shell has an ovoid or cylindrical irregular shape). 
It is composed of a ligneous, hard and capsule-shape epicarp and it is also covered by 
green-yellow hair, the endocarp of the fruit constitutes its pulp. 
The endocarp of ripe Baobab fruit appears off-white dehydrate and powdered and it has a 
characteristic acidic taste due to the presence of organic acids such as: citric acid, tartaric 
acid, malic acid and succinic acid. Several parts of it are used daily in the diet of rural 
communities in West Africa as reported by Brady (2011).
18
 To support its use and as proof 
of Baobab relevance as multi-purpose specie, it is worth mentioning that the Forestry 
Department of the Food and Agriculture Organization (FAO) of the UN has reported 
information on A. digitata (FAO 1988).
19
 The main reason for its use as a nutritional 
foodstuff and the relevance for the food industry, resides in its high nutritional values, due 
to the high fibre content, carbohydrates and high antioxidants content.
20,21
  
The fruit pulp is also used in the traditional medicine for its prebiotic activity.
22
 The term 
prebiotic refers to a non-digestible food ingredient able to beneficially affect the host by 
selectively stimulating the growth and/or activity of a limited number of bacteria in the 
colon leading to improvement of the host’s health.23  
Roberfroid
24
 revisited the concept and concluded that prebiotics should be evaluated 
according to three criteria: 
 Non-digestibility,  
 Fermentation by intestinal microflora, 
 Selective stimulation of microflora leading to health benefits. 
 21 
 
Increasing the assumption that Baobab dry pulp leads to an increase of bifidobacteria 
population and lactic bacteria,
25
 the gut microflora is capable of using complex sugars such 
as oligosaccharides
‡
 such as inulins and fructo-oligosaccharides
§
 (Figure 1.6.1) and xylo-
oligosaccharides
**,26
 (Figure 1.6.2) as a source of carbon. 
 
                                          
 
 
                                                          
‡
 Oligosaccharides are carbohydrates with a polymerisation degree ranging from 2 to 10 monomeric units.  
§
 Fructo-oligosaccharides (FOS) are carbohydrates composed of glucose and fructose subunits with a 
polymerisation degree between 3 and 10. 
**
 Xylo-oligosaccharides (XOS) are xylose polymers connected through β-1-4 composing the hemicellulose 
of the plants cell wall. They have a polymerisation degree between 2 and 10 and they are known as 
xylobiose, xylotriose, and so on. Xylobiose (DP = 2) is considered to be a xylo-oligosaccharide in food 
applications. 
Figure 1.6.1 Fructo-oligosaccharide structure. Figure 1.6.2 Xylo-oligosaccharide structure. 
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2.  Novel Characterisation Methods Applied to Phytochemicals: Aims 
and Background 
This first portion of this dissertation focuses on novel characterisation methods applied to 
phytochemicals. In particular, a new approach to bio-polymer (soluble fibre) determination 
was developed by means of High Performance Thin Layer Chromatography (HPTLC). 
Quality control is an important issue in the food industry; however, the lack of rapid and 
efficient analytical methods often hinders adequate and efficient characterisation of 
foodstuffs. The aim of this research was to apply a recently developed precise, reliable and 
green method for the qualitative characterisation of oligosaccharides in complex plant 
matrices, using Adansonia digitata as a case study. 
In the food industry, it is common practice to provide technical data sheets wherein 
information on soluble fibre is given as a difference in mass from other components (fat, 
proteins, etc.). Identifying the presence of certain soluble fibres in foodstuffs is important 
as this is often used to claim prebiotic activity for the product. 
Considering that the expression “soluble fibre” is used to refer to specific structures such 
as inulins, fructo-oligosaccharides, xylo-oligosaccharides etc. it is clear that the 
characterisation by mass difference, alone, cannot be used to support such a claim and 
more specific analytical methods are required. 
To demonstrate the application of our novel high performance thin layer chromatography 
(HPTLC) method, a sample of Adansonia digitata fruit pulp due was used due to its 
previously reported prebiotic activity. High performance liquid chromatography (HPLC) 
was used in order to validate the results before and after hydrolytic treatment, obtained by 
HPTLC. Widely accepted solvent and solvent/ultrasound assisted based extraction methods 
were used or adapted for preparation of the samples. 
In a second study, the samples were submitted to enzymatic digestion and, after 
optimisation of the enzymatic conditions, the polymer obtained was submitted to acid 
hydrolytic treatment in order to specifically identify their constituent components and 
confirm the results previously obtained. 
 23 
 
3.  Results and Discussion 
3.1.  Novel Characterisation Methods in Phytochemical Analysis 
Adansonia digitata dry fruit pulp was chosen as the sample in this study due its previously 
reported prebiotic activity and given the relevance it has in the support of rural community 
in Africa. De Caluwé et al. previously showed that increasing concentrations of baobab dry 
pulp led to an increase in the population of bifido-bacteria and lactic bacteria because the 
gut microflora is able to use complex sugars such as fructo-oligosaccharides and xylo-
oligosaccharides etc. as a source of carbon.
27
 
Furthermore, the Forestry Department of the Food and Agriculture Organization (FAO) of 
the UN has reported information on Adansonia digitata
28
 and the International Centre for 
Research in Agroforestry (ICRAF) continues to promote its use as a multipurpose species. 
It is worth mentioning that materials having low pH, high nutritional value and a relatively 
high content of antioxidants
29
 are often promoted as a nutritious foodstuffs. Up until the 
start of our investigations, no detailed analyses of Adansonia digitata dry fruit pulp were 
reported in the literature – the determination was always performed by mass difference. 
Initially, the aim was to apply our newly developed method to the specific characterisation 
of the oligosaccharides composing the Adansonia digitata dry pulp and to validate the 
method on this case study. 
The detailed analysis presented herein started with the extraction of one gram of accurately 
weighted baobab dried pulp following (or adapting) methods previously reported by Davis 
et al.
30
 and Wei et al.
31
 or Jaime et al.
32
 Samples for analysis were prepared through 
extraction with cold or hot water under magnetic stirring, with or without the assistance of 
ultrasound (Table 3.1.1Table 3.1.1).  
Ultrasound has been reported as one of the most effective tools to extract polysaccharides, 
such as inulins, from various plants tissues,3131 whereas extractions with a mixture of 
methanol/water 62.5% v/v3030  and pre-treatment with acetonitrile are reported to be useful 
for the removal of free sugars.
33
 Extraction with ethanol/water in a ratio of 70/30 was also 
employed.3232 Centrifugations were performed using an ALC 4242 centrifuge at 3500 rpm. 
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Table 3.1.1 List of samples obtained with different extracting procedures. 
Entry Samples Concentration Extraction Further processing 
before supernatant 
collection 
1 A1 0.97 g/100 mL 
distilled water 
12 h stirring 30 minutes 
centrifugation. 
3 A3 1.02 g/100 mL 
distilled water 
15 mL distilled water heated to 60 °C for 30 
minutes, 15 minutes ultrasound at 20 °C 
30 mL distilled water heated to 60 °C for 30 
minutes,15 minutes ultrasound at 20 °C 
30 mL distilled water heated to 60 °C for 30 
minutes, 15 minutes ultrasound at 20 °C 
25 mL distilled water heated to 60 °C for 30 
minutes,15 minutes ultrasound at 20 °C 
After each step 30 
minutes 
centrifugation. 
Supernatant 
collected and 
subsequent draws 
were made on the 
bottom body, 
collecting all 
supernatant 
fractions. 
4 A4 1.00 g /100 mL 
distilled water 
45 minutes ultrasound at 75 °C  
5 PTA5 1.00 g/50 mL 
acetonitrile 
(PTA5) 
Pretreatment: 10 minutes stirring, 
ultrasound assisted extraction after 15 
minutes. 
30 minutes 
centrifugation. 
6 PTA5, 
A5 
1.00 g/50 mL 
acetonitrile 
(PTA5) 
 
Pretreatment: 10 minutes stirring, 
ultrasound assisted extraction after 15 
minutes. 
Vacuum evaporation of the bottom body 
from pretreatment and extraction with 
mixture methanol/water 62.5% under 
stirring. 
Ultrasound extraction at 55 °C for 15 
minutes and vortex agitation every 5 
minutes for 20 seconds. 
Pre-treatment: 30 
minutes 
centrifugation. 
Supernatant 
collected. 
10 minutes 
centrifugation (6000 
rpm). 
7 A6 
EtOH  
1.0 g/250 mL 
ethanol 70%, 
50 mL water 
50 mL ethanol 70% heating 100 °C for 10 
minutes. 30 minutes centrifugation 
collecting supernatant on the bottom body 
extraction with ethanol, repeated 3 times. 
30 minutes 
centrifugation after 
each extraction test. 
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Final extraction with water at 80 °C for 10 
minutes. EtOH fraction collected 
8 A6 H2O 1.0 g/250 mL 
ethanol 70%, 
50 mL water 
50 mL ethanol 70% heating 100 °C for 10 
minutes. 30 minutes centrifugation 
collecting supernatant on the bottom body 
extraction with ethanol, repeated 3 times. 
Final extraction with water at 80 °C for 10 
minutes. 
H2O fraction collected 
30 minutes 
centrifugation after 
each extraction test. 
 
Refractive index (Brix index) was used to determine the dry substance, in the aqueous 
samples, expressed as the calculated % in w/v for the samples which were in aqueous 
solution. The results of analytical determinations for samples A1 (26%), A3 (32%) and A4 
(21%) are reported in (Tab 3.1.2). 
 Table 3.1.2 Brix index for water extract solutions. 
Samples Brix index (% w/v) 
A1 26 
A3 32 
A4 21 
The values obtained from the brix index measurements for samples A1 and A4 correspond 
to the certified concentration of soluble fibres content (Figure 3.1.1Figure 3.1.1), reported 
by the analysis certificate of the baobab dry fruit pulp used to prepare the samples 
presented in this work (Table 3.1.1Table 3.1.1). The value registered was slightly higher 
for sample A3 but it did not exceed the amount of soluble fibre plus sugar content 
according to the analysis certificate (Figure 3.1.1Figure 3.1.1) ranges between 28.3 % and 
31 %. 
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Figure 3.1.1 Dietary fibre and sugar content by analysis certificate of the dry fruit pulp used. 
After this first evaluation and some preliminary trials, samples obtained through the 
extraction procedures described in (Table 3.1.1Table 3.1.1) were loaded onto the diol 
HPTLC plate at volume of 1-5 and 10 µL.  
Figure 3.1.2Figure 3.1.2 shows the developed plate in which solutions of the standards at 
1000 ppm were prepared in a solvent mixture acetone: water in ratio 2:1, applied and 
compared to samples loaded at 1 µL. The samples deposited at 5 and 10 mL were 
“overloaded” and subsequently, the traces showed significant tailing, thus they are not 
presented herein.  
 
Figure 3.1.2 Derivatised plate for visualisation of sugars mixtures extracted. 
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Trace one (Figure 3.1.2Figure 3.1.2) corresponds to Actilight
®
, trace two to a mixture of 
glucose/fructose in a ratio 1:1 respectively and traces three, seven and ten correspond to 
sucrose. Fructose and glucose, when deposited in separate solutions with the method herein 
described, showed the same Rf value of 0.5. Sucrose instead had an Rf of 0.47, but at this 
point of our study, it was not of interest to discriminate between glucose and fructose, 
because the main objective was to detect and separate the oligosaccharide components and 
not the monomeric moieties. 
1 µL of the Actilight
®
 solution was applied at a 2% (w/v) concentration. Actilight
®
 is 
composed of dietary fibre and contains short chain fructo-oligosaccharides (FOS) which is 
a prebiotic ingredient. The standard oligosaccharides observed in trace one, include a range 
that goes from 0.5 µg for sucrose to 8.5 µg for nystose. Actilight standard solution was 
prepared at a different concentrations, in respect to other sugars taking into account that it 
is the result of the enzymatic synthesis process, thus the substances contained in it are not 
at the same concentration. A 2% w/v solution is a concentration we knew would have 
allowed us to visualise sucrose, the lowest concentrate substance in Actilight
®
. Next to the 
standard traces, the samples are shown: A3 in trace four, A4 in trace five, pre-treated A5 in 
trace six, A5 in trace eight, A6 ethanol fraction in trace nine and A6 aqueous in trace 
eleven. The method sensitivity is around 10 ppm for each sugar, as previously reported by 
Vaccari et al.,
34
 the detection limit has previously been extensively explained by our group 
with statistic data.
35
  
The chromatogram (Figure 3.1.2Figure 3.1.2) clearly shows the absence of 
oligosaccharides with higher molecular weight than sucrose and, as can be seen, the 
differences in intensity of the traces suggest that the different extraction methods used here 
affects only the quantitative analysis but not the qualitative extraction. The chromatograms 
as a result after analysis of the traces following acquisition with Camag Visualizer and data 
processing performed using Wincats Comparison Viewer and Camag Scanner III, 
confirmed what was suggested by Figure 3.1.2Figure 3.1.2. The chromatograms 
confirmed, with no doubt, that the different extraction procedures used influence the 
extractive efficiency with respect to glucose, fructose and sucrose. And none of the 
samples showed the presence of any fructo-oligosaccharides with a molecular weight 
higher than sucrose. The densitogram of Actilight
®
 (Figure 3.1.3Figure 3.1.3, a) shows 
every sugar component peak with good resolution whereas the densitogram of traces 5 
(sample A4) (Figure 3.1.3Figure 3.1.3, b) and 9 (sample A6 water fraction) (Figure 
3.1.3Figure 3.1.3, c) further demonstrate that no peaks at a molecular weights higher than 
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sucrose are present. No relevant amount of oligosaccharides (>10 ppm) were detected with 
the extracting procedures mentioned above. 
 
  
 
Figure 3.1.3 Densitograms over Camag Scanner III: a) Actilight
®
 standard; b) trace 5, sample A4; c) trace 
9, sample A6 water fraction. 
It was then considered necessary to compare the results obtained by means of HPTLC 
alongside HPLC analysis, matching all the samples before and after hydrolytic treatment, 
in order to provide further analysis on the free and bonded monosaccharide. This 
investigation was necessary to evaluate the concentrations of glucose and fructose before 
and after acidic treatment and verify the absence or presence of oligo-saccharides of higher 
molecular weight than sucrose through the fructose/glucose calculated ratio. This was used 
to confirm if the monomers derived after hydrolytic treatment were derived solely from the 
breakdown of sucrose (and thus confirm or disprove the results obtained with the 
application of our HPTLC method). In order to confirm the absence of oligosaccharides, as 
revealed by HPTLC analysis, the ratio between fructose and glucose obtained should be 
a) b) 
c) 
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approximately one-to one. A higher ratio would instead signify the presence of 
oligosaccharides and gave a measure of their medium chain length.  
The samples were analysed in triplicate and calibration curves were obtained by injection 
of sugar standards of glucose, fructose and sucrose in concentrations ranging from 0.01% 
to 0.3%. In order to verify the stability of the instrument response for inter-day 
reproducibility one of the standards was daily injected. Table 3.1.3Table 3.1.3 details the 
concentrations of sugars found in the samples together with their standard errors after acid 
hydrolysis of the samples.  
Table 3.1.3 HPLC results pre-hydrolysis and post-hydrolysis with their relative uncertainty. 
 
The variation of the monomeric sugar concentrations, highlighted by the HPLC analysis 
performed, between the samples obtained through different extracting procedures, clearly 
confirmed the different efficiency of the extracting strategies adopted from a quantitative 
evaluation perspective. 
This observation was further confirmed by the data reported in Table 3.1.4Table 3.1.4, the 
calculated fructose/glucose ratio values in the samples (which gives the medium length of 
the oligosaccharides eventually extracted) ranges between 1.1:1 and 1.5:1 supporting once 
more the absence of oligosaccharides with chain length longer than sucrose. These results 
confirmed the outcomes obtained through our HPTLC method and provided evidenced that 
all the fructose obtained after hydrolytic treatment was a result of sucrose breakdown. 
 
 
 
Samples Pre-hydrolysis Post-hydrolysis 
 Sucrose% Glucose% Fructose% Total Glucose % Total Fructose% 
A1 0.1636±0.0268 0.0570±0.0025 0.0469±0.0031 0.1408 ± 0.0029 0.1487±0.0034 
A3 0.1844±0.0268 0.0639±0.0025 0.0717±0.0031 0.1470 ± 0.0026 0.1617±0.0034 
A4 0.1216±0.0260 0.0465±0.0025 0.0380±0.0032 0.1070±0.0026 0.1131±0.0033 
A5  0.7112±0.0270 0.0703±0.0024 0.0148±0.0032 0.2715±0.0027 0.3270±0.0035 
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Table 3.1.4 HPLC results after hydrolysis and average length evaluation of carbohydrates chains. 
Samples Glucose% generated 
by hydrolysis 
Fructose% generated 
by hydrolysis 
Fructose/Glucose Ratio 
A1 0.08 0.10 1.2:1 
A3 0.08 0.09 1.1:1 
A4 0.06 0.07 1.1:1 
A5  0.20 0.31 1.5:1 
 
These preliminary outcomes highlight the need to develop a more accurate and precise 
method to characterise soluble fibre through the direct determination of oligosaccharides 
rather than by difference in mass. The method by mass difference commonly used in the 
food industry does not allow for an accurate attribution of the nutritional value of the 
product, and in this specific case study of Adansonia digitata we demonstrated the that this 
method led to an incorrect attribution of the known prebiotic activity of the baobab dry 
fruit pulp. The absence of oligosaccharides suggested that the prebiotic activity largely 
reported for baobab dry pulp must be attributed to other components rather than of the 
soluble fibre. Perhaps the simple monosaccharides or the flavonoids, which are present in 
high quantity, could account for this nutritional value.
36
 The direct comparison with HPLC 
validated the HPTLC method previously developed in our laboratory (see experimental 
section for method details) and applied to our current case confirmed the method to be 
suitable on real samples from complex matrices. 
Taking into account that the gut microbiota possess hydrolytic enzymes such as β-
fructosyl-furanosidase
††
 and enzymes able to digest and use as carbon source the 
“insoluble fibre” present in plant matrices such as endo-xylanase‡‡ (hemicellulase) it was 
decided to expand the study further by processing samples of Adansonia digitata samples 
with enzymatic treatments that could mimic the activity of gut microbiota. The aim was to 
verify if the lack of detectable oligosaccharides was due to the extracting procedures used. 
We speculated that the high complexity of the cell wall of the Adansonia digitata dry fruit 
pulp may be contributing to the lack of oligosaccharides identified through simple 
extraction. To investigate this, enzymatic treatments of the cell wall were applied and the 
                                                          
††
 Inulinase is able to selectively breakdown terminal fructose units, breaking down inulins, FOS and 
raffinose, they do not attack α-glycosidic bonds or residues different from fructose 
‡‡
 Enzymes that randomly breakdown xylan and xylo-oligosaccharides which are constituents of 
hemicellulose building cell walls in plant 
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samples analysed for its composition to determine the hemicellulose components herein 
present were any of the oligosaccharides preferred by gut microflora as carbon sources, 
such as xylo-oligosaccharides, in order to address the prebiotic activity of the baobab fruit 
pulp with certainty. 
In order to evaluate the optimal enzymatic conditions, several variables were evaluated 
including type of enzymes and associations at different ratios. The optimal conditions for 
processing the bottom bodies were identified as a 1:1 mixture of cellulase and 
hemicellulase. The enzymatic hydrolysis was carried out in a sodium acetate/acetic acid 
buffer solution at pH 5.00 at 37 °C for 12 hours in bath shaker. 
Several conditions to process bottom bodies before digestion with enzymatic treatments 
were also screened. Among those the following method was selected: to one gram of 
accurately weighted Adansonia digitata dried pulp 50 mL of acetonitrile were added. The 
mixture was stirred for ten minutes under mechanical force and 15 minutes with 
ultrasound. The resulting mixture was centrifuged for 30 minutes and the resulting bottom 
body was separated from the supernatant, dried under reduced pressure (Samples 1a-1f) 
and submitted to enzymatic treatment. Samples 1a-1f were compared with samples 2a-2f 
in which Adansonia digitata dry pulp was directly submitted to enzymatic digestion. 
As previously, mentioned pre-treatment with acetonitrile is useful for the removal of free 
sugars
3333
 whereas ultrasound is widely used as an effective method to extract sugars from 
different plants tissues.
3131
 Centrifugations were performed with an ALC 4242 centrifuge 
at 3500 rpm. After processing the samples through enzymatic digestion (Table 3.1.5), AMD-
HPTLC separation was performed in order to evaluate the result of breaking the cell wall 
prior to detection of oligosaccharide content.  
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Table 3.1.5 Cellulase/hemicellulase hydrolytic treatments. 
Entry Samples 
name 
Bottom bodies (mg) Cellulase (mg) Hemicellulase (mg) 
1 
1a 51.6 ∕ 51.8 
2 
1b 49.3 ∕ 24.9 
3 
1c 54.5 ∕ 19.6 
4 
2a 55.7 ∕ 52.9 
5 
2b 58.0 ∕ 25.0 
6 
2c 54.4 ∕ 19.6 
7 1d 52.1 25.0 .24.9 
8 1e 53.2 13.0 12.7 
9 1f 56.7 8.9 8.7 
10 2d 52.8 25.2 25.9 
11 2e 51.2 12.6 12.4 
12 2f 54.9 8.0 7.8 
 
Entries 1 to 6 (samples 1a-1c and 1a-1c) are samples treated just with hemicellulase to 
illustrate the difference between unoptimised and optimised treatment. The results after 
enzymatic digestion of the samples are shown below (Figure 3.1.4Figure 3.1.4). Formattato: Tipo di carattere: 12
pt, Non Grassetto, Non Corsivo
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Figure 3.1.4 AMD-HPTLC separation of baobab pulp fruit samples after enzymatic treatment (cellulase and 
hemicellulase) deposited from 1 to 3 μL. 
The first trace on the HPTLC plate (Figure 3.1.4Figure 3.1.4) corresponds to an Actilight
®
 
solution 2% standard that was deposited at 1 µL.  Traces from 2 to 7 correspond to samples 
1a, 1b, 1c, 2a ,2b and 2c at 1 µL. Traces from 8 to 13 correspond to samples 1d,1e,1f, 2d, 
2e and 2f at 1 µL. Traces from 14 to 17 correspond to samples 1a, 1c, 2a and 2c at 3 µL. 
Finally, traces from 18 to 20 samples 1d, 1e and 2d at 3 µL. Each sample deposited on the 
diol plate showed the presence of saccharides with higher molecular weight than sucrose. It 
should be highlighted that samples deposited from trace 2 to 7, which were treated with 
just hemicellulase, produced more intense spots at lower molecular weights. The samples 
displayed between traces 8 and 13, which are the result of the optimised enzymatic 
treatment with hemicellulase and cellulase in a ratio 1:1, produced instead a larger variety 
of polymers. Samples displayed between traces 8 and 13 also showed a wider range of 
molecular weights suggesting that the association of enzymes was more efficient. In these 
traces polymers with higher molecular weights can be detected in addition to the lower 
molecular weights ones displayed when the samples were treated just with hemicellulase 
traces 2 to 7.   
The linear gradient herein used to develop the TLC plate was performed with decreasing 
polarity on the polar stationary phase diol layer. This was to allow the most polar 
substances to run higher than the heavier ones. In Figure 3.1.5Figure 3.1.5, a densitogram 
of track 11 corresponding to sample 2d, is shown as representative example of the 
excellent separation obtained of the many analytes produced after enzymatic hydrolysis, 
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following application of our HPTLC based method (refer to experimental section for 
details) . 
 
Figure 3.1.5 Densitogram of HPTLC-AMD developed diol layer track 11 sample 2d at 1 µL. 
At this point it was considered necessary to verify if the polymers obtained and evidenced 
on the HPTLC plate contained oligosaccharides of interest to help the gut microflora to 
grow from the lag phase to the exponential phase. To achieve this, it was necessary to 
submit the samples to successive chemical hydrolysis in order to analyse their 
monosaccharide building blocks.  
Our strategy was to perform complete degradation with hydrochloric acid and to evaluate 
techniques to allow for good separation of the analytes. It is common use to utilise HPLC 
as convenient method to analyse non-complex mixtures of saccharides. The results 
obtained from the HPLC analysis and the relevant retention times are presented below 
(Figure 3.1.6Figure 3.1.6). Formattato: Tipo di carattere: 12
pt, Non Grassetto, Non Corsivo
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Figure 3.1.6 HPLC separation of monosaccharides expected from our hydrolysed samples with retention 
times: (1) galacturonic acid 8.7 min; (2) glucose 10.6 min; (3) rhamnose 10.6 min; (4) xylose 11.4 min; (5) 
fructose 12.0 min; (6) arabinose 12.9 min. 
Under these HPLC conditions (experimental section) rhamnose and glucose appeared to 
have the same retention times and xylose, fructose and arabinose were also not well 
resolved (Figure 3.1.6Figure 3.1.6). Considering that HPTLC is quicker, more green and 
reliable as a technique, we decided to investigate if our HPTLC method would allow for 
separation and resolution of the sugars that in the HPLC method, used herein, overlapped. 
Before switching to HPTLC we attempted to investigate if some of the sugars that 
overlapped, might be present after acid hydrolytic treatment but due to the poor resolution 
the results were inconclusive. To highlight this, a chromatogram of one of the samples 
submitted to acid hydrolysis after enzymatic digestion is shown below (Figure 3.1.7Figure 
3.1.7). 
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Figure 3.1.7 A representative HPLC trace after chemical hydrolysis of a typical sample. 
A representative HPLC chromatogram (Figure 3.1.7Figure 3.1.7) of these samples is 
characterised by a high peak of chlorides at 7.5 minutes that interferes with peaks at 8.6 
and 10.6 minutes. However, some useful information was gained from this data such as the 
complete absence of fructose and arabinose in our hydrolysed sample, which was evident 
from the lack of peaks at the corresponding retention times (12.0 and 12.9 minutes, 
respectively). However, this complex pattern (as well as the overlapping peaks of the 
sugars of interest in the HPLC chromatograms) was a driver for us to turn to the HPTLC 
technique, without further attempts to optimise the HPLC method. This also provided an 
opportunity to further evaluate the potential of HPTLC as an efficient separations 
technology. 
In the baobab case study herein presented, determination of standardised sugar Rf values 
was realised using standard mixtures of galacturonic acid, glucose, arabinose, xylose and 
rhamnose. The densitograms of the standardised sugar solutions obtained through HPTLC 
are shown below.  
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Figure 3.1.8 HPTLC densitograms of standards a) Standard Mixture 1:1:1 arabinose, xylose, rhamnose; b) 
Standard mixture 2:1 galacturonic acid, glucose; c) Two dimensional HPTLC standard separation of (1) 
galacturonic acid, (2) fructose, (3) arabinose, (4) xylose, (5) rhamnose; d) Representative sample 2d, after 
acid hydrolysis, diluted 1:10 and deposited 5 μL. 
From Figure 3.1.8Figure 3.1.8 it is evident that rhamnose and glucose show significantly 
different Rf values and are well resolved (rhamnose Rf = 0.69 and glucose Rf = 0.52). The 
excellent resolution is further demonstrated through the comparison of the standards and 
the two dimensional depiction of the HPTLC sample 2d after acid hydrolytic treatment 
(Figure 3.1.8Figure 3.1.8) where galacturonic acid (peak 1) and glucose (peak 2) were 
detected and well separated. Considering that our HPTLC method proved to be effective in 
clearly separating and discriminating between the different sugars, we proceeded with the 
characterisation of the monosaccharides deriving from the acid hydrolysis of all the 
samples described above (Table 3.1.5). 
 b) 
c) d) 
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Separations with representative samples were then performed using the original 
concentrations of standard mixtures. The concentrations of monosaccharides were 
evaluated with a Camag Visualizer by comparison of the spots density.  
 
Figure 3.1.9 HPTLC monosaccharides evaluation. Traces 1-8 standard solutions deposited at increasing 
volumes, traces 9-16 representative samples that had been submitted to enzymatic and subsequently to 
chemical hydrolyses. 
On traces 1, 3, 5 and 7 were deposited arabinose, xylose and rhamnose 1000 ppm standard 
mixture at 4, 8, 5 and 10 µL respectively. On traces 2, 4, 6 and 8 were deposited a 1000 
ppm standard solutions of glucose and galacturonic acid at 4, 8, 5, 10 µL respectively. 
Traces 9 to 16 were samples that had been submitted to enzymatic treatment with cellulase 
and hemicellulase at known concentrations (optimised conditions Table 3.1.5). No other 
monosaccharides, besides glucuronic acid and glucose, were detected. 
Processing the Visualizer evaluation (Figure 3.1.9Figure 3.1.9) gave the concentrations of 
galacturonic acid and glucose found after chemical degradation with hydrochloric acid and 
their ratio (galacturonic acid was present in 0.7% and glucose in 10.0% so the ratio 
between the two was 14.0). 
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4.  Conclusions 
The work presented here, on the characterisation of Adansonia digitata dry pulp, extended 
our groups previous research through the application of a modern instrumental HPTLC 
technique that provided a determination of different oligosaccharides at the nanogram 
level. It also confirmed that this technique allowed for a rapid screening of sugar-
containing samples simultaneously (16 traces were deposited simultaneously in this work, 
Figure 3.1.9Figure 3.1.9, but up to 24 traces can be run), with minimal solvent waste 
produced in the development process. The method herein described, not only was validated 
on a real case study, proving to be as efficient as the most common HPLC method in the 
first part of the study, but has also proven to be equally efficient and reliable in separating 
and discriminating between monosaccharides in a complex mixture, without need of 
further optimisation. The HPTLC method developed through this research, along with 
Isocratic and Automated Multiple Development (AMD), was used as an alternative to 
common and widespread analytical methods. It was used to rapidly analyse complex 
mixtures containing a broad variety of monosaccharides thus allowing to save the time that 
would have been instead necessary to adapt the HPLC method to the case study. 
Furthermore, and very noteworthy, this study represents a specific and accurate analysis of 
the soluble and insoluble fibre components compared to what previously done. The results 
obtained, demonstrated the absence of inulin and FOS which are the soluble fibre to which 
is usually accredited the prebiotic power of baobab, and highlighted that the calculation of 
soluble fibre by mass difference from the other nutrients is not sufficient.  For this reason a 
direct determination of the oligosaccharides content should be required and performed in 
order to accurately attribute the nutritional value of a food product, especially taking into 
account that this constitutes a very important issue for food industry. 
It should the responsibility of the food industry to guarantee the values of nutrient 
substances, in particularly those that selectively stimulate growth and/or biological activity 
of protective microflora of the human intestinal tract and contributing, if consumed 
systematically to the maintenance of its normal content and biological activity. It was 
demonstrated that our HPTLC method is suitable for this purpose and enabled a rapid and 
simultaneous screening of food extracts and was equally efficient in the separation of sugar 
polymers and monosaccharides and could be adopted as more accurate and informative 
characterisation of food products.  
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From this study, baobab fruit pulp was confirmed as a good source of carbohydrates, useful 
for nutrition; however, it was impossible to detect significant amounts of oligosaccharides 
responsible of the well-known prebiotic activity in the soluble fibre fraction.  
Furthermore, after many different enzymatic treatments were performed on dry pulp 
samples in order to identify the optimal processing conditions in terms of degradation 
product type and numbers an enzymatic treatment with the contemporary contribution of 
cellulase and hemicellulase enzymes were selected. The aim of these enzymatic digestions 
was to evaluate if, for some unclear reason, in our case, the commonly used extraction 
procedures failed to extract the soluble fibre and also to evaluate the composition of the 
dry pulp cell wall. Characterising the components of the cell wall such hemicellulose, 
could have helped to justify the prebiotic activity reported for baobab dried pulp after the 
presence of any soluble fibres such as inulins and FOS were excluded. 
The results obtained by processing the samples with enzymatic digestions and 
subsequently submitting them to acidic hydrolysis to characterise the monomeric building 
blocks of the polymers detected (Figure 3.1.4Figure 3.1.4) unequivocally excluded the 
presence of fructo-oligosaccharides (FOS). The oligomeric products from cell wall 
degradation were found to be composed of 10% glucose and 0.7% of galacturonic acid 
expressed over 100 grams of dry pulp, confirming once more that the method by mass 
difference (commonly used to attribute the nutritional value of the food product) does not 
lead to accurate attribution. No xylo-oligosaccharides attached to the cell wall were detect 
either along with no other oligomers normally preferred by the gut microflora.  
From our studies, we believe that the components at the base of the widely reported 
prebiotic activity of Adansonia digitata may be either the monosaccharides largely present 
(i.e., sucrose, glucose, and fructose) or the flavonoids.
3636
 These components may 
influence the microflora and have an impact on colonic health,
37
 which can bring the 
microorganism into an exponential phase of growth. 
To further confirm these hypotheses for the Adansonia digitata fruit pulp, different 
samples of dry pulp could be processed (following the protocols herein described) and 
analysed through our HPTLC method, alongside fresh baobab fruit pulp. The analysis on 
the effect of different processing methods on the content of oligosaccharides in Adansonia 
digitata dry pulp could, in the future, also provide further evidence for the prebiotic 
activity. 
Formattato: Tipo di carattere: 12
pt, Non Grassetto, Non Corsivo
Formattato: Rimando nota di
chiusura, Motivo: Trasparente
 41 
 
5.  Experimental Protocols 
All reagents and solvents were of analytical grade. Acetone, acetonitrile, ortho-phosphoric 
acid, acetic acid, ethanol, methanol, and hydrochloric acid were purchased from Merck 
(Darmstadt, Germany). The Adansonia digitata dried fruit pulp used to prepare the samples 
analysed in this study was obtained from Baobab Fruit Company Senegal (Thies, Senegal). 
The water used for chromatography, standards, and sample solutions was of ultrapure 
grade. D-(+)-Glucose (lot no. 9434820009 J. T. Baker Deventer, Holland), D-(+)-fructose 
(Carlo Erba reagent RP), sucrose (J. T. Baker Deventer, Holland), and pure fructo-
oligosaccharides (FOS: 1-kestose 33.1%, nystose 42.5%, fructosilnystose 11.3%, and 
sucrose 2.4%, Actilight
®
 C.F.M. Milano). Standards were dissolved in a mixture of 
water/acetone (2:1) to give Actilight
®
 solution 2 % w/v, D-(+)-glucose, D-(+)-fructose, 
sucrose, xylose, rhamnose, arabinose and galacturonic acid 1,000 ppm stock solutions for 
HPTLC applications. Dilution of the stock solutions with water yielded the working 
solutions applied at concentrations of 100 ppm only for daily use and only for Rf 
evaluation. Standard stock solutions can be stored at –18 °C and used for at least one 
month. For HPLC analysis, the standards were dissolved in ultrapure water to give 5% 
standard stock solutions. Subsequently, samples were diluted with distilled water between 
0.01 and 0.3 % (working solutions) for calibration curves in HPLC determinations. 
5.1.  Hydrolytic Treatment of Samples  
5.1.1.  Acid Hydrolysis 
The hydrolytic treatment procedure was optimised in our laboratories and has been 
successfully applied to FOS extracts (Icumsa Lane-Eynon method 1994).
38
 To each 
sample, HCl 6.3 M was added and the mixture was kept at 60 °C for 15 minutes. Samples 
were then cooled down to 0 °C in an ice bath and subjected to quantitative determinations. 
It is important to mention that the pH of each solution needed to be adjusted to neutral 
value after hydrolytic treatment, in order to avoid degradation of the silica thin layer of the 
plate. 
5.1.2.  Enzymatic Hydrolysis 
After several experimental trials, the optimal conditions to process our dry pulp were 
identified in a mixture with a 1:1 ratio of cellulase and hemicellulase. The enzymatic 
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hydrolysis was carried out in a sodium acetate/acetic acid buffer solution at pH 5.00 at 
37 °C for 12 hours in bath shaker. 
5.1.3.  HPTLC Protocols 
HPTLC gradient (Table 5.1.1Table 5.1.1) was performed with decreasing polarity in 
controlled humidity and temperature conditions. A 15-step gradient was performed using a 
Camag AMD apparatus following the conditions described below. The mixing of the 
eluent solutions (acetone/acetonitrile (1:1) and ultrapure water) was fully automated in the 
Camag AMD2 apparatus, until 70 mm of solvent front. 
Table 5.1.1 Elution conditions AMD2 with four solvent mixtures for 15 gradient steps. Solution Ace/ACN 
was in a ratio 1:1 (Ace = acetone, ACN = acetonitrile). 
Step (Ace/ACN)/H2O 
(75/25) 
(Ace/ACN)/H2O 
 (80/20) 
(Ace/ACN)/H2O 
 (85/15) 
(Ace/ACN)/H2O 
 (85/15) 
Eluent front (mm) 
1 100.0 0.0 0.0 0.0 12.4 
2 81.4 18.6 0.0 0.0 16.5 
3 52.6 47.4 0.0 0.0 20.0 
4 34.0 66.0 0.0 0.0 24.9 
5 22.0 78.0 0.0 0.0 29.1 
6 14.2 67.2 18.6 0.0 32.8 
7 9.2 43.4 47.4 0.0 36.3 
8 5.9 28.1 66.0 0.0 41.1 
9 3.8 18.1 78.1 0.0 45.3 
10 2.5 11.7 85.8 0.0 48.3 
11 1.6 7.6 72.2 18.6 51.1 
12 1.0 4.9 46.7 47.4 52.9 
13 0.7 3.2 30.1 66.0 56.1 
14 0.4 2.0 19.5 78.1 59.2 
15 0.3 1.3 12.6 85.8 64.9 
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The gradient shape (Figure 5.1.1Figure 5.1.1) shown below was performed on 20 cm × 10 
cm diol HPTLC plates (Merck) for oligosaccharides samples detection. Instead, separation 
was performed on silica plates 10 × 20 mm for monosaccharides detection after acid 
hydrolysis treatment. 
Samples were loaded on the appropriate HPTLC plate by means of Linomat V Camag as 
4 mm bands, 12 mm from the side edge and 10 mm from the bottom edge. The delivery 
rate for deposition was 15 μL/s. Runs were performed with 80 mm of eluent front 
(acetonitrile/acetic acid/water 63/33/5 mL) in a twin through-chamber without any 
precondition time. 
 
Figure 5.1.1 Profile of fifteen-step AMD linear gradient for oligosaccharides separation. 
5.1.4.  Derivatisation and Scanning 
The HPTLC plates loaded with samples A1-A6 and B, after development, were derivatised 
with 4-aminobenzoic acid (2 g), anhydrous acetic acid (36 mL), water (40 mL), 85% 
phosphoric acid (2 mL) and acetone (120 mL)
39
 by means of Camag dipping apparatus 
with an immersion time of 2 seconds. This derivatisation was made with 4-aminobenzoic 
acid to display only the sugars. This solution can be kept for 2 weeks at –18 °C with no 
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loss in reactivity. The derivatised layers were dried at 115 °C for 15 minutes in a 
convection heater.  
HPTLC plates loaded with samples 1a-1f and 2a-2f were derivatised with 10% sulfuric 
acid in ethanol3939 by means of Camag dipping apparatus and an immersion time of 9 
seconds, subsequently, the immersion plates were dried at 100 °C for 3 minutes. The 
solution can be stored for 2 weeks at –18 °C without deterioration. 
The derivatised layers were scanned with a Camag Scanner III interfaced with a personal 
computer using WinCats version 1.2.6. evaluation software, in fluorescence with a Hg 
lamp at 366 nm for samples and 400 nm. Layer images were acquired with Camag 
Visualizer and the results from different plates were compared using Wincats Comparison 
Viewer. The silica plates, for isocratic monosaccharides separation, were also scanned at 
400 nm. 
HPLC was used for quantification of glucose and fructose in the same samples before and 
after acid hydrolysis. An Aminex HPX-87H (Biorad
®
) column and a refraction index 
detector was used in HPLC-IE. 
For HPLC analysis, each solution was filtered through a 0.45 µm filter before injection. All 
stock solutions of sugars were prepared at 5% w/v (50000 ppm) and were stored in the 
dark at –18 °C and used within one week. External calibration curves were obtained using 
ultrapure water and preparing working solutions which were plotted as standard peak areas 
against relative concentrations (fig. 2). Calibration curves (Figure 5.1.2Figure 5.1.2) 
revealed good linearity with correlation coefficient R
2
 values between 0.9993-0.9999 
(below) and were obtained utilising three replicates of seven solutions between 0.01-0.3% 
w/v (100-3000 ppm). Samples were diluted with pure water or injected as prepared. 
Table 5.1.2 Linear regression parameters for calibration curves of targeted sugars. 
Standards Slope Intercept Correlation (R
2
) 
Sucrose 5889394 2577 0.9999 
Glucose 6386612 -49006 0.9998 
Fructose 5288958 40593 0.9993 
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Figure 5.1.2 Calibration curves for sucrose, glucose and fructose in pure water and confidence limits at 
95%. 
Calibration curves for xylose, rhamnose, arabinose and galacturonic acid are not shown 
considering that we moved away from HPLC, when all those sugars needed to be 
characterised at the same time, for the characterisation of such complex mixtures.   
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6.  Introduction 
6.1.  Polyphenols 
Polyphenols are secondary metabolites of higher plants and are among the most abundant 
and ubiquitous. There are obtained from renewable sources including plant materials
40
 
(blueberries, apples, grapes, cocoa beans, tea leaves etc.) and consequently widely 
consumed in the human diet. This has contributed to their widespread use in 
pharmaceuticals, cosmeceuticals and nutraceuticals.
41
 
They are from a class of heterogeneous molecules exerting different functions in plants 
such as mechanical supports. They are from a family of lignins and are a class of 
biopolymers constituted by random polymerisation of units of phenolic alcohols (e.g. p-
cumaryl alcohol, sinapyl alcohol and coniferyl alcohol), and those from the family of 
phyto-alexins offer protection against animals and pathogens. Furthermore, they can act as 
pollinator attractors and considering their antioxidant activity, are able to offer protection 
against UV-radiation, such as polyphenols from the class of flavonoids (Figure 6.1.1Figure 
6.1.1). 
 
Figure 6.1.1 Selected examples from the families of polyphenols. 
The antioxidant properties of polyphenols is related to the number of hydroxyl groups it 
possesses and their position in the aromatic ring. Previous reports have shown that they can 
exert beneficial effects on a wide range of diseases from cancer to infections, 
inflammation, allergic reactions, hepato-protection etc. Yet they are often characterised as 
having poor solubility issues and rapid metabolic degradation. They are metabolised in the 
human body through methylation, sulfonation and glucuronidation pathways.
42
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6.2.  Antioxidants 
The term “antioxidant” has a number of different definitions depending of the scientific 
field being considered. In general, an antioxidant may be a synthetic or natural compound 
(or mixture of compounds) capable of scavenging free radicals and inhibiting reactions 
promoted by these highly reactive species. As well as preserving the health of animal 
tissues, minimising the reactions of free radicals impacts materials such as plastics and 
rubbers and foodstuffs.
43
 
They can belong to different classes, each with different mechanistic actions, and can be 
metal chelators, oxidative enzyme inhibitors, antioxidant enzyme cofactors or free radical 
chain inhibitors. Free radicals are physiologically produced in the biological systems and 
they exert a dual role as both beneficial and harmful species. They can be divided in two 
main classes: reactive oxygen species (ROS) and reactive nitrogen species (RNS), which 
include also some non-radical species. From the reactive oxygen species include: 
superoxide anion radical (O2
–
·), elemental oxygen (O2), hydroxyl radical (OH·), hydrogen 
peroxide (H2O2) and lipid peroxyl radical (LOO·). Reactive nitrogen species include: nitric 
oxide radical (NO·) and nitrogen dioxide radical (NO2·).  
They are generated during cell metabolic activity through the regulation of enzymes such 
as NADH/NADPH or NOS (NO synthase). Under physiological conditions, they are 
present in low concentrations and activate signalling pathways to protect from e.g. 
infectious agents, but if homeostasis is disturbed and their concentration increases they can 
cause damage. High concentrations of ROS and RNS damage cell structures such as 
proteins, lipids, membranes and DNA. It is interesting to note that several ROS-mediated 
actions that happen under normal physiological conditions are actually to protect cells 
against ROS-induced oxidative stress and to maintain or re-establish the “redox balance”. 
In fact, ROS are involved in the signalling pathway that contributes to maintain the 
oncogenic phenotype but they can also induce senescence and apoptosis acting as anti-
tumorigenic agents.
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More commonly, free radical species have been reported to be involved in inflammation 
processes, aging, cardiovascular disease, atherosclerosis, rheumatoid arthritis, 
hypertension, ischemia/reperfusion injury, cancer, diabetes mellitus and neurodegenerative 
diseases (e.g. Alzheimer’s and Parkinson’s). The mechanism of radical-mediated reactions 
 48 
 
can be summarised as shown in (Scheme 6.2.1Scheme 6.2.1) where the cascade of radical 
reactions is shown for the lipid peroxidation. 
 
Scheme 6.2.1 Mechanism of radical oxidation process. LH = substrate, AH = antioxidant. 
Based on the above mechanism, it can be assumed that one mole of antioxidant scavenges 
two radicals and that molecular oxygen is present in a large excess. Antioxidants can be 
divided in two main classes: preventive antioxidants and chain breaking antioxidants.  
6.2.1.  Preventive Antioxidants  
Preventive antioxidants intercept the oxidising species before they can do the damage. 
They include metal deactivating compounds such as ethylenediaminetetraacetic acid 
(EDTA), diethylenetriaminepentaacetic acid (DETAPAC), polyphenols, transferrin, ferritin 
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and enzyme scavenging hydroperoxides e.g. glutathione peroxidase (GSH), superoxide 
dismutase (SOD), catalase and species able to quench singlet oxygen atoms such as 
β-carotene etc. 
Metals are able to promote the oxidation processes through generating hydroxyl radicals 
(OH·) which act as catalysts reactions such as the Fenton and the Haber–Weiss reaction 
(Scheme 6.2.2Scheme 6.2.2). 
 
Scheme 6.2.2 Fenton and the Haber–Weiss reaction. 
Iron and copper are present in biological tissues and are produced in the normal turnover of 
cells or in tissues lesions. They need to be quickly scavenged to avoid oxidative stress. The 
micro-organism herein prepossess plasmatic proteins such as transferrin, lactoferrin and 
ceruloplasmin that act as metal chelators and transporters in order to avoid oxidation stress 
due to those metals.  
 
Scheme 6.2.3 Intracellular scavenging enzymes. 
Enzymes that scavenge hydroperoxide are endogenous antioxidants resources.
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Superoxide dismuthase (SOD) accelerates the dismutation of superoxide anions into water 
and elemental oxygen whereas catalase converts hydrogen peroxide molecules also into 
water and oxygen. Glutathione peroxidase (GSH) is a tripeptide constituted of glycine, 
cysteine and glutamic acid that contains selenium. It scavenges hydrogen peroxide by 
converting it into water (Scheme 6.2.3Scheme 6.2.3). 
6.2.2.  Chain Breaking Antioxidants 
This type of antioxidant act on the chain, after the oxidation process has already begun, by 
retarding or stopping the oxidative process, intercepting the chain-carrying radicals such as 
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the peroxide radical ROO·. The ability to react with alkoxyl radicals can be significant to 
prevent the formation of cytotoxic agents.
46
 A characteristic property of an efficient chain 
breaker is the ability to react with the radicals more quickly than their substrate and that the 
generated antioxidant radical A· is stable enough to not react further (or react very slowly) 
with the substrate. Polyphenols, discussed later, has this characteristic. This category of 
antioxidants can be divided in two sub-classes: donor chain breaking antioxidants e.g. 
vitamin E (α-tocopherol), vitamin C (L-ascorbic acid) and β-carotene and sacrificial chain 
breaking antioxidants such as NO (nitric oxide). 
Donor chain breaking antioxidants donate hydrogen to form a radical on the phenolic 
hydroxyl group which is more stable due to resonance (Scheme 6.2.4Scheme 6.2.4). 
Polyphenols belongs to that class of antioxidants and structures such as ascorbic acid, are 
hydrosoluble donor chain braking antioxidants or biophenols as α-tocopherol are instead 
liposoluble donor chain breaking antioxidants. 
 
Scheme 6.2.4 Donor chain breaking antioxidant, α-tocopherol, radical scavenging mechanism. 
The vitamin E family includes both tocopherol and tocotrienol which are characterised by 
a chroman heterocycle that can differ in the number and position of methyl groups, and an 
hydrophobic phytol terpenoid chain. This chain is fully saturated in the case of tocopherol 
and a triene in the tocotrienols. 
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Other donor chain breaking antioxidants belonging from the polyphenol family include 
L-ascorbic acid, quercitin, gallic acid and caffeic acid (Figure 6.2.1Figure 6.2.1). 
Depending on their reduction potential, they can act in a synergistic way and recycle each 
other as is the case for L-ascorbate (+282 mV) which is able to regenerate α-tocopherol 
(+480 mV).
47
 
 
Figure 6.2.1 Examples of donor-breaking chain antioxidants. 
Antioxidants such as nitric oxide (NO) are sacrificial chain breaking antioxidants as it acts 
as a chain terminator reacting with chain-carrying peroxy radical (Scheme 6.2.5Scheme 
6.2.5).
48
 
 
Scheme 6.2.5 Nitric oxide acting as chain terminator. 
6.2.3.  Antioxidants Assays 
Considering that the action mechanism differs with each antioxidant active, several types 
of assay have been developed. It is important to note that “the antioxidant activity 
measured by an individual assay reflects only the chemical reactivity under the specific 
conditions applied in that assay, thus is inappropriate and misleading to generalize the data 
as indicators of total antioxidant activity”.1  
The assays can be divided in two major categories depending on the chemical reactions 
involved: single electron transfer (ET) and hydrogen atom transfer (HAT) assays. 
HAT-based assays monitor competitive reaction kinetics, and the kinetic curves provide 
the data necessary for quantitative analysis. They are generally composed of a synthetic 
free radical generator, an antioxidant and an oxidisable molecular probe. ET instead 
involves a redox reaction with the oxidant, which also constitutes the probe, to monitor the 
reaction. Both classes of antioxidant assays measure the scavenging capacity of an 
antioxidant rather than its preventive ability. 
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ET methods includes Folin–Ciocalteu (FCR), ferric iron reducing antioxidant power 
(FRAP) assay, the Trolox equivalent antioxidant capacity (TEAC), N,N-dimethyl-p-
phenylendiamine (DMPD) assay and the Cu(II) reduction capacity assay.  
They are based on the assumption that the antioxidant capacity is equal to the reducing 
capacity.
49
 They do not involve any oxygen-based radicals in the assay and there are no 
competitive reactions involved. In these type of assay, the oxidant also act as probe and it 
extracts electrons from the antioxidant. Analysis is determined by a change in colour (the 
reaction ends when the colour change stops). The change in absorbance (A) registered is 
plotted against the antioxidant concentration to give a linear curve. 
HAT methods includes oxygen radical capacity methods (ORAC), total radical trapping 
antioxidant parameter (TRAP), inhibited oxygen uptake (IOU), inhibition of LDL 
oxidation, inhibition of linoleic acid oxidation and Crocin bleaching assay. These assays 
are more relevant to the chain breaking antioxidant activity, considering that they quantify 
the hydrogen atom donating power of the antioxidant under analysis, which is a key step in 
the radical chain reaction. 
There are also other types of antioxidant assays that do not fall into one of the categories 
mentioned above such as H2O2 scavenging capacity assay, hydroxyl radical (OH·) 
scavenging assay, singlet oxygen scavenging capacity and peroxynitrite scavenging 
capacity assay. 
6.3.  Multi-Target Approach in Drug Design 
The heterogeneous class of polyphenols is known for its wide range of activity, they have 
been reported to prevent and counteract numerous diseases, as mentioned before, but the 
most interesting characteristic of those molecules and the reason underlying their recent 
rediscovery by medicinal chemists worldwide is that they are natural multi-target actives. 
One of those natural occurring molecules can efficiently target multiple pathways, leading 
to no off targets. A better understanding of the action mechanism of those multi-target 
phytochemicals, and the optimization of these natural occurring lead compounds can open 
up to new strategies in medicinal chemistry. Two famous examples of natural multi-target 
polyphenols are curcumin that has been reported to inhibit COX-1, 5-LO,
50
 NF-kb,
51
 
melanoma and other cancer cell line,
52
 and caffeic acid which has been demonstrated to be 
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hepatoprotective, act as 5-LO
53
 inhibitor, be efficient in inhibiting several kinds of tumours 
e.g. colon and fibrosarcoma,
54
 and reducing aflatoxin
§§
 production.
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Over the last two years the scientific community has begun to realise the advantages of a 
multi-target drug design compared to the traditional site-specific approach, going upstream 
compared to what was done over the past few decades from the medicinal chemistry 
community. The benefits from such an approach include not only a better balance between 
activity and side effects but also a reduction in cost and time to develop and reach the 
market.5656 
Several of the main advantages of poly-pharmacology over the site-specific target 
approach and combinatorial therapies include:
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1. Superior efficacy against advanced stage diseases compared to single target specific 
molecules, due to minimisation of efficiency of the body compensatory effect. 
2. More predictable pharmacokinetic profile compared to multiple drug administration 
in combinatorial therapies. 
3. Minor chances to develop target-based resistance. 
4. Lower risk of side effects compared to combinatorial therapy. 
5. More facile administration - simultaneous presence of the multi-target active 
principle where it is required. 
6. A multi-target active could potentially be easier to develop as the regulatory 
requirements to demonstrate safety and activity, compared to a combinatorial 
treatments, would be less arduous. 
It is possible to think of the multi-target concept as being dualistic. A multi-target drug can 
be designed to act on different locations of the same pathways. This was demonstrated by 
Werz and co-workers in 2014 through the development of new prenylated pyrazol-
curcuminoids as anti-inflammatory analogues capable of targeting 5-lipoxygenase (5-LO) 
alongside with microsomal prostaglandin E synthase (mPGES-1).
57
  
Alternatively, it is possible to think of multi-target strategies as a way to design molecules 
that can act on targets that are unrelated (or distantly related). This creates the opportunity 
to target different pathologies, as the case of methotrexate which has activity against target 
relating to cancer, psoriasis and rheumatoid arthritis. 
                                                          
§§
 Aflatoxin is a myco-toxin produced by Aspergillus Flavus and Aspergillus Parssiticus, fungi phatogenic 
fungi which attack trees and grains. 
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A major challenge in poly-pharmacology is to avoid excessive promiscuity in order to 
avoid side effects due to the interaction with anti-targets. For this reason, particular care 
should be addressed to try and optimise, during the design stage, the profiles of activity 
towards the selected targets in order to minimise the likelihood of side effects. 
In practice, multi-target structure–activity relationship (SAR) studies is therefore a primary 
necessity but it is still considered far from routine, mostly due to the fact that poly-
pharmacology, and the rational design of multi-target actives in itself, it is still in its 
infancy.  
Presented in this thesis, a library of compounds was designed with specific features that 
could lead to interaction with multiple targets. Three main targets were chosen for the 
compounds presented in this work, of which two are involved in human inflammation 
processes. The first selected target was 5-lipoxygenase, a crucial enzyme of the 
arachidonic acid (AA) cascade and involved in the first two catalytic reactions of the 
biosynthesis of leukotrienes (LTs).
58
 It has been established that the role of LTs as 
inflammatory mediators play a pathophysiological role in different diseases (asthma, 
allergic rhinitis, cardiovascular diseases and certain types of cancer).
59
 The second target 
was transcription factor Nrf2, which is responsible of recognising the antioxidant response 
element (ARE) regulating a number of cytoprotective genes. The significance of the Nrf2-
regulated cytoprotective adaptive response has been demonstrated in animal models of 
electrophilic and oxidative toxicity, carcinogenesis, inflammation-associated 
carcinogenesis, and acute inflammation.
60
 (This target will not be discuss in the present 
work, giving that the molecules herein presented are still under investigation for this 
target). 
The final target selected was 14 α-lanosterol demethylase a cytochrome P450 enzyme 
common to all dermatophytes. 14 α-Lanosterol demethylase is the target enzyme of azoles 
such as ketoconazole, miconazole and fluconazole. It is an enzyme involved in the 
synthesis of ergosterol, an important component of the dermatophytes cell wall. 
Considering that the mortality associated with dermatophytosis as reported by the World 
Health Organization (WHO) in sub-Saharan African region in 2001 was found to be 
similar to that attributed to gout, endocrine disease, panic disorders and war-related injuries 
and considering the increasing number of resistant strains, research in this area is still 
topical. 
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It is also noteworthy that dermatophytosis caused a higher mortality risk in patients 
affected by HIV. Furthermore, taking into account that mycosis is commonly associated 
with inflammation, the focus was directed towards multi-target actives that are able to act 
both on the inflammation process and dermatophyte infections. 
6.4.  Arachidonic Acid Pathway   
Arachidonic acid (ARA) is a fatty acid stored in membrane phospholipids, especially in 
phosphatidylcholine,
61
 and is released from the phospholipids through the action of 
phospholipase A2  where it is subsequently utilised by three major enzymes: 
cyclooxygenase (COX), lipoxygenases (5, 12 and 15-LO) and the cytochrome P450 
monooxygenase. 
Among the lipid mediators generated by those pathways is possible to discriminate two 
main classes of mediators: pro-inflammatory/non-resolving and anti-inflammatory/ pro-
resolving (Scheme 6.4.1Scheme 6.4.1). 
 
Scheme 6.4.1 Summary of arachidonic acid pathways: pro-resolving/anti-inflammatory mediators (blue) and 
pro-inflammatory/non-resolving (red). 
A significant challenge in targeting the inflammation cascade is to decrease the formation 
of pro-inflammatory lipids mediators, such as PGE2 and LTB4, without affecting the level 
of the anti-inflammatory ones, such as PGD2, lipoxins (LXs) or epoxy-eicosa-tetraenoic-
acids (EETs). This can be realised by targeting the enzymes isoforms responsible for the 
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production of pro-inflammatory mediators. The class of non-steroidal anti-inflammatory 
drugs known as Coxib (e.g. Etericoxib, Celecoxib), for example, specifically target the 
isoform COX-2 which is the one induced during inflammation processes, responsible for 
the production of inflammatory prostacyclin. The market has been saturated over the years 
with drugs targeting COX on the arachidonic acid pathway. Another important target is 
represented by 5-lipoxygenase (5-LO) but despite efforts to find drug candidates targeting 
5-LO, the only inhibitor to reach the market so far has been zileuton.
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Although 12- and 15-lipoxygenase have been shown to be involved in inflammation 
processes, they are also responsible of the synthesis of resolving mediators such as 
lipoxins. For this reason, it is more desirable to specifically target 5-LO among the 
lipoxygenase isoforms. The only products of 5-LO pathway are, in fact, leukotrienes which 
are pro-inflammatory mediators. Leukotrienes have been shown to be connected not only 
with pathologies such as asthma and allergic rhinitis as well as cardiovascular diseases but 
also with certain types of cancer.
63
 Thus it is important to avoid their formation in order to 
counteract the inflammation response. 
 
 
Scheme 6.4.2 5-Lipoxygenase pathway. 
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Leukotrienes (LTs) are paracrine lipid mediators that bind to rhodopsin-like G protein–
coupled receptors which has various roles in inflammation and immunological function. 
Among the leukotrienes, LTB4 is a potent chemotactic agent for inflammatory cells 
including neutrophils, macrophages and eosinophils alongside with the Cys-LTs, LTC4, 
LTD4, and LTE4 which are potent constrictors of airway smooth muscles leading to 
bronchoconstriction which is formed by the intervention of 5-LO on arachidonic acid 
(ARA). These LTs increase leukocyte tissue infiltration and play an important role in 
immune reactions by enhancing the release of pro-inflammatory cytokines by macrophages 
and lymphocytes and are involved in immediate hypersensitivity reactions. Cys-LTs are 
also responsible for the increase of vascular permeability leading to oedema through 
contraction of endothelial cells (EC) in the microvasculature. LTs can also interact with 
sensory nerve fibres, leading to changes in their excitability and enhanced release of 
tachykinins. Therefore they are important inflammatory mediators in a number of different 
inflammatory diseases and allergic disorders.
64
  
5-Lipoxygenase is one of six isoforms of lipoxygenase present in humans and it is 
expressed in different leukocytes poly-morphonuclear leukocytes (neutrophils and 
eosinophils), mast cells, monocytes/macrophages, B-lymphocytes, dendritic cells and foam 
cells. It is a monomeric enzyme containing 672/673 AA. Its structure is characterised by an 
N-terminal -sandwich and a C-terminal catalytic domain binding the prosthetic iron that 
is ferrous (Fe
2+
) for purified recombinant 5-LO treatment with lipid hydroxides such as 5-
HPETE which transforms it into ferric (Fe
3+
). It utilises two co-factors, Ca
2+ 
(fundamental 
for 5-LO activity)
 
that binds to
 
a C2 domain on the N-terminal -sandwich and adenosine 
triphosphate (ATP).
65
 It seems that ATP has a stabilising role on the enzyme and its 
hydrolysis is not needed. The affinity between 5-LO and the ATP is used in the 
purification processes of the enzyme, although the precise binding site of ATP has not 
been determined yet.
66
 5-LO also utilises 5-LO activating protein (FLAP), a member of the 
Membrane-Associated Proteins in Eicosanoid and Glutathione metabolism (MAPEG) 
family, through protein-protein interactions for catalytic activity. FLAP appears to 
facilitate the transfer of ARA to 5-LO, a hypothesis which is supported by the evidence 
that when FLAP is inhibited (or not expressed) the transformation of endogenous amino 
acid into 5-LO products is blocked.
67
 Interestingly, ARA supplied from the exogenous 
environment is able to be metabolised even when the FLAP activity is inhibited. 5-LO can 
be stimulated through phosphorylation by kinases, in particular p38 mitogen activated 
protein kinase (p38 MAP kinase) on Ser-271, serine kinase ERK2 on Ser-663 and cAMP-
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dependent protein kinase PKA catalytic subunit on Ser-523. Regarding polymorphonuclear 
leukocyte (PMNL), evidence has shown that p38 MAP kinase and ERK2 were important 
for ARA-induced 5-LO product formation.6767 
As shown in Scheme 6.4.2Scheme 6.4.2, the metabolism of arachidonic acid (ARA) by 5-
LO starts by generating 5-(S)-HPETE, which is subsequently either reduced to the 
corresponding alcohol, 5-HETE, or to the short lived epoxy-leukotriene, LTA4. The latter 
is further metabolised to release a series of LTs either via the hydrolysis of its epoxide by 
LTA4 hydrolase (LTA4H) to the corresponding diol, LTB4, or its metabolism to the 
cysteine-adduct LTC4 from which other cysteinyl-LTs (Cys-LTs), LTD4 and LTE4, are 
sequentially formed from LTC4.
68
  
Strategies to counteract the pro-inflammatory activity of the product of 5-LO have 
involved blocking the leukotrienes receptors (montelukast and zafirlukast), direct inhibitors 
of 5-LO of which the only representative on the market up to date is zileuton. 
Given the recent findings on the multiple factors that influence the regulation of 
leukotriene formations such as FLAP, ERK2, p38 MAP kinase and Ca
2+
 etc. more focus is 
being placed nowadays on targeting these as well (e.g. licofelone FLAP inhibitor), in order 
to achieve a larger success chance on the intact cell environment. Multi-target strategies 
that attempt to inhibit the arachidonic acid pathway at different sites are starting to be 
explored. 
The 5-lipoxygenase inhibitors can be classified based on the stage they are interacting at: 
 Direct 5-LO inhibitors:69 
 Iron ligand inhibitors70 (zileuton)  
 Redox inhibitors (polyphenols) 
 Non redox competitive inhibitors (they compete with arachidonic acid to 
bind to the enzyme active site)6969 
 Inhibitors of LTA4 hydrolase
71
 
 FLAP inhibitors (Licofelone)72 
 Leukotriene receptor inhibitors (Montelukast, Zafirlukast) 
Among the direct 5-LO inhibitors, despite the 25 years of research on the topic, the only 
commercial compound, as previously mentioned, is N-[1-(1-benzothien-2-yl)ethyl]-N-
hydroxyurea  (zileuton) (Figure 6.4.1Figure 6.4.1). 
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Figure 6.4.1 Structure of zileuton. 
The N-hydroxyurea portion of the molecule acts by chelating to iron in the active site of 
5-LO preventing it from oxidising and thus entering the catalytic cycle. It also possesses 
weak reducing properties auxiliary to the inhibitory activity towards 5-LO.
73
 It has various 
drawbacks such as short half-life and liver toxicity which is due to irreversible inhibition of 
glutathione S-transferase through alkylation. 
Among the redox inhibitors, it is worth mentioning a few polyphenols including curcumin, 
resveratrol, baicalin, catechin, quercitin and caffeic acid (Figure 6.4.2Figure 6.4.2). Their 
antioxidant potential is well-known, thus they interact with 5-LO avoiding the oxidation of 
ferrous iron present in the catalytic site. 
 
Figure 6.4.2 Examples of polyphenols targeting 5-LO product formation. 
A combination of baicalin and catechin, known as Flavocoxid (Limbrel), is currently under 
clinical development for the treatment of osteoarthritis.
74
 Other polyphenols such as 
curcumin are effective in inhibiting 5-LO product formation and inflammation processes, 
not only because of its antioxidant properties but also due to its ability to interact at 
different locations of the arachidonic acid pathway. They are a natural lead compound 
towards the development of multi-target actives with proven safety and activity.6262 
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Another site on the arachidonic acid pathway that is emerging as good target in 
anti-inflammatory therapy is FLAP. Licofelone (Figure 6.4.3Figure 6.4.3) is an active that 
was developed as dual COX/5-LO inhibitor and has been proven to target FLAP.
75
 It is 
currently undergoing phase III clinical trials for therapy of osteoarthritis.7272 
 
Figure 6.4.3 FLAP inhibitor in phase III clinical trials. 
The mode-of-action of licofelone targeting FLAP was first evidenced by the fact that the 
compound showed only weak inhibition of 5-LO in cell free assays and instead, showed 
high inhibition power on PMNL, highlighting that licofelone needed the intact cell 
environment to exert its function. In the intact cell environment, FLAP is present thus 
Fisher et al. investigated its interference with FLAP, finding in this interaction the reason 
of its activity. 
Another strategy to counteract the inflammatory response catalysed from the 5-LO 
pathway is to inhibit the leukotriene receptors. This is the action mechanism of clinically 
approved montelukast and zafirlukast (Figure 6.4.4Figure 6.4.4), which inhibit the 
cysteinyl-leukotrienes on the CysLT1 receptors. 
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Figure 6.4.4 Cysteinyl-leukotrienes inhibitors used in asthma therapy. 
6.5.  Dermatophytes 
Fungi can be classified as either pathogens or non-pathogens, depending on their ability to 
cause pathological states or not. The majority of fungi are non-pathogens. Dermatophytes 
are fungi that invade and grow in dead keratin. They are hyaline separate molds. The 
hyphae of these mycelial organism are able to penetrate the stratum corneum of nails and 
skin and they possess keratinolytic proteases, which enable the microorganism to entry the 
living cells.
76
 A wide number of the known keratinolytic fungi belong to either the family 
of Arthrodermataceae (which include genera Epidermophyton, Microsporum and 
Trichophyton) or Onygenaceae from the phylum Ascomycota.77 They are spore shooter 
microorganisms, the spores generate the mycelium. These families are generally 
homogeneous with respect to appearance, physiology, taxonomy, antigenicity, basic 
growth requirements, infectivity and diseases they cause. They tend to grow outwards on 
skin producing a ring-like pattern – hence the term ‘ringworm’. They are very common 
and affect different parts of the body causing dermatophytosis.
78
 They can affect nails 
leading to onychomycosis a general term that denotes any fungal nail infection
79
 (tinea 
unguium specifically describes a dermatophytic invasion of the nail plate, Tricophyton 
rubrum is the dermatophyte that is generally responsible), onychomycosis generally leads 
to destruction and deformity of toe and fingernails, nail thickens, change colour, split and 
lift from the nail bed.
80
  
Dermatophytes can also affect the scalp (tinea capitis, Tricophyton and Micosporum genera 
are mainly responsible) they cause patches on the scalp of hair loss, sometimes associated 
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with a “black dot” pattern, accompanied by inflammation, swelling, itching, pustules and 
scaling. Tricophyton tonsurans and Tricophyton violaceum are examples of dermatophytes 
causing scalp dermatophytosis. 
Furthermore, they can affect skin, causing scaling, crusting, sometimes blister-like lesions, 
rushes and the classic round spots pattern, typical of ringworm lesions, it can be associated 
with inflammation, an example of microorganism responsible for this dermatophytosis is 
M. canis. 
The mycosis generated by dermatophytes can be separated in localised and profound 
dermatophytosis,
81
 although with the clinically approved drugs it is possible to obtain high 
success rates, systemic mycosis are much more difficult to treat which is why continued 
research into antimycotic actives for systemic application is essential. One of the 
difficulties of treating a systemic dermatophyte infection is the fact that dermatophytes 
tend to attack tissues poorly vascularised and thus are more challenging for the delivered 
drug to reach the site of infection. Furthermore, there is a problem in selectively targeting 
the dermatophytes towards the fungi cells rather than the human forms. 
Systemic mycosis mainly affect, and are a main concern for, people with a compromised 
immunosystem, such as patients with HIV or cancer, in which the dermatophytes grow and 
develop quicker and easily. These infections, in immuno-depressed subjects can degenerate 
to cause fatality. Other factors that can enhance the risk of dermatophytosis are prolonged 
hospitalisations, alcohol abuse, radiotherapy, haemodialysis and serious burns. 
6.5.1.  Targets for Dermatophyte Therapy 
All dermatophytes are characterised by an unusual cell structure. It is important to know 
the dermatophyte strain in order to understand in which way different antimycotic drugs 
exert their function. 
The cellular membrane, also known as cytoplasmic membrane, covers the cytoplasm with 
all its components and forms a barrier between the cell environment and its components. If 
the membrane is damaged, all the cytosolic components are released leading to the death of 
the cell. 
The cell wall that protects and shapes the cell membrane in dermatophytes, is made up of a 
dense network of fibrils of chitin (β-1-4 polymer of N-acetyl-glucosamine). 
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The cell membrane is primarily composed of lipids (phospholipids), among which sterols 
ergosterol and lanosterol are the most important, and their synthetic pathways are preferred 
targets in the antimycotic therapy. Ergosterol is synthesised from lanosterol and is 
fundamental to keep the homeostatic equilibrium of the cell membrane and its integrity. 
 
Figure 6.5.1 Steroidal backbone. 
Sterols are compounds characterised by a fused tetracyclic motif (Figure 6.5.1Figure 
6.5.1). Natural hormones belonging from the sterols class such as cortisol, estrogens, 
testosterone, or actives such as cortisone and its derivative possess have this tetracyclic in 
common. 
 
Figure 6.5.2 Synthesis of cell membrane in dermatophytes. 
The synthesis of ergosterol provides a privileged target for antimycotic drugs. Different 
classes of molecules act at different levels, for example, allylamine (amorpholine and its 
derivatives) act by blocking the squalene epoxidase (Figure 6.5.2Figure 6.5.2) azole-
containing derivatives act against 14 α-lanosterol-demethylase (Figure 6.5.2Figure 6.5.2), 
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morpholines target, instead, Δ14-reductase and Δ8, Δ9 isomerases 4 and 5 (Figure 
6.5.2Figure 6.5.2). 
6.6.  Azole-containing derivatives 
Azole-containing antimycotic drugs include structures containing imidazole or triazole 
rings which possess the same antimycotic action mechanism.  
 
Figure 6.6.1 Azole-containing derivatives general structures, 1 imidazole, 2 triazole.  
The activity demonstrated by azole-containing derivatives is due to the heteroaromatic ring 
(imidazole or triazole) and to the tetrahedral symmetry to which the heterocycle is bound.
82
 
All the azole-containing derivatives act by inhibiting the 14 α-lanosterol demethylase 
through the basic nitrogen of the heterocycle which binds the haem group of CYP450 in 
the position normally occupied by oxygen. The remaining portion of the molecule interacts 
with other parts of the apo-protein and allows the active compound to specifically 
recognise that enzyme among all the CYP450 ones. Blocking the activity of 14 α-
lanosterol demethylase leads to a backlog of sterols still bearing the methyl at the 14 α-
position, which changes the membrane permeability making it less efficient and altering 
the functionality of membrane’s proteins.83 
Studies on Saccharomices Cervisiae indicate that two nitrogen atoms of the azole ring 
structures, nitrogen in position 3 for imidazoles, and nitrogen in position 4 in triazoles, is 
necessary to stabilise and to complex the ferric ion of the haem group. The other portion of 
the azole-containing molecules, such as the alkyl substituents R and R1 in the molecules 
are important in determining the binding interactions with it (Figure 6.6.2Figure 6.6.2).
84 
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Figure 6.6.2 Interaction of the azole rings with 14 α-lanosterol demethylase of S. Cervisiae. 
Among the azole-containing examples of drugs used in localized infections are miconazole 
and econazole, and for systemic therapy, ketoconazole, voriconazole and fluconazole 
(Figure 6.6.3Figure 6.6.3). 
 
Figure 6.6.3 Examples of azoles antimycotic drugs. 
Is important to mention that triazoles, compared to imidazoles, have a slower metabolic 
breakdown pathway and are more specific towards the CITP450 of the dermatophytes over 
the human one. 
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7.  Project aims and background 
7.1.  Novel Semi-Synthetic Polyphenol Analogues and Related SAR Studies 
The originally proposed project centred on the design of semi-synthetic polyphenol 
analogues. The aim was to find new carriers for those natural compounds and to enhance 
their bioavailability, half-life in the blood, facilitate their transport across cell membranes 
and consequently result in an increase in their biological activity.  
Initially, it was believed this could be achieved through the syntheses of polyethylene 
glycol (PEG)-linked conjugates or sugar derivatives - changing the type and position of the 
sugars. Evidence in the literature supported this proposal, particularly research from Jun Li 
et al.
85 
on PEG-derivatives of curcumin, Kunihiko et al.
86 
on glycosyl-curcuminoids and of 
L. Biasutto et al.
87 
on resveratrol. Based this precedence, efforts were focused to achieve 
the pegylation of curcumin.  
Curcuminoids and polyphenols, in general, have attracted a strong interest because of their 
versatility in terms of biological activities, applications and available sources. These 
classes of compounds demonstrate anti-cancer, anti-inflammatory, anti-oxidant, anti-
artherosclerotic properties, as well as neuro- and cardio-protective activities. They have 
been used in prebiotics, pharmaceuticals, cosmetics, nutraceuticals and can be extracted 
from renewable sources such as tea leaves, grapes, cocoa beans and vegetables.
88
  
After preliminary studies inherent to these classes of molecules, efforts were re-directed to 
consider alternative ways to enhance the performance of the polyphenols of interest. The 
focus of the project was, consequently, redirected. New linkers were chosen that not only 
could act in a similar way to polyethylene glycol, i.e. increasing water solubility through 
hydrogen bond interactions, but could also serve as active pharmacophores, thereby no 
more acting just as simple passive connection units. It was thought that this would expand 
the activity profile of the synthesised analogues and enable the introduction of molecular 
diversity. To achieve this, linkers based on a triazole core were targeted as building blocks 
(Figure 7.1.1Figure 7.1.1).  
 
Figure 7.1.1 General scheme for the library of compounds. 
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Triazoles are known to act as pharmacophores, capable of interacting with a broad range of 
targets. They have been attributed to the activity in several antifungal, antibacterial and 
anticancer agents, HIV protease inhibitors
89
 and anti-inflammatory compounds.
90
 
From a synthetic standpoint, an advantage of incorporating the triazole motif into the linker 
is the relatively simple and inexpensive method of preparation: the copper catalysed azide–
alkyne cycloaddition (CuAAC) better known as “click chemistry”. Modifications to the 
azide and alkyne coupling fragments facilitate the introduction of molecular diversity.
91
 
This choice of linker also opened the scope of the project to the concept of poly-
pharmacology, which is an area of increasing interest amongst the medicinal chemist 
community. There are several benefits of a multi-target approach which include not only a 
better balance between activity and side effects but also a reduction of costs and time of 
development to reach the market.
92 
 
When considering the concept of a multi-target approach it is possible to think about it as 
dualistic. A multi-target drug can be designed to act on different levels of the same 
pathways, as demonstrated by Werz and co-workers
93 
by the development of new 
prenylated pyrazole-curcuminoids as anti-inflammatory analogues able to target 5-LO 
alongside with mPGES-1. Alternatively, it can be thought of as a way to design molecules 
that can act either on un-related or distantly related targets in order to reach different 
pathologies, as is the case of methotrexate which is used in treatment therapies from cancer 
to psoriasis to rheumatoid arthritis. 
A major challenge in poly-pharmacology is to avoid excessive promiscuity in order to limit 
the side effects as much as possible caused by interaction with anti-targets. For this reason, 
particular care should be during the optimisation process, the synthetic-design stage and 
the activity profiles towards the selected targets. In the field of medicinal chemistry, multi-
target structure–activity relationship (SAR) studies is therefore a primary necessity but it is 
still far from routine mostly due to the fact that poly-pharmacology, and the rational design 
of multi-targets active as a science, is still in its infancy. Therefore, further research into 
this area is required to fully understand the value of this concept. 
Three main targets were chosen for our library of compounds of which two are reported to 
be involved in the human inflammation process. The first of which was 5-lipoxygenase, a 
crucial enzyme of the arachidonic acid (AA) cascade and involved in the first two catalytic 
reactions of the biosynthesis of leukotrienes (LTs).
94
 It has been established that the role of 
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LTs as inflammatory mediators play a pathophysiological role in different diseases, for 
example, asthma and allergic rhinitis as well as cardiovascular diseases and certain types of 
cancer.
95
 The second target was transcription factor Nrf2, which is responsible of 
recognising the antioxidant response element (ARE) regulating a number of cytoprotective 
genes. The significance of the Nrf2-regulated cytoprotective adaptive response has been 
demonstrated in animal models of electrophilic and oxidative toxicity, carcinogenesis, 
inflammation-associated carcinogenesis, and acute inflammation.
96
 (This target will not be 
discuss in the present work, giving that the molecules herein presented are still under 
investigation on this target). 
The final target selected was 14 α-lanosterol demethylase a cytochrome P450 enzyme 
common to all dermatophytes. Dermatophytes are fungi that enter and grow in dead keratin 
tissue. Several species commonly invade human keratin and these belongs to the 
Epidermophyton, Micosporum and Trichophyton genera. They tend to grow outwards on 
skin producing a ring-like pattern, hence the term ‘ringworm’. They are very common and 
can affect different parts of the body.
97
 
14 α-Lanosterol demethylase is the target enzyme of azoles such as ketoconazole, 
miconazole and fluconazole. It is an enzyme involved in the synthesis of ergosterol, an 
important component of dermatophytes cell wall. This enzyme is targeted by a number of 
triazole-containing fungicide drugs. Considering that the mortality associated with 
dermatophytosis as reported by the World Health Organization (WHO) in Sub-Saharan 
African region in 2001 was found to be similar to that attributed to gout, endocrine disease, 
panic disorders and war related injuries and considering the increasing number of resistant 
strains, research in this area is still topical. 
It is also noteworthy that dermatophytosis cause a higher mortality risk in patients affected 
by HIV. Furthermore, taking into account that mycosis and inflammation are commonly 
associated, we focused the present studies toward multi-target actives that are able to act 
both on the inflammation process and dermatophyte infections.
98
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8.  Results and Discussion 
8.1.  Preliminary Studies Toward Curcumin Analogues 
The substrate initially chosen within the polyphenol family was curcumin, given its known 
multi-target activity. It is, in fact, largely reported to be an anti-oxidant, anti-cancer
1
 
(against, for example, melanoma, pancreatic cancer etc.) and anti-inflammatory active.
9
 
Some of the main problems connected with the use of polyphenols include their poor 
solubility in organic media, rapid metabolic clearance and issues associated with in vivo 
delivery which overall leads to poor bioavailability. In the past numerous synthetic 
strategies were adopted to overcome these issues including pegylation,
1
 liposomes
99
 and 
glycosylation (a chemical modification used in nature to protect polyphenols from 
enzymatic oxidation enhance their half-life in cells).
100
 
Based on this precedence, analogue 1 was initially set as a target to evaluate the possibility 
of synthesising a new family of semi-synthetic curcuminoids (Figure 8.1.1Figure 8.1.1). 
 
Figure 8.1.1 Semi-synthetic analogue of curcumin. 
Starting materials 2 and 3 (Scheme 8.1.1) were prepared via known procedure before the 
O-alkylation reaction was investigated (Scheme 8.1.2). 
Scheme 8.1.1 Syntheses of silyl-protected curcumin (2)
101
 and tosyl-protected tetraethylene glycol (3).
102
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Scheme 8.1.2 O-Alkylation between silyl-protected curcumin (2) and bis-tosylated tetraethylene glycol (3). 
Initial screening of the O-alkylation reaction lead to no product formation (Table 8.1.1). 
Instead, the reaction mixtures indicated the conversion of mono-protected curcumin 2 back 
to curcumin. 
Table 8.1.1 Reaction conditions for O-alkylation. DMF = dimethylformamide. 
ENTRY BASE SOLVENT TEMP. [°C] TIME 
[HOURS] 
1 K2CO3 DMF 80 12 
2 K2CO3 DMF 20 12 
 
The tert-butyldimethylsilyl (TBS) protecting group revealed to be unexpectedly unstable 
under basic conditions and we thus decided to perform a more detailed screening of the 
stability of mono-protected curcumin 2 under different combinations of solvent and base 
(Table 8.1.2) 
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Table 8.1.2 Stability test of mono-protected curcumin 2 under different solvent/base combinations. The 
stability was monitored by thin layer chromatography. DIPEA = diisopropylethylamine; DMF = 
dimethylformamide; DCM = dichloromethane; THF = tetrahydrofuran; DMSO = dimethyl sulfoxide; NMP 
= N-methyl-2-pyrrolidone; MTBE = methyl tert-butyl ether. 
Entry Base Solvent Comments 
1 K2CO3 DMF Curcumin recovered 
2 NaH DMF Curcumin recovered 
3 DIPEA DMF Curcumin recovered 
4 Cs2CO3 DMF Curcumin recovered 
5 Cs2CO3 DCM TBS-protected curcumin 2 was stable 
under these conditions 
6 Cs2CO3 Acetone Curcumin recovered 
7 Cs2CO3 THF TBS-protected curcumin 2 was stable 
under these conditions 
8 Cs2CO3 Dioxane TBS-protected curcumin 2 was stable 
under these conditions 
9 Cs2CO3 DMSO Curcumin recovered 
10 Cs2CO3 NMP Curcumin recovered 
11 Cs2CO3 Methanol Curcumin recovered 
12 Cs2CO3 MTBE TBS-protected curcumin 2 was stable 
under these conditions 
13 Cs2CO3 Ethanol TBS-protected curcumin 2 was stable 
under these conditions 
14 Cs2CO3 Acetonitrile Curcumin recovered 
 
The conditions in entry 7 were used for subsequent O-alkylations of mono-protected 
curcumin 2 as it was noted that these conditions had a better solubility profile than those 
used in entries 8, 12 and 13. However, it was found that under these conditions, when 
proceeding with the O-alkylation a complex mixture of products was formed and it proved 
difficult to isolate and/or characterise the desired product. It was thought that the complex 
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mixture formed may have been caused by the nature of the protecting group and so a 
variety of mono-protected curcumin analogues were prepared and screened under the 
optimal O-alkylation conditions (Scheme 8.1.3Scheme 8.1.3). 
 
Scheme 8.1.3 Synthesis of mono-protected curcumin analogues 4, 5 and 6 were achieved following 
procedures previously reported in the literature.
15,103,104
  
Table 8.1.3 Reactions between differently mono-protected curcumin and bis-tosylated PEG 7. DMF = 
dimethylformamide. 
Entry Mono-
protected 
curcumin 
PEG 
analogue 
Base [EQ.] Solvent Temp. [°C] Result 
1 4 7 Cs2CO3 (4.0) DMF 20 Curcumin recovered 
2 5 7 Cs2CO3 (4.0) DMF 20 Complex mixture 
3 6 7 Cs2CO3 (4.0) DMF 20 Complex mixture 
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Despite changing the protecting group on curcumin, it was not possible to afford the 
desired product and again, the silyl protecting group (triisopropylsilyl) proved to be 
unstable in basic conditions furnishing only curcumin (entry 1,  
Table 8.1.3 
Table 8.1.3). It was then hypothesised that a possible issue for the lack of product formation 
could be due to the slow reactivity of the tetra-ethylene glycol intermediate. And so, bis-
bromo tetraethylene glycol 8 was prepared and used in the O-alkylation reaction (Table 
8.1.4Table 8.1.4). 
Table 8.1.4 Reactions between mono-protected curcumin 6 and bis-tosylated PEG 8. DMF = 
dimethylformamide; THF = tetrahydrofuran. 
Entry Mono-
protected 
curcumin 
PEG 
analogue 
Catalyst Base [eq.] Solvent Temp. 
[°C] 
Results 
1 6 8  Cs2CO3 (4.0) DMF 20 Complex mixture 
2 6 8 NaI Cs2CO3 (4.0) DMF 20 Complex mixture 
3 6 8  Cs2CO3 (4.0) THF 20–70 Complex mixture 
4 6 8  NaH (4.0) THF 60 Complex mixture 
5 6 8  K2CO3 (4.0) Acetonitrile 120 Complex mixture 
 
Despite these variations, it was never possible to isolate the desired O-alkylated product. 
Due to these persistent difficulties, it was decided to reshape the project to employ 
alternative linkers and substrates. 
8.2.  Library Planning Strategy Assisted Through In Silico Evaluation 
8.2.1.  Molecular Modelling Studies 
The design of the synthesised compounds was assisted by molecular modelling studies, 
which were performed in collaboration with the group of Prof. Bender from Cambridge 
University. The preliminary docking screen performed, directed the choice of the linkers 
backbone.  
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Computational studies, on the proposed targets, were performed on human 5-lipoxygense 
(5-LO) PDB: 3O8Y, and on 14 α-lanosterol demethylase from S. Cerevisiae PDB: 4K0F. 
Docking studies on Nrf2 were not performed because of insufficient data on the amino acid 
composition of the active site. 
Caffeic acid and zileuton were docked and used as references as they are known binding 
ligands of 5-LO. Caffeic acid is stabilised in the 5-LO binding pocket through the 
formation of hydrogen bonds with Ala424, blocking the binding site of the arachidonic 
acid in 5-LO. In a similar way, the binding site of zileuton, a well-known potent inhibitor 
of 5-LO, is located within the inner part of the binding pocket and is stabilised by the 
formation of a network of hydrogen bonds with the main chains of Leu420 and Ala424 and 
the side chain of Asn425, as can be noted in Figure 8.2.1Figure 8.2.1. 
 
Figure 8.2.1 Caffeic acid (left) and Zileuton (right) bound into the 5-LO arachidonic acid binding site. 
To validate the docking procedure in 14 α-lanosterol demethylase, fluconazole was docked 
into the protein and used as a reference. Fluconazole is stabilised in the binding cavity 
through π-π interactions between one of its triazoles ring and Tyr126 as can be noted 
Figure 8.2.2Figure 8.2.2. It is known that the main interaction of triazole-containing 
antimycotic actives is its interaction with the iron of the HEME group. 
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Figure 8.2.2 Fluconazole stabilised in the binding cavity of 14 α-lanosterol demethylase. 
The general structures of the two initially designed classes of compounds are shown in 
Figure 8.2.3Figure 8.2.3.  
 
Figure 8.2.3 General structures of the alkyl triazoles (left) and polyethylene-glycol triazoles (right) families. 
The preliminary docking studies suggested that the alkyl linker presents better interaction 
in the hydrophobic binding site of 5-LO with respect to the peg-triazole linkers. Binding 
energies for the alkyl triazole linkers were generally lower compared to the polyethylene 
glycol analogues. Considering that zileuton has a lower binding energy than caffeic acid (–
8.8 kcal/mol and –6.5 kcal/mol respectively) and is known to be a better inhibitor of 5-LO, 
the difference in the binding energies between the alkyl triazole linkers and the peg-
triazole linkers suggested a significant outcome.  
Compounds bearing the polyethylene-glycol chain, P1 (binding energy –9.00 kcal/mol) and 
P3 (binding energy –8.4 kcal/mol) showed a binding energy comparable to the clinically 
approved zileuton (binding energy –8.8 kcal/mol). They have shown a stronger binding 
interaction, in our predictions, compared to the relatively poor inhibitor caffeic acid (–6.5 
kcal/mol), although, the compounds bearing the alkyl linkers have generally shown lower 
binding energies (8a –9.4 kcal/mol and 8d –9.5 kcal/mol) than the polyethylene-glycol 
ones.  
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Furthermore, it was observed that the polyethylene-glycol chain of compound P3 sits at the 
limit of the binding site. Inhibitors with a longer linker chain cannot enter completely into 
the binding site of 5-LO, thus the binding energy starts to increase. The portion that 
remains out with the binding site plus the interaction with the solvent can increase the 
entropy of the complex (e.g. P4 n=6, –7.0 kcal/mol). Figure 8.2.4Figure 8.2.4 shows the 
comparison between compounds 8a, 8d, P1 and P3 , where it can be noted that P3, 
compared to the other molecules, is at the limit of the binding site. 
 
Figure 8.2.4 Predicted binding images for 8d (A), 8a (B), P1 (C), P3 (D) on 5-lipoxygenase. 
Instead, on 14-α-lanosterol demethylase, the polyethylene-glycol analogues form hydrogen 
bonds with His381 favouring a different orientation of the molecule and of the triazole 
ring. Alkyl triazole 8d is oriented towards the iron of the HEME group, similar to 
fluconazole. Instead, with polyethylene-glycol analogues, P1 and P3 the triazole ring is 
oriented in the opposite direction (Figure 8.2.5Figure 8.2.5). This difference in orientation 
did not translate into a relevant difference in binding energy. Considering that the action 
mechanism of triazole-containing antimycotic drugs involves the interaction between the 
basic nitrogen atom of the heteroaromatic ring and the iron of the HEME of the CYP450 
(thereby preventing the enzyme from oxidising its normal substrate
105
), the different 
orientation observed between the two families might lead explain the difference in the in 
vitro activity. 
Formattato: Tipo di carattere: 12
pt, Non Grassetto
Formattato: Tipo di carattere: 12
pt, Non Grassetto
 77 
 
 
Figure 8.2.5 Predicted binding orientations of 8d (A), 8a (B), P1 (C), P3 (D) on 14 α-lanosterol demethylase. 
Therefore, the simple triazole core was selected as common feature to all our final 
compounds and it has been synthesised via a copper(I) catalysed alkyne-azide 
cycloaddition - a modern version of the Huisgen 1,3 dipolar cycloaddition also known as 
“click chemistry”.106  
8.2.2.  Molecular Modelling Parameters 
The structure of all compounds herein presented were optimised using the MMFF94x force 
field. The torsional root and branches of the ligands were chosen using AutoDockTools 
(version May_03_13),
107
 allowing flexibility for all rotatable bonds of the ligand. 
Subsequently, AutoDockTools was used to assign Gasteiger–Marsilli atomic charges to all 
ligands. On the other hand, all water molecules were removed from the 5-LO and 
14 α-lanosterol demethylase crystal structures (PDB ID: 3O8Y and 4K0F, respectively). It 
is worth mentioning that this structure of 5-LO was crystallised without any ligands. In 
order to obtain an active conformation of this enzyme, the coordinates of arachidonic acid 
were extracted from crystal structure 3V99 and docked in 3OY8 using a rigid docking 
approach. The complex obtained was then submitted to a structure optimisation using the 
MMFF94x force field and the resulting protein structure was used to perform the 
calculations presented in this study (Figure 8.2.6Figure 8.2.6). AutoDockTools was also 
used to merge all non-polar hydrogen atoms and to assign Gasteiger charges for each atom 
of the macromolecule. 
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Figure 8.2.6 Predicted binding conformations of arachidonic acid. 
Figure 8.2.6Figure 8.2.6 shows the arachidonic acid of crystal structure 3V99 overlapped 
on crystal structure 3O8Y (green); the result of the rigid docking of arachidonic acid on 
3O8Y (blue); and the result of the flexible docking of the same molecule after the structure 
optimisation of the protein (pink). 
Docking calculations were performed with AutoDock Vina 1.1.2 software.
108
 The 
searching area was defined by a box of 30 × 20 × 30 Å centred at the coordinates of the 
catalytic Fe
2+
 for 5-LO and a box of 30 × 25 × 25 Å centred at 17.39, 11.13 and 16.78 in 
the 14 α-lanosterol demethylase crystal structure. The conformational search of the ligand 
was performed using and exhaustiveness value of 8 to generate maximum 9 binding modes 
with a maximum energy difference of 4 kcal/mol between the best and worst 
conformations. The conformation with the lowest predicted binding energy was used for 
further analysis. In order to maintain the reproducibility of this study, all the calculations 
were performed using a seed equal to 1. 
8.3.  Design and Synthesis of the Compound Library 
8.3.1.  Rationale Behind the Design 
The synthesised library of compounds was based on the readily available polyphenol 
caffeic acid. In order to determine the key features for the anti-inflammatory and fungicide 
activities associated with this family of compounds, strategic structural modifications were 
conceived. Focus was placed on the substitution of the aromatic portion (A), the type of 
linker (B), the chain length (C) and functionalisation of the hydroxyl group (D) (Figure 
8.3.1Figure 8.3.1). 
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Figure 8.3.1 Generic structure of the synthetic triazole-containing analogues.  
The synthesis of these compounds relies on an initial esterification or amidation of caffeic 
acid which also installs either the alkyne or azide fragment prior to formation of the 
triazole ring through a copper(I) catalysed azide-alkyne cycloaddition (CuAAC).  
A fundamental objective for this library of compounds was to obtain a certain degree of 
molecular diversity, through a concise and expedient synthetic approach, in order to 
explore the structure–activity relationship (SAR) on the selected targets. Initially, the effect 
of the chain length of the linker fragment between the polyphenol and the triazole core was 
investigated (Figure 8.3.2Figure 8.3.2). This variable was considered relevant for both of 
the considered targets. 5-Lipoxygenase consists of a relatively large binding site and it is 
not yet well known what are the key structural features that are required for an efficacious 
drug candidate. This is highlighted by the fact that zileuton is still the only molecule on the 
market that is prescribed as a specific inhibitor of 5-lipoxygenase.
9
  
Instead, on the 14 α-lanosterol demethylase, the chain length of the linkers could be an 
important feature that influences the efficacy of the new molecules, not just for the binding 
interactions at the active site, but also because increasing lipophilicity could affect their 
ability to pass through the dermatophytes cell wall, thereby increasing the potential to exert 
their antifungicide function. In both cases, maintaining a certain degree of lipophilicity is 
important to facilitate efficient intestinal adsorption and to achieve a reasonable oral 
bioavailability for systemic treatment.
109
 
  
Figure 8.3.2 Synthetic analogues with varying chain lengths between diacetyl caffeic acid and the triazole 
ring.  
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Substitution of the ester with an amide group was also examined (Figure 8.3.3Figure 8.3.3) 
in order to determine the effect the ester group has on the activity of these compounds 
whilst also evaluating the effect of the more metabolically stabile amide group.
110
 
 
Figure 8.3.3 Substitution of the ester functionality with an amide group. 
Alternate functionality to the aromatic acetate groups was also considered (Figure 
8.3.4Figure 8.3.4). Replacing the acetate groups with fluorine could lead to a weaker 
interaction with the binding site of 5-lipoxygenase or 14 α-lanosterol demethylase but, on 
the other hand, could also lead to improved pharmacological properties. Fluorine has been 
widely used in pharmaceutical compounds for enhancing biological activity through 
hydrogen bonding interactions (I added this but check this if correct).
111
 In 2008, the US 
Food and Drug Administration (FDA) approved 238 fluorine-containing drugs. From this 
data, fluorine emerges as the second most-widely used heteroatom in drug design and 
synthesis behind nitrogen.
112
 
 
Figure 8.3.4 Substitution of the diacetyl groups on the aromatic ring with fluorine atoms at chain lengths n = 
2 (8f) and n = 8 (8g).  
An isomer of analogue 8a was also prepared (8h) (Figure 8.3.5Figure 8.3.5) to evaluate if 
the different mobility arising from the isomer resulted in a significant change in the 
activity. 
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Figure 8.3.5 Triazole isomer of compound 8a.  
Finally, taking into account that the terminal hydroxylalkyl chain could affect the activity 
against the selected targets, or the passage through the cellular membrane, the last variation 
of the compound library examined the derivatisation of this group (Figure 8.3.6Figure 
8.3.6).  
 
Figure 8.3.6 Orthogonal derivatives with caffeic acid (9) and trolox (10). 
8.3.2.  Synthesis of the Library 
Following optimisation (Table 8.3.1Table 8.3.1), 3-azido-1-propanol was prepared one 
step from commercially available 3-bromopropan-1-ol through an SN2 reaction (Table 
8.3.1Table 8.3.1).
***
 
Table 8.3.1 Reaction optimisation of 3-azidopropan-1-ol. 
Entry X Solvent Time [h] Temp [°C] Conv (%)
†††
 
1
‡‡‡
 Br DMF 24 60 100 
2
‡‡‡
 Br H2O 24 60 100
 
3
‡‡‡
 Cl H2O 30 75 30
§§§ 
4
****
 Br H2O 30 75 86
 
5
********
 Br H2O 15 75 83 
                                                          
***
 3-Azidopropan-1-ol is commercially available it was more cost effective to prepare it in-house 
†††
 Conversion was calculated by 
1
H-NMR 
‡‡‡
 These reactions were performed in batch mode  
§§§
 Trace amounts of by-product (~5%) was determined by NMR 
****
 These reactions were performed in microwave mode 
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6
********
 Br H2O 45 75 97 
7
********
 Br H2O 30 120 100 
8
********
 Br DMF 30 120 100 
 
 
 
Scheme 8.3.1 Synthesis of 3-azido-1-propanol. 
The optimal conditions to prepare azido-propan-1-ol are shown in entries 1, 2 and 7 (Table 
8.3.1Table 8.3.1). Going forward, the conditions reported in entry 1 were used to prepare 
3-azidopropan-1-ol. The syntheses of intermediates 3a, 3b, 3c, 3d, 3f, 3g and 5 (Scheme 
8.3.2Scheme 8.3.2) were realised via an esterification reaction between α,β-unsaturated acids 
1a-b and terminal alkynes 2a-d or azide 4 as reported in the literature.
113
 The reactions 
proceeded smoothly in moderate to good yields. The same conditions used for the 
esterification were also suitable for the formation of amide 3e from 1a and 2e in good 
yield. 
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Scheme 8.3.2 Synthetic procedures for esters (3a–3f, 5, 7). Reagents and conditions: (i) thionyl chloride (25 
eq.), 1a–1b (1.0 eq.), DMF (1.2 eq.), benzene, Δ, then pyridine (1.2 eq.) and 2a–2e or 4 (1.2 eq.), r.t. (ii) 
DCC (1.0 eq.), DMAP (1.0 eq.), 6 (1.0 eq.), DCM, r.t., then 4 (1.0 eq.), r.t. DMF = dimethylformamide; 
DCC = dicyclohexylcarbodiimide; DMAP = dimethylaminopyridine; DCM = dichloromethane. 
To prepare azide 7, the esterification protocol was changed. It was necessary to submit 
6-acetoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox) to milder esterification 
conditions. Steglich esterification conditions were used for this reason (Scheme 
8.3.2Scheme 8.3.2). In the Steglich esterification reaction, the carboxylic acid is activated 
with dicyclohexylcarbodiimide (DCC) instead of generating the acyl chloride. Attempts to 
perform the esterification of 6 under the same conditions used for the esterification of 1a 
and 1b led to consumption of starting material but it proved impossible to isolate the 
desired product through column chromatography. Figure 8.3.7Figure 8.3.7 shows the NMR 
overlay between the esterification of Trolox to afford compound 7 with method (i) (Figure 
8.3.7Figure 8.3.7 a), and Steglich esterification method (ii) (Figure 8.3.7Figure 8.3.7 b). It 
can be seen at 3.68, and 3.45 ppm (Figure 8.3.7Figure 8.3.7 a) there is a singlet and a triplet, 
respectively, not belonging to the desired product, which proved impossible to separate 
from the product through column chromatography. Instead, this by-product is not observed 
when submitting compound 6 to the esterification method (ii) (Figure 8.3.7Figure 8.3.7 b).  
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Figure 8.3.7 Comparison of the crude 
1
H-NMR spectra resulting from esterification method (i) (a) and 
method (ii) (b) on Trolox 6. 
The intermediates were then submitted to the copper catalysed 1,3-dipolar azide-alkyne 
cycloaddition, also known as click chemistry, to afford the final analogues 8a–8h, 9 and 
10. Click chemistry is a powerful tool to quickly generate molecular diversity and 
chemoselectivity (the 1,4-isomer is afforded using a copper catalyst and the 1,5-isomer is 
prepared using a ruthenium catalyst), however, there are many conditions reported. For the 
formation of the 1,4-regioisomers, the most commonly employed catalyst is used CuSO4 
with a co-reagent such as metallic copper or sodium ascorbate, to produce copper(I) in situ. 
This method for directly generating copper(I) in situ is generally preferred given the air-
sensitive nature of the isolated salts.
114
 Although, copper(I) species can also be used in 
aqueous media. Preliminary reactions were performed on a model system (Scheme 
8.3.3Scheme 8.3.3) to determine which strategy should be employed (Table 8.3.2Table 
8.3.2).  
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Scheme 8.3.3 Model reaction to optimise the copper(I) catalysed azide–alkyne cycloaddition step. 
Table 8.3.2 Reaction condition optimisation of the copper catalysed azide-alkyne cycloaddition reaction.  
Entry Catalyst [mol%] Solvent Time [H] Temp. [°C] Conv [%] 
1 CuSO4 [20] and Cu [80] H2O–t-BuOH (1:1) 15 125 >90% 
2 CuI [10] H2O–t-BuOH (1:1) 15 125 >90% 
 
Under both reaction conditions, full conversion was achieved which was evident through 
comparison of the 
1
H-NMR spectra of 3-azidopropan-1-ol (Figure 8.3.8Figure 8.3.8 a), the 
crude reaction mixture (Figure 8.3.8Figure 8.3.8 b) and 3-butyn-1-ol (Figure 8.3.8Figure 
8.3.8 c). 
 
Figure 8.3.8 Comparison of the 
1
H NMR spectra of (a) 3-azidopropan-1-ol; (b) crude reaction mixture from 
entry 2 of Table 8.3.2Table 8.3.2; and (c) 3-butyn-1-ol. 
Although both reactions proceeded to full conversion, the reaction in which copper(I) was 
generated in situ proceeded in a less clean manner than the reaction that used a direct 
source of copper(I). From Figure 8.3.9Figure 8.3.9, the presence in the NMR spectra of 
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trace amounts of by-products formed when using the conditions from entry 1 (Figure 
8.3.9Figure 8.3.9 a) is evident whereas these impurities are instead absent in the NMR 
spectra obtained from the reaction conditions used in entry 2 (Figure 8.3.9Figure 8.3.9 b). 
 
Figure 8.3.9 Comparison of the NMR spectra obtained from the reaction conditions used in (a) entry 1 Table 
8.3.2Table 8.3.2 and (b) entry 2 Table 8.3.2Table 8.3.2. 
It was therefore decided to proceed using copper(I) iodide to perform the cycloaddition. 
However, attempts to synthesise triazole 8a using the optimised conditions lead to no 
conversion. The reaction time was increased to 75 minutes and the ratio of 3a to 
3-azidopropan-1-ol was changed from 1:1 to 1.2:1. The reaction was carried out in both 
microwave and standard batch mode. Both gave conversions to the desired product higher 
than 95% and no significant differences were observed in the crude NMR spectra.  
For convenience and future scale up considerations, it was decided to continue with the 
synthesis using standard thermal conditions. Compounds 3a-g, 5 and 7 were subsequently 
submitted to copper catalysed cycloaddition reaction with 4, 2a and 3a respectively, which 
afforded the final target compounds 8a-g, 9 and 10. The reaction conditions for the 
cycloaddition revealed to be suitable to prepare all the desired triazole derivatives. The 
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reactions proceeded to completion and gave moderate to good isolated yields (Scheme 
8.3.4Scheme 8.3.4 and Scheme 8.3.5Scheme 8.3.5).  
 
Scheme 8.3.4 Synthetic procedures for the preparation of triazoles (8a-h). Reagents and conditions: (i) 
t-BuOH–H2O (1:1), 2a or 3a-g (1.2 eq.), 4 or 5 (1.0 eq.), CuI (0.1 eq.), 125 °C. 
 
 
Scheme 8.3.5 Synthetic procedures for the preparation of triazoles 5 and 7. Reagents and conditions (i) 
t-BuOH–H2O (1:1), 3a (1.2 eq.) 5 or 7 (1.0 eq.), CuI (0.1 eq.), 125 °C. 
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8.4.  Reaction Mechanisms of the Key Steps  
8.4.1.  Steglich Esterification 
The Steglich esterification is a reaction that allows the conversion of acids into esters and 
amides under mild conditions using dicyclohexylcarbodiimide (DCC) as a coupling agent 
and 4-dimethylaminopyridine (DMAP) as catalysts. Compared to other methods, the 
Steglich esterification method works efficiently for more sterically hindered substrates. 
The first step involves the activation of the carboxylic acid through the formation of 
O-acylisourea (I) (Scheme 8.4.1Scheme 8.4.1). This intermediate I provides a similar 
reactivity to the corresponding carboxylic acid anhydride and is more susceptible to 
nucleophilic attack. The alcohol then adds to the activated carboxylic acid to form the 
desired ester and dicyclohexylurea (DHU) as a stable by-product.  
 
Scheme 8.4.1 Proposed mechanism of the Steglich esterification. 
N-Acylisoureas (Scheme 8.4.2Scheme 8.4.2) are the side products of an acyl migration that 
takes place slowly, and could be quantitatively isolated in the absence of any nucleophile. 
The reaction with strong nucleophiles such as amines proceeds fast and so this side product 
is not observed. 
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Scheme 8.4.2 Reactivity of the O-acylisourea intermediate I. 
The reaction between amines and carboxylic acids in the presence of DCC leads to amides 
generally without too many problems. For the efficient formation of esters, the addition of 
5 mol% of 4-dimethylaminopyridine (DMAP) is crucial. 
 
Figure 8.4.1 Both the nucleophilicity and basicity of the pyridine nitrogen are increased due to the electron-
donating effect of the dimethylamino group. 
The acceleration of the reaction with the alcohol accomplished using DMAP, is due to the 
fact that. DMAP is a stronger nucleophile than the alcohol and so reacts with the 
protonated O-acylisourea (I) leading to a reactive amide. This more reactive intermediate 
is then susceptible to attack from the alcohol. Formally, DMAP acts as an acyl transfer 
reagent and subsequent reaction with the alcohol gives the ester. 
 
Scheme 8.4.3 Mechanism of the DMAP catalysed esterification. 
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8.4.2.  Copper(I) Catalysed Azide–Alkyne Cycloaddition (CuAAC).   
“Click Chemistry” is a stereospecific, high yielding, wide-in-scope reaction. It can be 
conducted in green and easily recyclable solvents. It is used extensively in material 
sciences (polymers and dendrimers formations), in pharmaceutical industry and biological 
sciences (Inc., 2009).
115
 
Sharpless introduced the term “click chemistry” in 2001. It is an optimisation of the 
Huisgen 1,3-dipolar cycloaddition which, differently from the method developed by 
Sharpless and co-workers, required elevated temperatures and so was generally not suitable 
for chemical biology or any thermally unstable substrates. Moreover, it produces a mixture 
of the 1,4- and 1,5-regioisomers. The copper catalysed cycloaddition method, instead, 
makes it possible to discriminate between the two regioisomers based on the catalyst 
choice. Copper(I) catalysts make it possible to exclusively obtain the 1,4-regioisomer, 
whereas ruthenium catalysts access the 1,5-regioisomer. 
The first step involves the activation of the alkyne through a bond with copper(I) 
forming the key intermediate acetylide I (Scheme 8.4.4Scheme 8.4.4). Afterwards, the 
azide coordinates to the copper dissociating a ligand L and forming the intermediate II that 
turns into a 6-membered copper(III) metallacycle III. The 6-membered ring formation is 
then followed by the contraction of the ring to give IV a triazoyl-cuprate which undergoes 
protonolysis to afford the final product V - the 1,4-substituted triazole ring. 
  
Scheme 8.4.4 Copper catalysed azide–alkyne cycloaddition. 
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The ruthenium catalysed azide–alkyne cycloaddition proceeds through an oxidative 
coupling of azide and alkyne to give a six membered ruthenium cycle. In this case, the first 
bond is formed between the most electronegative atom of the alkyne and the terminal 
azide. This step is followed by the reductive elimination that leads to the triazole 
formation. The reductive elimination step is the rate-determining one according to DFT 
(Density Functional Theory) calculations. 
 
Scheme 8.4.5 Ruthenium catalysed azide–alkyne cycloaddition. 
8.5.  In Vitro Assays  
8.5.1.  Antioxidants Evaluation 
The compounds synthesised herein (Figure 8.5.1Figure 8.5.1) were tested for their 
antioxidant capacity by means of DPPH (2,2-diphenyl-1-picrylhydrazyl radical) and FRAP 
(Ferric Reducing Antioxidant Power) testing (Table 8.5.1Table 8.5.1). 
It is important, whenever screening the antioxidant capacity of a compound, to perform the 
testing on different assays, in order to understand the radical scavenging selectivity. The 
different radical that can be encountered in biological systems has different reactivity 
profiles, thus one molecule can be selective towards one radical species over another. 
It was particularly relevant for our study to check the performance of the newly 
synthesised compounds against FRAP considering that the active site of both our selected 
targets contain iron and, in particular, the action mechanism of zileuton against 5-LO is 
known to involve the reduction of the iron in the active site. 
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Figure 8.5.1 Summary of compounds synthesised and tested on their antioxidant power. 
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Table 8.5.1 Antioxidant assay results expressed in µmol of Trolox unit for gram of sample. 
Entry Compound DPPH (µmol Trolox/g) FRAP (µmol Trolox/g) 
1 Zileuton  755.95 ± 1.9 
2 Caffeic Acid 396.10 ± 0.5 9273.49 ± 2.2 
3 1a 5.43 ± 0.3 8.07 ± 0.8 
4 3a 248.52 ± 2.9 64.71 ±1.1 
5 3b 129.59 ± 1.7 104.38 ± 1.3 
6 3c 191.39 ± 0.5 65.03 ± 0.7 
7 3d 77.32 ± 0.6 31.81 ± 1.5 
8 3e 59.38 ± 0.3 29.15 ± 0.6 
9 3f <LOQ
††††
 54.42 ± 1.2 
10 5 92.81 ± 0.9 3,87 ± 0.2 
11 7 <LOQ 91,47 ± 1.1 
12 8a 131.8 ± 1.2 2738.55 ±  3.4 
13 8b 48.75 ± 0.4 598.58 ± 1.6 
14 8c 117.40 ± 0.8 32.13 ± 1.2 
15 8d 185.36 ± 1.1 98.90 ± 2.1 
16 8e 553.27 ± 0.8 391.81 ± 1.3 
17 8f <LOQ <LOQ 
18 8h 157.2 ± 1.7 322.45 ± 1.8 
19 9 472.74 ± 1.4 93.74 ± 0.7 
20 10 341.22 ± 2.1 42.77 ± 0.8 
 
Protecting the phenolic hydroxyl group on caffeic acid as in compound 1a leads to almost 
complete loss of antioxidant activity, as expected (for DPPH tests from 396.10 to 5.43 
µmol Trolox/g, for FRAP from 9273.49 to 8.07 µmol Trolox/g). The esterification of 1a to 
                                                          
††††
 Quantification limit 
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afford terminal alkyne compounds 3a-3d recovered a reasonable amount of the antioxidant 
activity on both the assays tested, but the elongation of the alkyl chain going from 3a to 3d 
decreased the antioxidant power (in DPPH 3a 248.52 µmol Trolox/g, 3d 77.32 µmol 
Trolox/g; FRAP 3a 64.71µmol Trolox/g, 3d 31.81µmol Trolox/g). The decrease in 
activity that follows the chain elongation does not seem to be linear and this effect will be 
investigated in the future. Compound 3f, in which the two phenolic hydroxyl groups have 
been substituted with two fluorine atoms does not show any activity against DPPH but 
showed some activity in the Frap test (although considered negligible 54.42 µmol 
Trolox/g) possibly due to the interaction between the terminal alkyne and the iron radicals. 
It is interesting to note that the response of the chain elongation in the compounds bearing 
the triazole linker core is different in the two assays. Increasing the chain length going 
from compound 8a to 8d, the DPPH test demonstrated  significant improvement in 
activity, whereas the results in the FRAP assay exhibited a decrease in antioxidant capacity 
(Entries 12-15, Table 8.5.1Table 8.5.1), the intermediate length between 8a and 8d do not 
sow a linear relationship between the chain length and the antioxidant power. Experiments 
to investigate the reasons behind this behaviour are currently undergoing.  
Substituting the ester bond for an amide linkage between the caffeic acid moiety and the 
linker as in compound 8e enhances the antioxidant ability on DPPH but lowers its potency 
against FRAP (Entry 16, Table 8.5.1Table 8.5.1). The orthogonal derivatives 9 and 10 
instead had negligible activity on the FRAP assays but they maintained a good activity 
profile in DPPH assays with compound 9 exceeding the antioxidant ability of its parent 
compound, caffeic acid (396.10 µmol Trolox/g of caffeic acid, 472.74 µmol Trolox/g for 
compound 9). Compound 10 preserved an activity profile (341.22 µmol Trolox/g) 
comparable to its parent compound caffeic acid (396.10 µmol Trolox/g). 
To summarise these results, the most interesting compounds for their antioxidant activity 
in DPPH assays were found to be 8e and 9 which exceeded the activity of their parent 
compound caffeic acid by 157.10 µmol Trolox/g and 76.64 µmol Trolox/g respectively. 
With respect to the FRAP analysis, the compound of highest interest was 8a that, although 
was less powerful than caffeic acid, exceeded the scavenging power over iron radicals of 
1982.6 µmol Trolox/g compared to zileuton, currently the leading commercial compound 
for directly inhibiting 5-lipoxygenase. 
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8.5.2.  Antimycotic Assays 
The molecules presented herein were tested for their antimycotic activity against eight 
strains of dermatophytes, which are responsible for the most common dermatomycosis: M. 
canis (M.c.), M. gypseum (M.g.), T. violaceum (T.v.), T. mentagrophytes (T.m.), T. 
tonsurans (T.t.), T. rubrum (T.r.), E. floccosum (E.f.) and A. cajetani (A.c.)at two 
concentrations 20 µg/mL and 100 µg/mL.
‡‡‡‡
 
Fluconazole was used as a reference material (Table 8.5.2Table 8.5.2). Its IC50, expressed 
in mg/mL, was checked on all the dermatophytes considered in this study (Table 8.5.3Table 
8.5.3) and it was shown that on A. cajetani fluconazole is inactive (IC50  >200 µg/mL). 
Table 8.5.2 Percentage of growth inhibition at 20 µg/mL and 100 µg/mL of reference compound on the 
chosen dermatophytes strains. 
Compounds Fluconazole 
 Microorganism M. g. M. c. T. v. T. m. T. t. T. r. E. f. A. c. 
Concentrations 
tested 
20 µg/mL 56.35 38.10 46.51 99.14 51.11 39.42 100.00 + 
100 µg/mL 79.37 79.37 89.39 103.45 66.67 67.31 102.27 5.35 
 
Table 8.5.3 IC50 of reference compounds Fluconazole and Econazole on the dermatophytes of interest. 
Compounds Fluconazole 
Microorganism M.g M.c T.v T.m T.t T.r E.f A.c 
IC50 [µg/mL] 18.5 29.6 31.03 3.53 19.41 37.16 0.08 > 200 
The compounds were tested following the diffusive method in Sabouraud Dextrose Agar 
(SDA), using DMSO as solvent. The growth inhibition of the compounds tested on the 
microorganism are reported in Table 8.5.4Table 8.5.4 and Table 8.5.5Table 8.5.5 at 20 
µg/mL and 100 µg/mL. The compounds were initially tested at concentrations 20 µg/mL 
and 100 µg/mL to evaluate, by comparison with the results obtained for the clinically 
                                                          
‡‡‡‡
 Given our available resources, we proceeded with the testing on the live microorganism. Our laboratories 
are currently in the process of acquiring the capabilities and expertise to run the testing on the isolated 14 α-
lanosterol demethylase which will verify if the obtained results are influenced by the interaction with the 
dermatophytes cell environment.  
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approved wide spectrum antimycotic drug, fluconazole, at the same concentrations, if there 
a compound within our library which showed potential to investigate further in terms of 
IC50 and MIC.  
Table 8.5.4 Percentage of growth inhibition intermediates. 
Microorganism [mg/mL] Caffeic 
Acid 
1a 3a 3b 3c 3d 3e 3f 5 7 
M. gypseum 20 µg/mL + 4.76 8.41 4.76 26.67 10.83 1.89 + 11.21 13.33 
100 µg/mL 1.06 10.48 64.49 29.52 37.50 5.83 3.77 46.22 47.66 28.57 
M. canis 20 µg/mL + + 24.14 29.55 23.61 18.87 1.37 20.73 22.41 21.64 
100 µg/mL 6.32 2.78 68.97 42.42 31.94 16,98 15.07 50.61 56.03 28.36 
T. violaceum 20 µg/mL 0 + 50.00 33.33 32.26 13.33 + 28.26 0.00 13.79 
100 µg/mL 62.5 12.90 93.33 66.67 25.81 15.56 13.79 63.04 46.15 20.69 
T. 
mentagrophytes 
20 µg/mL 1.23 + 29.90 25.81 28.95 10.17 0.00 18.33 4.04 10.20 
100 µg/mL 2.47 + 78.35 66.67 39.47 8.47 + 49.17 36.36 26.53 
T. tonsurans 20 µg/mL 2.50 2.38 2.38 19.51 21.82 + 7.32 14.86 40 + 
100 µg/mL 12.50 57.14 57.14 29.27 32.73 + 7.32 45.95 40 2.63 
T. rubrum 20 µg/mL + 22.22 26.47 45.45 30.95 20.83 + 12.50 35.71 16.67 
 100 µg/mL 54.55 33.33 67.65 42.42 33.33 12.50 6.82 43.75 60.71 30.56 
E. floccosum 20 µg/mL + + 27.27 52,08 59.02 13.56 + 16.22 20.00 + 
100 µg/mL 0.00 13.51 69.70 83,33 68.85 6.78 + 47.30 91.11 + 
A. cajetani 20 µg/mL + 4.23 10.94 16,28 41.67 4.42 6.25 3.91 20.00 + 
 100 µg/mL 9.41 8.45 53.13 44,19 50.00 + 13.28 30.47 26.67 12.00 
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Table 8.5.5 Percentage of growth inhibition final compounds. 
Microorganism  [mg/mL] Caffeic 
acid 
8a 8b 8c 8d 8e 8f 8h 9 10 
M. gypseum 20 µg/mL + 0.00 + 11.40 32.32 + 8.74 8.60 4.39 9.84 
100 µg/mL 1.06 0.00 + 22.81 34.34 5.94 21.36 8.60 3.51 9.84 
M. canis 20 µg/mL + 1.09 0.00 0.89 22.22 7.21 + + 1.27 0.00 
100 µg/mL 6.32 1.09 5.37 16.96 34.34 8.11 12.61 1.32 2.55 2.53 
T. violaceum 20 µg/mL 0 0.00 2.50 9.09 14.81 + + ++ + 0.00 
100 µg/mL 62.5 11.76 5.00 21.21 14.81 9.09 0.00 ++ + 7.69 
T. 
mentagrophytes 
20 µg/mL 1.23 5.88 1.83 6.80 24.18 + 2.53 7.29 2.65 8.85 
100 µg/mL 2.47 8.82 2.75 15.53 34.07 + 13.92 7.29 1.77 + 
T. tonsurans 20 µg/mL 2.50 10.34 6.45 18.18 4.65 + 3.13 + 14.75 + 
 100 µg/mL 12.50 13.79 9.68 18.18 9.30 1.92 9.38 4.0 4.92 + 
T. rubrum 20 µg/mL + 25.0 10.42 + 27.03 3.85 + + 0.00 6.12 
100 µg/mL 54.55 31.25 25.00 0.00 37.84 38.46 0.00 8.0 + 2.04 
E. floccosum 20 µg/mL + 4.35 + 16.22 20.51 11.11 + + 10.29 4.48 
100 µg/mL 0.00 21.74 + 18.92 33.33 22.22 + + 20.59 5.97 
A. cajetani 20 µg/mL + 6.06 17.65 5.63 24.62 0.00 + 1.49 1.25 1.33 
100 µg/mL 9.41 7.58 29.41 7.04 30.77 0.00 + 0 5.00 2.67 
 
Although it was not possible to draw a clear profile in the relationship between the 
structures and the activity profile, one main conclusion was evident from this pool of data. 
Unexpectedly, the compounds that revealed to be more promising were not the ones 
bearing the triazole core. Compound 3a (Table 8.5.4Table 8.5.4) showed the broadest 
activity profile, at a concentration of 100 mg/mL and exhibits inhibitions at >50% on all the 
dermatophytes strains herein considered. Compound 3a was also the one that showed the 
strongest inhibition values among all the compounds with the exception of  E. floccosum in 
which compound 3b at 100 mg/mL shows a slightly higher growth inhibition value 
(83.33%) compared to the same concentration of 3a (69.70%).  
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Among the compounds bearing the triazole core (Table 8.5.5Table 8.5.5), the only one that 
gave moderate inhibition growth was 8d with the best inhibition values for this class of 
compounds ranging between 30% and 40% at concentration of 100 mg/mL. None of the 
compounds synthesised showed more promising activity over the reference compound, 
Fluconazole. Only 3a gave, in some cases, similar results compared to fluconazole e.g. 
against T. rubrum and T. violaceum with inhibition values of 67.75% and 93.33% 
respectively compared to 67.31% and 89.39% for Fluconazole. 
Taking into account, that Fluconazole proved to be inactive on A.cajetani, it would be 
valuable to consider further investigations, in the future, on the compounds showing 
growth inhibition higher than 40% at 100 µg/mL. From this category, the actives that 
performed well are 3a, 3b and 3c. 
It is also worth mentioning, that the compounds 3a-g, 5 and 7 as a general trend showed 
higher inhibitory power on the dermatophytes investigated compared to their parent 
compound caffeic acid (Table 8.5.4Table 8.5.4). 
8.5.3.  5-Lipoxygenase Activity Studies 
The compounds presented above were tested for their ability to inhibit leukotriene 
formation on purified 5-lipoxygenase (5-LO) in cell-free assays and in intact cells 
polymorphonuclear leukocyte (PMNL). It is important to evaluate the inhibitory power 
both in cell-free assays and in intact cells, due to the more complex pathways involved in 
the intact cells that can interact with the actives before reaching the sight of action.
116
 To 
study the ability of the compounds to inhibit the 5-LO product formation in intact cells, 
human neutrophils stimulated by means of Ca
2+
 ionophore A23187 with exogenous AA at 
20 µM were used.
117,118
 The commercially available zileuton served as a reference 
compound and the analysis of the products formed from 5-LO (LTB4, its two trans-isomers 
and 5-H(P)ETE) was performed with reverse-phase high-performance liquid 
chromatography (RP-HPLC). Preliminary experiments were carried out at 10 µM 
concentration and the concentrations used to evaluate the IC50 of the compounds were 
0.1µM, 0.3µM, 1 µM and 3µM (Table 8.5.6Table 8.5.6).§§§§  
 
                                                          
§§§§
 These studies were possible thanks to the collaboration with Professor Oliver Werz from the Department 
of Pharmaceutical/Medicinal Chemistry,
 
Institute of Pharmacy, University of Jena, Germany. 
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Table 8.5.6 IC50 values on PMNL and isolated 5-LO. 
Entry Comp.No 5-LO in PMNL 
IC50 in mM 
(% remaining activity) 
Isolated 5-LO 
IC50 in mM 
(% remaining activity) 
1 Caff. >10 (104 ± 4.0) 8.5 ± 0.6 
2 1a >10 (84.7 ± 3.5) >10 (90.3 ± 1.6) 
3 3a 1.8 ± 0.2 >10 (50.2 ± 3.7) 
4 3b 0.92 ± 0.34 >10 (84.3 ± 1.8) 
5 3c 0.47 ± 0.15 >10 (70.7 ± 4.7) 
6 3d 0.18 ± 0.01 >10 (71.8 ± 4.6) 
7 3e 8.23 ± 0.15 >10 (53.5 ± 3.1) 
8 3f >10 (88.2 ± 3.9) >10 (52.6 ± 3.0) 
9 5 1.3 ± 0.4 >10 (73.9 ± 8.2) 
10 7 2.6 ± 0.1 >10 (86.3 ± 4.8) 
11 8a 9.9 ± 1 7.4 ± 0.5 
12 8b 6.1 ± 0.5 7.6 ± 0.3 
13 8c 3.1 ± 0.6 6.7 ± 0.3 
14 8d 0.2 ± 0.03 3.2 ± 0.2 
15 8e >10 (103.7 ± 4.3) > 10 (53.6 ± 14.3) 
16 8f >10 (101.4 ± 6.6) > 10 (90.3 ± 9.7) 
17 8h > 10 (75.1 ± 4.3) 7.6 ± 3.0 
18 9 0.6 ± 0.09 > 10 (81.3 ± 10.4) 
19 10 0.16 ± 0.01 > 10 (60.5 ± 8.2) 
 
The data highlighted a clear profile in the structure–activity relationship (SAR). Initially, 
we protected the phenolic hydroxyl groups of caffeic acid and, as expected, the activity on 
the isolated enzyme decreased (IC50 from 8.5 µM to >10 µM). Although in the cell 
environment, 1a has a better inhibitory profile on the formation of leukotrienes than caffeic 
 100 
 
acid, the residual leukotrienes formed after incubation with 1a is 84% against 104% when 
incubated with caffeic acid. We expect that the acetyl group is facilitating the transit across 
the cell membrane over the free hydroxyl derivatives similar to the case reported by 
Biasutto et al.
119
 
First of all, the chain length appears to play a critical role in the activity profile, both on 
isolated enzyme and on intact cells, as can be seen in Figure 8.5.2Figure 8.5.2 and Figure 
8.5.3Figure 8.5.3. 
 
Figure 8.5.2 Chain elongation effect on IC50 values on isolated 5-LO. 
 
Figure 8.5.3 Chain elongation effect on IC50 values against PMNL. 
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Elongating the chain length leads to a decrease in the IC50 values (8a>8b>8c>8d) on both 
the isolated enzyme and intact cells. The effect of the chain elongation is more evident in 
intact cells where the IC50 between 8a and 8d is 9.7 µM compared to 3.2 µM on the 
isolated 5-LO. However, the activity profiles on the isolated enzyme and on the cell based 
assays are comparable in compounds 8a-8d, confirming that they specifically targeting 5-
LO in the leukotriene pathway. 
Intermediates 3a-3d did not show relevant activity on the isolated enzyme (residual 
activity at all concentrations checked was higher than 50%, IC50 >10 mM), but they 
demonstrated a good activity profile on the intact cells with IC50 between 1.8 and 0.18 µM 
(compounds 3a and 3d respectively). The chain length seems to play a role in this case as 
well (Figure 8.5.4Figure 8.5.4) although less significant – the IC50 from 3a to 3d is 1.0 
µM.  
 
Figure 8.5.4 Effect of increasing the chain length of the active compounds (3a-3d) on PMNL. 
It can be speculated that this lower impact of the chain length on the activity against 5-LO 
for intermediates 3a-3d compared to 8a-8d could be due to the fact that their mode of 
action on the intact cells is mainly due to interactions with other targets involved in the 
leukotrienes formation, and only partially interacts on 5-LO. The hypothesis that 
compounds 3a-3d interact mainly with other targets in the leukotrienes pathway, is 
supported by the difference in the IC50 values between intact cell environment and isolated 
5-LO, where compounds 3a-3d show IC50 values between 1.8 and 0.18, and higher than 10 
µM respectively. The IC50 values higher than 10 µM in the isolated enzyme proof that 
compounds 3a-3d do not inhibit, to a significant extent, the 5-LO activity, and thus the 
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anti-inflammatory effect evidenced in PMNL could be mainly due to interactions with 
other targets involved in the leukotrienes pathway. 
The isomer of triazole 8a (i.e. 8h) led only to a slight decrease in the activity profile 
against 5-LO on both cell based (8h IC50 >10 µM; 8a 9.9 µM) and cell free assays (8h IC50 
7.6 µM; 8a 7.4 mM). 
The corresponding amide 8e of ester 8a was inactive in cell based assays (IC50 >10 mM 
and 9.9 µM respectively) and cell-free assays (IC50 >10 µM and 7.4 mM respectively). A 
similar decrease in the activity profile is observed for intermediate 3e compared to the 
corresponding ester 3a (Table 8.5.6Table 8.5.6). Substituting the acetoxy groups of 8a with 
fluorine in 8f led to an inactive derivative. The same trend is evidenced in intermediate 3a 
compared to its fluorine derivative 3f. 
The orthogonal derivatives 9 and 10 failed to significantly suppress the activity of isolated 
5-LO, but potent inhibition of 5-LO in intact cells was evident with IC50 values of 0.6 µM 
and 0.16 µM, respectively. Compounds 9 and 10, along with 3d are inhibitors of cellular 
5-lipoxygenase products, but they are inefficient on isolated 5-LO, suggesting a possible 
interaction of these compounds with other targets on the leukotriene pathways that requires 
the intact cell environment to be suppressed such as FLAP.
120
 
Experiments to validate this hypothesis have been carried out in transfected HEK (Human 
Embryonic Kidney cells) cell with or without FLAP, on representative compounds 3a, 9 
and 10 among the molecules showing good inhibition in intact cells (PMNL) but no 5-LO 
inhibition on the isolated enzyme. The results highlighted that the inhibitory activity of the 
compounds are slightly better in HEK cells expressing just 5-LO compared to HEK cells 
expressing both 5-LO and FLAP. This suggests that the compounds need the intact cellular 
environment to act as strong inhibitors of 5-LO product formations, but the action 
mechanism does not involve interaction with FLAP. Hypothesis and experiments to clarify 
how the action mechanism changes in parallel to the structural modifications are ongoing. 
Compounds 3d, 9 and 10 turned out to be the most potent inhibitors of cellular 5-LO 
activity with IC50 values 0.18 mM, 0.6mM and 0.16 mM respectively. The lead compound 
against 5-LO in cell free and cell based assays is 8d with IC50 value of 0.2 mM and 3.2 mM 
in cell based and cell free assays respectively. 
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8.5.4.  Cytotoxicity Assays  
U937 cell line are characterised by monocytic-like properties and represent a good cell 
standard for EC(ATCCCRL1593.2 ) 50 evaluation.
*****
 U937 were used to determine if the 
decrease in the cell 5-LO lines was a consequence of a possible cytotoxic effect of the 
synthesised compounds. 
The incubation of U937 for 24 hours with representative compounds from the library was 
performed to evaluate if the cell viability expressed as EC50, which is the concentration 
required to inhibit MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) -
reducing mitochondrial dehydrogenase activity by 50%, adheres to this hypothesis (Figure 
8.5.5Figure 8.5.5). 
 
Figure 8.5.5 EC50 of representative compounds on U397. 
As is evident from the above results, the representative compounds chosen from the library 
to evaluate cell viability, caused cytotoxic effects at concentrations similar to caffeic acid. 
Compound 8f, which was one of the less active among the compounds tested in biological 
assays, presented the highest effect on cell viability with an EC50 of 5 µM. These data 
suggest that the inhibition of 5-LO is unrelated to the cytotoxic effects of the compounds in 
the present library. 
                                                          
*****
 Cytotoxicity assays were performed by Dr Roberta Rizzo (Department of Medical Sciences, University 
of Ferrara, Italy) 
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9.  Conclusions 
In this dissertation, a new series of derivatives based on caffeic acid has been designed, 
synthesised and tested against eight strains of dermatophytes and 5-lipoxygenase free cell 
and cell based assays. Although a clear profile in the structure–activity relationship (SAR) 
on the dermatophytes did not emerge, it was, however, possible to obtain some useful 
information. However, with respect to the 5-LO assays, it was possible to obtain a clear 
pattern in the SAR’s. Concerning the experiments on the dermatophytes, the most 
promising molecules, unexpectedly, were not those containing the triazole core. 
Compound 3a was the most potent and exhibited the widest spectrum of action. Its growth 
inhibition values exceeded 50% at 100 µM/mL concentration on all the strains considered 
in this study. It constitutes a remarkable improvement in the activity compared to its parent 
compound caffeic acid which showed no activity at both concentrations tested on M.c., 
M.g., A.c., E.f., T.m. and T.t. showing instead a growth inhibition rate of 62.5% on  T.v. 
and of 54.55% on T.r., but also on T.v. and on T.r. compound 3a set a remarkable 
improvement with growth inhibition values of 93.33% and 67.65% respectively. The only 
exception was on E. Floccosum in which compound 3b at 100 µg/mL shows an higher 
growth inhibition value (83.33%) then 3a (69.70%). The only analogue to give moderate 
inhibition growth was 8d with the best inhibition values ranging between 30% and 40% at 
concentration of 100 µg/mL. Overall almost none of the compounds synthesised showed 
more promising activity than the reference compounds Fluconazole and Econazole. Only 
3a gave, in some cases, similar results compared to Fluconazole e.g. against T.r. and T.v. 
with inhibition values of 67.75 % and 93.33% respectively against the 67.31 % and 89.39 
% of Fluconazole.  
On the other hand, against the 5-LO assays a clear pattern was evident. Linker length 
proved to be critical for inhibitory power against 5-LO product formations on both isolated 
enzyme and PMNL (IC50 8a>8b>8c>8d). The presence of the triazole ring seemed critical 
for selectivity towards 5-LO (IC50 3d on isolated 5-LO >10 µM, 8d IC50 3.2 µM). The 
absence of the triazole core (compounds 3a-3e, 5 and 7) led to very good activity in cell 
based assays (IC50 between 1.8 µM and 0.18 µM) but no activity against the isolated 
enzyme, suggesting an action mechanism which requires the intact cell environment.  
Compound 8d has been highlighted, among all the molecules tested, to be the lead 
compound for selective inhibition of 5-LO products formation either on isolated enzyme or 
on cell based assays with IC50 of 3.2 mM and 0.2 mM respectively, with a power exceeding 
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the clinically approved zileuton which has IC50 of  3.5 mM and 1.9 mM respectively. 
Substitution of the acetoxy substituents on the aromatic ring of caffeic acid with fluorine 
(compounds 3f and 8f) leads to complete loss in activity on both isolated 5-LO and PMNL. 
Substitution of the ester motif with an amide (compounds 3e and 8e) led to significant 
decrease or total loss of activity (Table 8.5.6Table 8.5.6). Moreover, rearrangement of 8a 
or 8h impaired the 5-LO activity in PMNL. Instead azide 5 compared to alkyne 3a 
maintains the same activity against PMNL suggesting that an electron dense portion could 
be crucial for inhibition of 5-LO product formation in intact cells (they show no activity 
against isolated 5-LO). Furthermore, the orthogonal derivatives 9 and 10, although failing 
to inhibit 5-LO directly, proved to be more powerful than the clinically approved zileuton 
in inhibiting leukotrienes formation in PMNL with IC50 of 0.6 mM and 0.16 mM 
respectively. After evaluating compound 3a, 9 and 10 for FLAP interactions, they all 
resulted in a slightly higher inhibitory activity on HEK cells where just 5-LO was 
expressed compared to HEK cells where both 5-LO and FLAP were expressed. These 
findings highlight that the action mechanism of those compounds does not involve FLAP 
but needs the intact cell environment. Studies to explain the different mechanism taking 
place with the modifications of the structures in this class of compounds are currently 
ongoing. 
The cytotoxicity test performed excluded the possibility that activity against leukotrienes, 
for the compounds herein presented was due to a cytotoxic effect. 
To summarise, the results obtained in this research enabled the design of a new potential 
class of 5-LO inhibitors based on caffeic acid and triazole core moiety, identifying key 
elements necessary to selectively address the activity against 5-LO and drew a clear 
relationship between structure and activity for the synthesised compounds against this 
target. 
The only compound among those containing the triazoles ring that may be developed as 
part of a multi-target strategy, capable of blocking 5-LO alongside 14 α-lanosterol 
demethylase is compound 8d. In fact, it demonstrated very good activity against 5-LO in 
both cell free and cell based assays, as mentioned above, and showed a growth inhibition 
rate on dermatophytes of around 30%. The action against the dermatophytes was not ideal 
but leaves hope for improvement. The first step to verify its potential as multi-target drug 
will be to evaluate 8d against isolated 14 α-lanosterol demethylase in order to evaluate if 
its moderate inhibition on the microorganism is due to a scavenging mechanism possessed 
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by the fungus and to confirm that its inhibitory activity is not due to some unexpected 
action mechanism. 
Compounds 3a-3d revealed to be potential multi-target analogues, considering they give 
good growth inhibition rates on the evaluated dermatophytes strains and they are powerful 
against 5-LO product formations in intact cells. Taking into account that these analogues 
proved to be active in cell environments they will be now screened against isolated 
enzymes involved in dermatophyte cell growth and enzymes involved in the arachidonic 
acid pathways, in order to identify their specific targets and understand how to optimise 
their structure towards a successful multi-target strategy. 
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10.  Experimental Protocols and Compounds Characterisation 
10.1.  Antioxidants Protocols 
10.1.1.  DPPH Test  
The antioxidant assays involving the DPPH· (1,1- diphenyl-2-picrylhydrazyl) free radical 
is used to measure the scavenging ability of complex mixtures of pure compounds. It is 
very popular in the measure of the antioxidant power of natural products. Its success is due 
to the high sensitivity and the simplicity of operation, furthermore the DPPH· radical is 
one of the few organic nitrogen radical which are stable and commercially available. The 
theory underlying this assays is that H-donor molecules act as antioxidant toward the 
DPPH· radical. The action mechanism is shown in Figure 10.1.1Figure 10.1.1. The 
antioxidant power exerted by the compound/mixture tested is proportional to the 
disappearance of the DPPH· radical in the solution. Its disappearance is monitored 
commonly by UV spectrometer considering that the DPPH· radical shows a strong 
maximum absorption at max = 517 nm, which translates to a deep purple colour. The 
absorbance value, and thus the colour fades, in a proportional fashion with the decrease of 
the DPPH· radical in solution.  The antioxidant power is measured by monitoring the 
reduction of absorbance at 517 nm. The antioxidant value is expressed in µmol Trolox per 
g of samples.
121
 To standardise the method a calibration curve using trolox is done prior to 
experiments. Trolox is a commercially available water-soluble vitamin-E portion. Is 
common practice to express the results of this assay in trolox unit (TE) or as EC50 which 
is the amount of antioxidant necessary to decrease the DPPH· free radical of 50%. To 
scavenge 2 moles of DPPH· free radical 1 mole of trolox is necessary. It is important to 
mention that this method is not appropriate to evaluate the antioxidant activity of plasma 
due to precipitation of proteins in the alcoholic media.
122
 
Figure 10.1.1 DPPH· free radical scavenging mechanism. 
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The experimental protocol was adapted from the one reported by Wang et al. (1998)
123
. In 
1.5 mL of a 1.0 × 10
-4
 M methanol solution of DPPH·, 0.750 mL of solutions at different 
concentrations of tested compounds were added. Then the solutions with samples to 
analyse was shaken vigorously and kept in the dark for 30 minutes. The absorbance of the 
samples was measured on a spectrophotometer (Beckman Coulter 
TM
, DU

 530, Life 
Science UV-Vis Spectrophotometer) at max = 517 nm against a blank of methanol without 
DPPH·. The standard for preparation of calibration curve used was trolox. The values are 
expressed in µmol trolox unit for gram of sample, calculated as linear regression of the 
results obtained for the samples at different dilution. All tests were run in triplicate and 
averaged. 
10.1.2.  FRAP (Ferric reducing ability of plasma) Test 
Differently from the DPPH· antioxidant test is adequate not only to measure the 
antioxidant activity of pure compounds or mixtures, but also the plasma antioxidant 
capacity and for this specific purpose was developed by Benzie and Strain in 1996.
124
 
This assays measures the ability to reduce the ferric ion (Fe
3+
), in acidic conditions, to 
ferrous ion (Fe
2+
) in presence of 2,4,6-tripyrididyl-s-triazine (TPTZ) Figure 10.1.2Figure 
10.1.2. TPTZ forms a yellow complex with the Fe
3+
 ion, the complex of TPTZ with Fe
2+
 is 
instead blue. The absorbance increase with the reduction of the ferric iron to the ferrous 
one. The chemical reaction is reported in Scheme 10.1.1 FRAP action mechanism.Scheme 
10.1.1 FRAP action mechanism. 
 
Scheme 10.1.1 FRAP action mechanism. 
The increase in the absorbance is proportional to the reducing ability of the antioxidant 
under analysis
125
. The absorbance is measured at the max = 593 nm. 
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Figure 10.1.2 TPTZ structure. 
The reducing power of each standard solution was calculated according to the procedure 
reported by Xu et al. in 2007.
39
 The samples under investigation were dissolved in the 
selected solvent (methanol and/or water). The FRAP reagent is freshly prepared from the 
mixing of solutions A:B:C in a ratio 10:1:1 and left at 37 °C for 30 minutes. It needs to be 
stored at 37 °C while preparing the samples for analysis. Solution A: acetate buffer 0.3 M 
(pH 3.6), Solution B: TPTZ 10 mM in 40 mmol of HCl, Solution C: FeCl3 20 mM. 
To 1.9 mL of frap reagent was added 0.1 mL of solvent to perform the blank, or of 
extracted sample.  
Measurements were carried on at max = 593 nm with a spectrophotometer (Beckman 
Coulter 
TM
, DU

 530, Life Science UV-Vis Spectrophotometer). 
The standard used to prepare the calibration curve is Trolox, and the results are given in 
µmol Trolox/g. 
10.2.  Dermatophytes Experimental Protocols 
The dermatophytes used in this study were:  
1. Microsporum gypseum (Iran) CBS 130948 strain 
2. Microsporum canis (Iran) CBS 131110 strain 
3. Trichophyton violaceum (Africa) CBS 459.61 strain 
4. Trichophyton mentagrophytes (Netherlands) CBS 160.66 strain 
5. Trichophyton tonsurans (Netherlands) CBS 483.76 strain 
6. Trichophyton rubrum (Turkey) CBS 132252 strain 
7. Epidermophyton floccosum var. floccosum (Netherlands) CBS 358.93 strain 
8. Arthroderma cajetani (Netherlands), CBS 495.70 strain 
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The cell cultures were stored in agar’s slants or in an appropriate culture medium (SDA, 
Difco). 
In order to evaluate the antifungal activity of the compounds herein presented, cells 
cultures of each fungus were obtained after transplanting mycelium disks, 10 mm in 
diameter, from a single culture on a stationary phase. Consequently, these were incubated 
at 26 ± 1 °C on the appropriate medium (SDA), on thin sterile sheets of cellophane, until 
the logarithmic phase of growth was reached. The grown fungi were transferred then to 
Petri supports containing the medium loaded with the test compound. Each molecule was 
dissolved into dimethyl sulfoxide (DMSO), and a proper dilution in order to reach a final 
concentration of 20, or 100 µg/mL was aseptically added to the medium at 45 °C. In the 
final solutions the concentration of DMSO was adjusted to 0.1%. Controls were set up with 
equivalent quantities (0.1%) of DMSO. Determination of growth rate was achieved by 
registering the daily modifications in the colony diameter for a period of 7 days after the 
transport of the fungus onto supports containing the substance under investigation. At day 
7
th
 the d (difference in colony diameter between day 7 and control) in comparison with 
the control was evaluated for each fungus in order to evaluate the percentage values of 
growth inhibition on all the dermatophytes considered. The experiments were run in 
duplicates for each concentration considered. The growth inhibition values were expressed 
as the mean of values obtained in two independent experiments. 
The relative inhibition rate of the circle mycelium compared to the blank assay was 
calculated by means of Equation 10.2.1Equation 10.2.1. 
Relative inhibition rate (%) = [(dex − dex')/dex] × 100% 
Equation 10.2.1 Equation for the relative inhibition rate. 
In Equation 10.2.1Equation 10.2.1Errore. L'origine riferimento non è stata trovata. dex 
represents the extended diameter of the circle mycelium during the blank assay, whereas 
dex' the extended diameter of the circle mycelium during testing. 
10.3.  5-Lipoxygenase Protocols 
10.3.1.  Human Recombinant 5-LO Expression and Purification 
E. coli Bl21 (DE3) cells were transformed with pT3–5LO plasmid, lysed in a solution 50 
mM triethanolamine/HCl at pH 8.0 with addition of EDTA (5 mM), then soybean trypsin 
inhibitor (60 µg/mL), phenylmethanesulphonyl fluoride (1 mM), dithiothreitol (1 mM) and 
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pt, Non Grassetto, Non Corsivo,
Motivo: Trasparente (Bianco)
Formattato: Tipo di carattere: 12
pt, Non Grassetto, Non Corsivo,
Italiano (Italia), Motivo: Trasparente
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lysozyme (1 mg/mL) and were added and the mixture was subsequently sonicated (3  15 
sec). The homogenate was centrifuged at 10,000  g for 15 min and the remaining 
supernatant at 40,000  g for 70 min at 4 °C. 5-LO in the supernatant was partially purified 
by affinity chromatography on an ATP-agarose column as described by Fisher et al. in 
2003.
126
 The resulting semi-purified 5-LO was diluted in PBS containing EDTA (1 mM) 
and ATP (1 mM) and immediately used for activity assays. 
10.3.2.  Activity Assay for Human Recombinant 5-LO 
Human recombinant 5-LO was pre-incubated with the test compounds for 10 min at 4 °C 
and pre-warmed for 30 s at 37 °C. 5-LO product formation was initiated by addition of 2 
mM CaCl2 and 20 µM arachidonic acid. After 10 min at 37 °C, the reaction was terminated 
by addition of 1 mL ice-cold methanol. Formed 5-LO metabolites (all-trans isomers of 
LTB4 and 5-H(P)ETE) were analysed by means of RP-HPLC as described by Koeberle et 
al. in 2009.
127
  
10.3.3.  Determination of 5-LO Product Formation in Neutrophils 
Freshly isolated neutrophils (1 × 10
7
/mL) were pre-incubated with the test compounds for 
15 min at 37 °C. 5-LO product formation was then started by addition of 2.5 µM Ca
2+
-
ionophore A23187. The reaction was stopped after 10 min at 37 °C with 1 mL of 
methanol. Major 5-LO metabolites (LTB4 and its all-trans isomers and 5-H(P)ETE) were 
extracted and analysed by HPLC as described by Werz et al.
128
 Cysteinyl-LTs C4, D4 and 
E4 and oxidation products of LTB4 were not determined.  
10.4.  Cytotoxicity assays 
U937 (ATCCCRL1593.2 ) cell line, derived from malignant cells of a pleural effusion of 
37 year old Caucasian male with diffuse histiocytic lymphoma, was grown in RPMI 1640 
(Gibco) added with 10% FBS (Foetal Bovine Serum), 10% Hepes Buffer, 5% 
penicilin\strepatamicin at 37 °C in a humidified 5% CO2 atmosphere for 72 hours. 100 µL 
of cells at the density of 1 × 10
6
/mL were seaded into 96-well plates (Nunc) and added 
with the different compounds at different concentrations (Caffeic acid at 1, 10, 20 µM; 8a, 
8d, 8e,8f, 9,10 at 3, 10, 20 µM) and analysed by MTT assay (Sigma-Aldrich) after 24 hrs 
incubation. MTT stock solution (5 mg/mL) was added to each culture being assayed to 
equal one-tenth the original culture volume and incubated for 4 hr. At the end of the 
incubation period, we added acidic isopropanol (100 µL of 0.04 N HCl in absolute 
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isopropanol). Absorbance of converted dye was measured at a wavelength of 570 nm with 
background subtraction at 630–690 nm using ELISA-reader (Victor, Perkin-Elmer). We 
expressed the effect on cell viability as EC50, which is the concentration required to inhibit 
MTT-reducing mitochondrial dehydrogenase activity by 50%. The absorbance of untreated 
cells (RPMI+DMSO) was taken as 100% viability to calculate cytotoxicity.  
10.5.  General Synthetic Procedures and Compounds Characterisation 
All solvents were used as supplied unless otherwise stated.  
Flash column chromatography (FCC) was performed using Breckland Scientific silica gel 
60, particle size 40-63 nm under air pressure. Analytical thin layer chromatography (TLC) 
was performed using silica gel 60 F254 pre-coated glass backed plates and visualised by 
ultraviolet radiation (254 nm) and/or potassium  permanganate or ammonium molybdate as 
appropriate. Isolated yields are reported to 0 decimal places and “quant.” signifies a yield 
of 99.5% or higher. 
1
H NMR spectra were recorded on Bruker DRX-400 (400MHz) or 
DRX-600 (600 MHz) spectrometer. Chemical shifts are reported in ppm with the 
resonance resulting from incomplete deuteration of the solvent as the internal standard 
(CDCl3: 7.26 ppm, or DMSO-d6: 2.54 ppm, q). 
13
C NMR spectra were recorded on Bruker 
DRX-400 (100 MHz) or DRX-600 (150 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the internal 
standard (CDCl3: 77.0 ppm, t or DMSO-d6 : 30.73, ep.). Data are reported as follows: 
chemical shift δ/ppm , multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = 
broad, m = multiplet or combinations thereof. 
13
C signals are singlets unless otherwise 
stated), coupling constants J Hz, integration (
1
H only). 
1
H NMR signals are reported to 2 
decimal places and 
13
C signals to 1 decimal place unless rounding would produce a value 
identical to another signal. In this case, an additional decimal place is reported for both 
signals concerned. 
19
F NMR signals are reported to 2 decimal places and trifluoro-toluene 
(BTF) was used as internal standard. High resolution mass spectrometry (HRMS) was 
performed on a Waters Micromass LCT spectrometer using electrospray ionization, time-
of-flight analysis and Micromass MS software HRMS signals are reported to 4 decimal 
places and are within ±5 ppm of theoretical values. Infrared spectra were recorded neat as 
thin films on a Perkin-Elmer Spectrum One FTIR spectrometer and only selected peaks are 
reported (s = strong, m = medium, w = weak, br = broad). Melting points were collected 
using a Stanford Research Systems Optimelt automated melting point system using a 
gradient of 1 °C per min. 
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Purity was checked by elemental analysis or by HPLC traces using a C18 waters bondapak 
.10 mm*125Å, 3.9*150 mm. 
10.5.1.  Di-acetylation General Procedure 
To caffeic acid in pyridine (1.00 eq.) was added acetic anhydride (5.00 eq.) under magnetic 
stirring until the reaction was complete. The reaction mixture was then diluted with DCM 
and consequently washed three times with 3 M HCl and three times with brine, it was then 
dried over MgSO4 and concentrated to dryness to afford the pure product. 
10.5.2.  Esters Derivatives Synthesis: Method A.  
A mixture of diacetylcaffeic acid or 3,4 di-fluoro cinnamic acid (1.00 eq.), thionyl chloride 
(25.0 eq), a catalytic amount of DMF in dry benzene (1.00 mL each mmol of diacetyl-
caffeic acid) was refluxed for 4 hours. The excess of thionyl chloride was removed in 
vacuo. The residue was dissolved in dry benzene (4 mL for each mmol of diacetylcaffeic 
acid) before pyridine (0.001 eq.) was added drop-wise followed by the appropriate alcohol 
derivatives was added (1.2 eq.). The mixture was stirred at room temperature overnight 
under an atmosphere of argon. The resulting mixture was dried in vacuo, the residue re-
dissolved in DCM (10 mL) and the organics washed with water (3 × 10 mL), washed with 
brine (3 × 10 mL), dried over MgSO4 and solvents were removed in vacuo to afford the 
crude material. The crude was purified by column chromatography EtOAc/petroleum ether 
in the appropriate ratio according to the compound polarity. 
10.5.3.  Esters Derivatives Synthesis: Method B 
To 6-acetyl-2,5,7,8-tetramethylchromane-2-carboxylic acid (Acetyl-Trolox 1.00 eq.), 
prepared following the literature,
5
 in DCM was added DCC (1.00 eq.) and DMAP 
(1.00eq.). The mixture was allowed to stir for 10 minutes at room temperature before the 
azide or alcohol (1.00 eq.) was added. The mixture was stirred at room temperature 
overnight under an atmosphere of argon. The resulting mixture was filtered, washed with a 
10% solution of KHSO4 three times and dried over MgSO4 before the solvent removed in 
vacuo to afford the crude material.
6
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(E)-4-(3-(But-3-yn-1-yloxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (3a) 
 
According to the general esterification procedure method A, a solution of di-acetyl-caffeic-
acid (166 mg, 0.6 mmol, 1.0 eq) in SOCl2 (2.5 mL), DMF (44 µL) and dry benzene (1 mL) 
was refluxed for 4 hours. The mixture was then concentrated in vacuo. The residue was re-
dissolved in dry benzene (4 mL) before pyridine was added drop-wise followed by 3-
butyn-1-ol (52.98 mg, 0.75mmol, 1.2 eq). The reaction was allowed to stir for 12 hours at 
room temperature under an atmosphere of argon. The resulting mixture was concentrated 
in vacuo re-dissolved in DCM (10 mL) washed with water (3 × 10 mL), washed with brine 
(3 × 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
30:70). Recrystallised from EtOAc/hexanes (10:90) to give a white solid (176 mg, 0.56 
mmol, 93%).  
MP: 82 °C. Rf 0.23 (EtOAc/petroleum ether 30:70). 
1
H NMR (600 MHz, CDCl3) δ 7.65 (d, 
J = 16.0 Hz, 1H), 7.41 (dd, J = 8.4, 1.9 Hz, 1H), 7.36 (d, J = 2.0 Hz, 1H), 7.23 (d, J = 8.4 
Hz, 1H), 6.40 (d, J = 16.0 Hz, 1H), 4.32 (t, J = 6.8 Hz, 2H), 2.61 (m, J = 6.8, 2.7 Hz, 2H), 
2.31 (s, 3H), 2,30 (s, 3H), 2.03 (t, J = 2.7 Hz, 1H). 
13
C NMR (150 MHz, CDCl3) δ 168.0, 
167.9, 166.2, 143.6, 143.3, 142.4, 133.2, 126.4, 123.9, 122.8, 118.8, 80.0, 70.0, 62.3, 20.7, 
20.6, 19.1. FT-IR (Neat, υmax cm
-1
) 3272, 1765, 1714, 1638. HRMS m/z calculated for 
C17H17O6
 
[M+H]
+
 317.1020, found 317.1016. Elemental analysis calculated for C17H16O6 
found C 64.26 %, H 5.12%, requires C 64.55%, 5.10%. 
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(E)-4-[3-(Hex-5-yn-1-yloxy)-3-oxoprop-1-en-1-yl]-1,2-phenylene diacetate (3b) 
 
According to the general esterification procedure method A, a solution of di-acetyl-caffeic-
acid (1.0 g, 3.8 mmol, 1.0 eq) in SOCl2 (5 mL), DMF (280 µL) and dry benzene (4 mL) 
was refluxed for 4 hours. The mixture was then concentrated in vacuo. The residue was 
then re-dissolved in dry benzene (12 mL) before pyridine was added drop-wise followed 
by 5-hexyn-1-ol (445 mg, 4.54 mmol, 1.2 eq). The reaction was allowed to proceed for 12 
hours at room temperature under an atmosphere of argon. The resulting mixture was 
concentrated in vacuo, re-dissolved in DCM (10 mL) washed with water (3 × 10 mL), 
washed with brine (3 × 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
30:70). Recrystallised from hexanes (100%) to give a white solid (900 mg, 2.6 mmol, 
69%). MP: 48 °C. Rf 0.35 (EtOAc/petroleum ether 30:70). 
1
H NMR (400 MHz, CDCl3) δ 
7.58 (d, J = 16.0 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H), 7.33 (overlapping, br, s, 1H), 7.18 (d, J 
= 8.3 Hz, 1H), 6.35 (d, J = 16.0 Hz, 1H), 4.19 (t, J = 6.3 Hz, 2H), 2.26 (s, 3H), 2.25 (s, 
3H), 2.22 (overlapping m, 2H), 1.96 (s, 1H), 1.86 – 1.73 (m, 2H), 1.65 – 1.58 (m, 2H). 13C 
NMR (100 MHz, CDCl3) δ 167.7, 167.6, 166.2, 143.2, 142.5, 142.2, 133.0, 126.1, 123.7, 
122.5, 119.0, 83.7, 68.7, 64.0, 27.6, 24.8, 20.50, 20.46, 18.0. FT-IR (Neat, υmax cm
-1
) 3290, 
2933, 2864, 1762, 1707, 1638, 1507. HRMS m/z calculated for C19H21O6 [M+H]
+
 
345.1338,  found 345.1347. Elemental analysis calculated for C19H20O6 found C 66.23%, H 
5.87%, requires C 66.27%, 5.85%. 
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(E)-4-[3-(Hept-6-yn-1-yloxy)-3-oxoprop-1-en-1-yl]-1,2-phenylene diacetate (3c) 
 
According to the general procedure method A, a solution of Di-acetyl-caffeic-acid (1.5 g, 
5.6 mmol, 1 eq) in SOCl2 (10 mL), DMF (1 mL) and dry benzene (6 mL) was refluxed for 
4h. The mixture was then concentrate in vacuo. The residue was then re-dissolved in dry 
benzene (24 mL), pyridine was added drop-wise followed by 6-heptyn-1-ol (763.5 mg, 
6.72 mmol, 1.2 eq). The reaction was allowed to proceed for 12 hours at room temperature 
under an atmosphere of argon. The resulting mixture was concentrated in vacuo re-
dissolved in DCM (10 mL) washed with water (3 × 10 mL), washed with brine (3 × 10 
mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
30:70). Recrystallised from hexanes (100%) to give a white solid (823 mg, 2.29 mmol, 
41%). MP: 68 °C. Rf 0.23 (EtOAc/petroleum ether 30:70). 
1
H NMR (400 MHz, CDCl3) δ 
7.59 (d, J = 16.0 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 7.34 ( br, s, 1H), 7.19 (d, J = 8.3 Hz, 
1H), 6.36 (d, J = 16.0 Hz, 1H), 4.18 (t, J = 6.6 Hz, 2H), 2.272 (s, 3H), 2,266 (s, 3H), 2.19 
(td, J = 6.6, 2.3 Hz, 2H), 1.94 (t, J = 2.4 Hz, 1H), 1.76 – 1.64 (m, 2H), 1.62 – 1.43 (m, 4H). 
13
C NMR (100 MHz, CDCl3) δ 167.9, 167.8, 166.4, 143.3, 142.6, 142.3, 133.2, 126.2, 
123.8, 122.6, 119.2, 84.1, 68.4, 64.4, 28.1, 27.9, 25.0, 20.48, 20.45, 18.2. FT-IR (Neat, 
υmax cm-1) 3294, 2940, 2861, 1764, 1705, 1638. HRMS m/z calculated for C20H23O6 
[M+H]+ 359.1489, found 359.1479. Elemental analysis calculated for C20H22O6 found C 
66.99%, H 6.24%, requires C 67.03%, H 6.19%. 
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(E)-4-[3-(Dec-9-yn-1-yloxy)-3-oxoprop-1-en-1-yl]-1,2-phenylene diacetate (3d) 
 
According to the general procedure method A, a solution of di-acetyl-caffeic-acid (1.0 g, 
3.8 mmol, 1.0 eq) in SOCl2 (5 mL), DMF (1 mL) and dry benzene (4 mL) was refluxed for 
4 hours. The mixture was then concentrated in vacuo. The residue was then re-dissolved in 
dry benzene (12 mL) before pyridine was added drop-wise followed by 9-decyn-1-ol 
(703.4 mg, 5 mmol, 1.2 eq). The reaction was allowed to stir for 12 hours at room 
temperature under an atmosphere of argon. The resulting mixture was concentrated in 
vacuo re-dissolved in DCM (10 mL) washed with water (3 × 10 mL), washed with brine (3 
× 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
30:70). Recrystallised from hexanes (100%) to give a white solid (669.58 mg, 1.7 mmol, 
44%). MP: 49 °C. Rf 0.43 (EtOAc/petroleum ether 30:70). 
1
H NMR (400 MHz, CDCl3) δ 
7.61 (d, J = 16.0 Hz, 1H), 7.40 (dd, J = 8.4, 1.9 Hz, 1H), 7.36 (d, J = 1.8 Hz, 1H), 7.22 (d, 
J = 8.4 Hz, 1H), 6.38 (d, J = 16.0 Hz, 1H), 4.19 (t, J = 6.7 Hz, 2H), 2.31 (s, 3H), 2.30 (s, 
3H), 2.21 – 2.15 (m, 3H), 1.94 (t, J = 2.6 Hz, 1H), 1.74 – 1.64 (m, 2H), 1.59 – 1.46 (m, 
4H), 1.38 (m, 7H). 
13
C NMR (100 MHz, CDCl3) δ 168.34, 168.26, 167.0, 143.7, 142.9, 
142.7, 133.7, 126.6, 124.2, 123.0, 119.8, 85.0, 68.4, 65.1, 29.4, 29.3, 29.0, 28.9, 28.7, 26.2, 
21.0, 20.9, 18.7. FT-IR (Neat, υmax cm
-1
) 3303, 2932, 2862, 1764, 1709, 1638. HRMS m/z 
calculated for C23H29O6 [M+H]
+
 401.1959,  found 401.1956. Elemental analysis calculated 
for C23H28O6 found C 68.87%, H 7.03%, requires C 68.98%, H 7.05%. 
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(E)-4-(3-(But-3-yn-1-ylamino)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (3e) 
 
According to the general esterification procedure method A, a solution of di-acetyl-caffeic-
acid (264.23 mg, 1 mmol, 1.0 eq) in SOCl2 (2 mL), DMF (300 µL) and dry benzene (1 
mL) was refluxed for 4 hours. The mixture was then concentrated in vacuo. The residue 
was re-dissolved in dry benzene (4 mL) before pyridine was added drop-wise followed by 
1-amino-3-butyne (82.93 mg, 1.2 mmol, 1.2 eq). The reaction was allowed to stir for 12 
hours at room temperature under an atmosphere of argon. The resulting mixture was 
concentrated in vacuo re-dissolved in DCM (10 mL) washed with water (3 × 10 mL), 
washed with brine (3 × 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified column chromatography (EtOAc/petroleum ether 60:40). 
Recrystallised from EtOAc/hexane (90:10) to give a white solid (254 mg, 0.8 mmol, 80%). 
MP: 143 °C. Rf 0.32 (EtOAc/petroleum ether 60:40). 
1
H NMR (600 MHz, CDCl3) δ 7.57 
(d, J = 15.6 Hz, 1H), 7.37 (dd, J = 8.4, 1.7 Hz, 1H), 7.34 (d, J =1.6 Hz, 1H), 7.19 (d, J = 
8.3 Hz, 1H), 6.33 (d, J = 15.5 Hz, 1H), 5.97 (s, 1H), 3.54 (q, J = 6.3 Hz, 2H), 2.47 (td, J = 
6.3, 2.5 Hz, 2H), 2.301 (s, 3H), 2.296 (s, 3H), 2.04 (t, J = 2.5 Hz, 1H). 
13
C NMR (150 
MHz, CDCl3) δ 168.09, 168.07, 165.4, 142.9, 142.3, 139.2, 133.7, 126.2, 123.7, 122.2, 
121.7, 81.5, 70.1, 38.2, 20.58, 20.55, 19.4. HRMS m/z found 316.1191 requires 316.1185. 
FT-IR (Neat, υmax cm
-1
) 3274, 3241, 3073, 1755, 1658, 1614, 1569. HRMS m/z calculated 
for C17H18NO5 [M+H]
+
 316.1191, found 316.1185. Elemental analysis calculated for 
C17H17NO5 found C 64.37%, H 5.38%; N 4.30%, requires C 64.75%, H 5.43%, N 4.44% 
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But-3-yn-1-yl (E)-3-(3,4-difluorophenyl) acrylate (3f) 
 
According to the general esterification procedure method A, a solution of 3-4 di-fluoro 
cinnamic acid (3.0 g, 16 mmol, 1.0 eq) in SOCl2 (30 mL), DMF (1.5 mL) and dry benzene 
(16 mL) was refluxed for 4 hours. The mixture was then concentrated in vacuo. The 
residue was re-dissolved in dry benzene (50 mL) before pyridine was added drop-wise 
followed by 3-butyn-1-ol (1.36 mg, 19.5 mmol, 1.2 eq). The reaction was allowed to stir 
for 12 hours at room temperature under an atmosphere of argon. The resulting mixture was 
concentrated in vacuo re-dissolved in DCM (10 mL) washed with water (3 × 10 mL), 
washed with brine (3 × 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
10:90). Recrystallised from petroleum ether (100%) to give a white solid (2.2g, 9.3 mmol, 
58%). MP: 48 °C. Rf 0.4 (EtOAc/petroleum ether 10:90). 
1
H NMR (400 MHz, CDCl3) δ 
7.61 (d, J = 16.0 Hz, 1H), 7.40 – 7.30 (m, 1H), 7.28 – 7.23 (m, 1H), 7.18 (dt, J = 16.6, 8.2 
Hz, 1H), 6.37 (d, J = 16.0 Hz, 1H), 4.32 (t, J = 6.8 Hz, 2H), 2.61 (td, J = 6.8, 2.6 Hz, 2H), 
2.03 (t, J = 2.6 Hz, 1H). 
13
C NMR (100 MHz, CDCl3) δ 166.2 , 152.9 , 151.9 (d, J = 13.2 
Hz), 150.3 (d, J = 12.9 Hz), 149.4 (d, J = 13.2 Hz), 142.9 , 124.9 (dd, J = 6.6, 3.6 Hz), 
118.9 , 117.9 (dd, J = 17.8, 0.7 Hz), 116.5 (dd, J = 17.7, 0.9 Hz), 80.2 , 77.5 , 77.2 , 76.8 , 
70.1 , 62.6 , 19.3 . 
19
F NMR (376 MHz, CDCl3) δ -63.61 (d, J = 3.5 Hz), -134.83 (d, J = 
20.9 Hz), -137.41 (d, J = 20.8 Hz). FT-IR (Neat, υmax cm
-1
) 3296, 1710, 1640, 1612, 1602, 
1513. HRMS m/z calculated for C13H11F2O2 [M+H]
+ 
237.0722, found 237.0710. Elemental 
analysis calculated for C13H10F2O2 found C 66.07%, H 4.30%, requires C 66.10%, H 
4.27%. 
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(E)-Dec-9-yn-1-yl-3-(3,4-difluorophenyl)acrylate (3g) 
 
White solid (70%). MP 34 °C. Purified by column chromatography (EtOAc/hexane 10:90). 
Recrystallised from EtOAc/hexane (10:90). Rf 0.4 (EtOAc/hexane 10:90). 
1
H NMR (600 
MHz, CDCl3) δ 7.58 (d, J = 16.0 Hz, 1H), 7.34 (ddd, J = 10.8, 7.6, 2.0 Hz, 1H), 7.28 – 
7.24 (m, 1H), 7.18 (dt, J = 9.9, 8.2 Hz, 1H), 6.36 (d, J = 15.9 Hz, 1H), 4.21 (t, J = 6.7 Hz, 
2H), 2.19 (td, J = 7.1, 2.6 Hz, 2H), 1.95 (br s, 1H), 1.78 – 1.67 (m, 2H), 1.54 (m, 2H), 1.47 
– 1.28 (m, 8H). 13C NMR (150 MHz, CDCl3) δ 166.5, 151.8 (dd, J= 130.0, 13.0 Hz), 150.2 
(dd, J = 126.3, 13.0 Hz), 142.1 (t, J= 2.1 Hz), 131.7 (dd, J = 6.0, 4.0 Hz), 124.7 (dd, J = 
6.5, 3.4 Hz), 119.4 (d, J = 2.5 Hz), 117.8 (d, J = 17.7 Hz), 116.3 (d, J = 17.6 Hz), 84.7, 
68.1, 64.8, 29.1, 28.9, 28.6, 28.6, 28.4, 25.9, 18.3 . 
19
F NMR (376 MHz, CDCl3) -135.33 
(d, J = 20.8 Hz), -137.67 (d, J = 20.9 Hz). FT-IR (Neat, υmax cm
-1
) 3298, 2936, 2925, 2853, 
1712, 1639, 1516, 1272, 1179, 828, 666. HRMS m/z calculated for C19H23F2O2 [M+H]
+
 
321.1666, found 321.1657. Elemental analysis calculated for C19H22F2O2: C 71.23, H 6.92; 
found: C 71.25, H 6.88. 
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(E)-4-(3-(3-Azidopropoxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (5) 
 
According to the general esterification procedure method A, a solution of di-acetyl-caffeic-
acid (2.0 g, 7.5 mmol, 1.0 eq) in SOCl2 (10 mL), DMF (550 µL) and dry benzene (8 mL) 
was refluxed for 4 hours. The mixture was then concentrated in vacuo. The residue was re-
dissolved in dry benzene (24 mL) before pyridine was added drop-wise followed by 
3-azidopropan-1-ol (918.4 mg, 9.08 mmol, 1.2 eq). The reaction was allowed to stir for 
12 hours at room temperature under an atmosphere of argon. The resulting mixture was 
concentrated in vacuo re-dissolved in DCM (10 mL) washed with water (3 × 10 mL), 
washed with brine (3 × 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
40:60) to give a yellow oil (1.88 g, 5.4 mmol, 72%). Rf 0.28 (EtOAc/petroleum ether 
30:70). 
1
H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 16.0 Hz, 1H), 7.36 (dd, J = 8.4, 1.9 Hz, 
1H), 7.33 (d, J = 1.8 Hz, 1H), 7.17 (d, J = 8.3 Hz, 1H), 6.34 (d, J = 16.0 Hz, 1H), 4.23 (t, J 
= 6.2 Hz, 2H), 3.38 (t, J = 6.7 Hz, 2H), 2.25 (s, 3H), 2.24 (s, 3H), 1.96 – 1.88 (m, 2H). 13C 
NMR (100 MHz, CDCl3)
 δ 168.35, 168.25, 166.7, 143.9, 143.5, 142.8, 133.4, 126.7, 124.3, 
123.1, 119.2, 61.9, 48.5, 28.5, 20.93, 20.89. FT-IR (Neat, υmax cm
-1
) 2096, 2933, 2864, 
1770, 1710, 1639. HRMS m/z calculated for C16H18N3
 
O6 [M+H]
+ 
348.1190, found 
348.1189  
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3-Azidopropyl 6-acetoxy-2,5,7,8-tetramethylchromane-2-carboxylate (7) 
 
According to general esterification procedure method B, to a solution of 6-acetyl -2,5,7,8-
tetramethylchromane-2-carboxylic acid (Acetyl-Trolox 1.00 g, 3.4 mmol, 1.0 eq.) in DCM 
(15 mL) DCC (701 mg, 3.4 mmol, 1.00 eq.) and DMAP (415 mg, 3.4 mmol, 1.0 eq.) were 
added. The mixture was allowed to stir for 10 minutes before 3-azidopropan-1-ol (356 mg, 
3.4 mmol, 1.0 eq.) was added and the mixture was stirred at room temperature overnight 
under an atmosphere of argon. The resulting mixture was filtered, washed with a 10% 
solution of KHSO4 three times, dried over MgSO4 and the solvents removed in vacuo to 
afford the crude material. 
The crude material was purified by column chromatography (EtOAc/petroleum ether 
40:60). Rf 0.24 (EtOAc/petroleum ether 60:30) to give a colourless oil (1.0 g, 2.6 mmol, 
78%).  
1
H NMR (400 MHz, DMSO-d6) δ 4.13 (m, 1H), 3.97–4.03 (m, 1H), 3.10–3.03 (m, 
2H), 2.68 – 2.56 (m, 1H), 2.50 – 2.32 (m, 2H), 2.29 (s, 3H), 2.09 (s, 3H), 1.96 (s, 3H), 1.87 
(s, 3H), 1.86-1.77 (m, 1H), 1.75 – 1.65 (m, 2H), 1.57 (s, 3H). 13C NMR (100 MHz, 
DMSO-d6) δ 172.4, 168.8, 148.7, 140.9, 126.5, 124.9, 121.7, 117.0, 77.00, 61.8, 47.2, 
29.9, 27.5, 25.1, 20.24, 20.20, 12.7, 11.8, 11.6. FT-IR (Neat, υmax cm
-1
) 2934, 2097, 1731, 
1752. HRMS m/z calculated for C19H25N3O5Na [M+Na]
+
 398.1705,  found 398.1692 
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10.5.4.  Synthesis of Triazole Derivatives: 
To a stirred solution of azide analogues (1.0 eq.) and terminal alkyne derivatives (1.2 eq.) 
in a 1:1 ratio of H2O–tert-BuOH (4 mL for each mmol of alkyne derivative) was added 
copper(I) iodide (0.1 eq.). The mixture was heated at 125 °C for one hour until the limiting 
starting material disappeared (TLC 80% EtOAc-petroleum ether 20%). The reaction was 
allowed to cool to room temperature before the addition of water followed by extracted 
with DCM (3 × 10 mL), the organics separated and dried over MgSO4, concentrated and 
purified by column chromatography with the appropriate eluent system to afford the pure 
triazole derivatives. 
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(E)-4-(3-(2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)ethoxy)-3-oxoprop-1-en-1-yl)-
1,2-phenylene diacetate (8a) 
 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, reported above, to 3-azidopropan-1-ol (286  mg, 2.83 mmol, 1.0 eq.) in (1:1) 
H2O–tert-BuOH (7 mL) was added (E)-4-(3-(but-3-yn-1-yloxy)-3-oxoprop-1-en-1-yl)-1,2-
phenylene diacetate (1.07 g, 3.4 mmol, 1.2 eq.). Then copper(I) iodide (54 mg, 0.283 
mmol, 0.1 eq.) was added. The mixture was heated at 125 °C for one hour in a sealed tube. 
The reaction was then allowed to cool to room temperature than diluted with water, 
extracted with DCM (3 × 10 mL), dried over MgSO4, concentrated and purified by column 
chromatography (EtOAc/petroleum ether 70:30) to give a yellow oil (0.87 g, 2.1 mmol, 
74%). Rf 0.20 (EtOAc 100%). 
1
H NMR (600 MHz, CDCl3) δ 7.62 (d, J = 16.0 Hz, 1H), 
7.45 (s, 1H), 7.40 (dd, J = 8.4, 1.8 Hz, 1H), 7.37 (d, J = 1.8 Hz, 1H), 7.23 (d, J = 8.4 Hz, 
1H), 6.38 (d, J = 16.0 Hz, 1H), 4.52-4.48 (m, 4H), 3.64 (q, J = 5.6 Hz, 2H), 3.20 – 3.12 (m, 
2H), 2.35 (s, 1H), 2.32 (s, 3H), 2.31 (s, 3H), 2.15 – 2.10 (m, 2H). 13C NMR (150 MHz, 
CDCl3) δ 168.3, 168.1, 166.5, 143.7, 143.3, 142.5, 133.3, 126.6, 124.1, 122.9, 122.3, 
119.1, 63.5, 58.8, 47.0, 32.7, 31.1, 25.7, 20.77, 20.76. FT-IR (Neat, υmax cm
-1
) 2954 (br), 
1771, 1710, 1638, 1505. HRMS m/z calculated for C20H24O7N3 [M+H]
+
 418.1609, found 
418.1605.   
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(E)-4-(3-(4-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)butoxy)-3-oxoprop-1-en-1-yl)-
1,2-phenylene diacetate (8b) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, reported above, to 3-azidopropan-1-ol (25 mg, 0.25 mmol, 1.00 eq.) in (1:1) 
H2O–tert-BuOH (2 mL) was added (E)-4-[3-(hex-5-yn-1-yloxy)-3-oxoprop-1-en-1-yl]-1,2-
phenylene diacetate (106 mg, 0.3 mmol, 1.2 eq.). Copper(I) iodide (5 mg, 0.025 mmol, 0.1 
eq.) was then added. The mixture was heated at 125 °C for one hour in a sealed tube. The 
reaction was then allowed to cool to room temperature before dilution with water. The 
reaction mixture was extracted with DCM (3 × 5 mL), dried over MgSO4, and the volatiles 
removed in vacuo and the crude product purified by column chromatography 
(EtOAc/petroleum ether 70:30) to give a yellow oil (40% ) Rf 0.22 (EtOAc 100%). 
1
H 
NMR (400 MHz, CDCl3) δ 7.59 (d, J = 16.0 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 7.35 (br, s, 
2H), 7.20 (d, J = 8.3 Hz, 1H), 6.35 (d, J = 16.0 Hz, 1H), 4.46 (t, J = 6.7 Hz, 2H), 4.20 (t, J 
= 5.4 Hz, 2H), 3.61 (t, J = 5.6 Hz, 2H), 2.74 (t, J = 6.6 Hz, 2H), 2.29 (s, 3H), 2.28 (s, 3H), 
2.10-2.07 (m, 2H), 1.82 – 1.71 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 168.2, 168.1, 
166.8, 147.7, 143.6, 142.9, 142.5, 133.4, 126.5, 124.0, 122.8, 121.4, 119.4, 64.5, 58.8, 
46.9, 32.8, 28.3, 25.9, 25.3, 20.73, 20.70. FT-IR (Neat, υmax cm-1) 2948 (br), 1770, 1706, 
1638, 1505 HRMS m/z calculated for C22H28O7N3 [M+H]
+
 446.1927, found 446.1927   
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(E)-4-(3-((5-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)pentyl)oxy)-3-oxoprop-1-en-
1-yl)-1,2-phenylene diacetate (8c) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, to 3-azidopropan-1-ol (141 mg, 1.4 mmol, 1.0 eq.) in (1:1) H2O–tert-BuOH 
(12 mL) was added  (E)-4-[3-(hept-6-yn-1-yloxy)-3-oxoprop-1-en-1-yl]-1,2-phenylene 
diacetate (600 mg, 1.7 mmol, 1.2 eq.). Copper(I) iodide (31 mg, 0.14 mmol, 0.1 eq.) was 
then added. The mixture was heated at 125 °C for one hour in a sealed tube. The reaction 
was then allowed to cool to room temperature before dilution with water. The reaction 
mixture was extracted with DCM (3 × 5 mL), dried over MgSO4, and the volatiles 
removed in vacuo and the crude product purified by column chromatography 
(EtOAc/petroleum ether 70:30) to give a yellow oil (390 mg, 0.85 mmol, 61%). Rf 0.22 
(EtOAc 100%). 
1
H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 16.0 Hz, 1H), 7.36 (dd, J = 8.4, 
1.9 Hz, 1H), 7.33 (d, J = 1.9 Hz, 1H), 7.31 (s, 1H), 7.18 (d, J = 8.4 Hz, 1H), 6.34 (d, J = 
16.0 Hz, 1H), 4.41 (t, J = 6.9 Hz, 2H), 4.15 (t, J = 6.6 Hz, 2H), 3.57 (t, J = 5.8 Hz, 2H), 
3.12 (s, 1H), 2.69 (t, J = 7.6 Hz, 2H), 2.26 (s, 3H), 2.25 (s, 3H), 2.07 – 2.01 (m, 2H), 1.73 – 
1.63 (m, 4H), 1.47 – 1.37 (m, 2H). 13C NMR (150 MHz, CDCl3) δ 168.0, 167.9, 166.5, 
147.7, 143.3, 142.6, 142.3, 133.1, 126.3, 123.8, 122.6, 121.1, 119.2, 64.4, 58.4, 46.7, 32.6, 
28.8, 28.2, 25.4, 25.3, 20.48, 20.45. FT-IR (Neat, υmax cm
-1
) 2939, 2860, 1770, 1707, 1639, 
1505. HRMS m/z calculated for C23H30O7N3 [M+H]
+ 
460.2071, found 460.2084   
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(E)-4-(3-((8-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)octyl)oxy)-3-oxoprop-1-en-1-
yl)-1,2-phenylene diacetate (8d) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, to 3-azidopropan-1-ol (41 mg, 0.42 mmol, 1.0 eq.) in (1:1) H2O–tert-BuOH 
(3 mL) was added (E)-4-[3-(dec-9-yn-1-yloxy)-3-oxoprop-1-en-1-yl]-1,2-phenylene 
diacetate (200 mg, 0.5 mmol, 1.2 eq.). Copper(I) iodide (8 mg, 0.04 mmol, 0.1 eq.) was 
then added. The mixture was heated at 125 °C for one hour in a sealed tube. The reaction 
was then allowed to cool to room temperature before dilution with water. The reaction 
mixture was extracted with DCM (3 × 5 mL), dried over MgSO4, and the volatiles 
removed in vacuo and the crude product purified by column chromatography 
(EtOAc/petroleum ether 70:30) to give a white solid (130 mg, 0.26 mmol, 62%) MP: 73 
°C. Recrystallised from hexanes (100%). Rf  0.25 (EtOAc 100%). 
1
H NMR (400 MHz, 
CDCl3) δ 7.60 (d, J = 16.0 Hz, 1H), 7.40 (d, J = 8.4 Hz, 1H), 7.36 (s, 1H), 7.29 (s, 1H), 
7.21 (d, J = 8.4 Hz, 1H), 6.38 (d, J = 16.0 Hz, 1H), 4.47 (t, J = 6.7 Hz, 2H), 4.18 (t, J = 6.6 
Hz, 2H), 3.63 (t, J = 5.8 Hz, 2H), 2.70 (t, J = 7.6 Hz, 2H), 2.30 (s, 3H), 2.29 (s, 3H), 2.13-
2.07 (m, 2H), 1.70-1.65 (m, 4H), 1.40-1.30 (m, 8H). 
13
C NMR (100 MHz, CDCl3) δ 168.0, 
167.9, 166.6, 143.3, 142.5, 142.3, 133.3, 126.3, 123.8, 122.6, 120.9, 119.4, 77.14, 64.7, 
58.8, 46.6, 32.6, 29.3, 29.1, 29.00, 28.99, 28.6, 25.8, 25.5, 20.6, 20.5. FT-IR (Neat, υmax 
cm
-1
) 3460, 2920, 2853, 1760, 1731, 1702, 1635, 1504. HRMS (ESI
+
) calculated for 
C26H36O7N3 m/z
 
502.2567, found 502.2553  Elemental analysis calculated for C26H35O7N3 
requires C 62.11%, H 7.00%, N 8.38% found C 62.12%, H 6.97%, N 8.30%. 
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(E)-4-(3-((2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)ethyl)amino)-3-oxoprop-1-en-
1-yl)-1,2-phenylene diacetate (8e) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, reported above, to 3-azido-1-propanol (32 mg, 0.32 mmol, 1.0 eq.) in (1:1) H2O–
tert-BuOH (4 mL) was added (E)-4-(3-(but-3-yn-1-ylamino)-3-oxoprop-1-en-1-yl)-1,2-
phenylene diacetate (120 mg, 0.38 mmol, 1.2 eq.). Copper(I) iodide (6 mg, 0.03 mmol, 0.1 
eq.) was added. The mixture was heated at 125 °C for one hour in a sealed tube. The 
reaction was then allowed to cool to room temperature before dilution with water. The 
reaction mixture was extracted with DCM (3 × 10 mL), dried over MgSO4, and the 
volatiles removed in vacuo and the crude product purified by column chromatography 
(MeOH/DCM 5:95), recrystallised from EtOAc/ hexanes (20:80) to give a white solid ( 
155 mg, 0.29 mmol, 76%). MP: 84°C. Rf 0.25 (MeOH/DCM 10:90). 
1
H NMR (600 MHz, 
CDCl3) δ 7.54 (d, J = 15.6 Hz, 1H), 7.45 (s, 1H), 7.37 (dd, J = 8.4, 2.0 Hz, 1H), 7.33 (d, J 
= 2.0 Hz, 1H), 7.21 (d, J = 8.2 Hz, 1H), 6.48 (m, 1H), 6.33 (d, J = 15.6 Hz, 1H), 4.51 (t, J 
= 6.7 Hz, 2H), 3.78-3.75 (m, 2H), 3.64-3.61 (m, 2H), 2.99 (t, J = 6.3 Hz, 2H), 2.32 (s, 3H), 
2.31 (s, 3H), 2.19 (s, 1H), 2.16 – 2.10 (m, 2H), 1.97 (t, J = 4.9 Hz, 1H). 13C NMR (150 
MHz, CDCl3) δ 168.18, 168.15, 165.7, 142.9, 142.31, 142.29, 139.0, 133.8, 126.2, 123.8, 
122.3, 122.0, 58.6, 46.9, 38.8, 32.4, 29.7, 25.5, 20.64, 20.60. FT-IR (Neat, υmax cm
-1
) 3348, 
3243, 3060, 2933, 2256, 1768, 1663.21, 1620, 1574, 1505. HRMS m/z calculated for 
C20H25O6N4 [M+H]
+ 
417.1778, found 417.1774 . Elemental analysis calculated for 
C20H24O6N4 requires C 57.69%, 5.81%, N 13.45% found C 58.19 %, H 6.04%, N 10.25%. 
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2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)ethyl (E)-3-(3,4-difluorophenyl)acrylate 
(8f) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, to 3-azido-1-propanol (178 mg, 1.8 mmol, 1.0 eq.) in (1:1) H2O–tert-BuOH 
(12 mL) was added but-3-yn-1-yl (E)-3-(3,4-difluorophenyl) acrylate (500 mg, 2.11 mmol, 
1.2 eq.). Copper(I) iodide (34 mg, 0.18 mmol, 0.1 eq.) was then added. The mixture was 
heated at 125 °C for one hour in a sealed tube. The reaction was then allowed to cool to 
room temperature before dilution with water. The reaction mixture was extracted with 
DCM (3 × 10 mL), dried over MgSO4, and the volatiles removed in vacuo and the crude 
product purified by column chromatography (EtOAc/petroleum ether 70:30), recrystallised 
from petroleum ether to give a white solid (637 mg, 1.88 mmol, quantitative ). MP: 82 °C. 
Rf 0.11 (EtOAc/petroleum ether 80:20). 
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 16.0 
Hz, 1H), 7.47 (s, 1H), 7.34 – 7.27 (m, 1H), 7.20 (s, 1H), 7.16 – 7.06 (m, 1H), 6.30 (d, J = 
16.0 Hz, 1H), 4.46 (dt, J = 13.2, 6.6 Hz, 4H), 3.62 (t, J = 5.5 Hz, 2H), 3.10 (t, J = 6.2 Hz, 
2H), 2.14 – 2.01 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 165.9 (s), δ 152.0 (dd, J = 96.8, 
13.0 Hz), 149.5 (d, J = 79.7 Hz) 143.7 (s), 142.6 – 142.3 (m), 131.2 (dd, J = 6.0, 4.1 Hz), 
124.5 (dd, J = 6.6, 3.5 Hz), 121.7 (s), 118.6 (d, J = 2.3 Hz), 117.5 (d, J = 17.8 Hz), 116.0 
(d, J = 17.7 Hz), 63.2 (s), 58.6 (s), 46.7 (s), 32.4 (s), 25.4 (s). 
19
F NMR (376 MHz, CDCl3) 
δ -62.75 (s), -133.92 (s), -133.98 (s), -136.52 (d, J = 20.9 Hz). FT-IR (Neat, υmax cm-1) 
3328, 3124, 3055, 2962, 2885, 1712, 1638, 1600, 1516. HRMS m/z calculated for 
C16H18O3N3F2 [M+H]
+
 338.1316, found 338.1316. Elemental analysis calculated for 
C16H17N3O3F2 requires C 56.97%, H 5.08%, N 12.46% found C 56.97%, H 5.19%, N 
12.16%.  
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(E)-8-[1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl]octyl-3-(3,4-difluorophenyl)acrylate. 
(8g) 
 
White solid (75%). MP 62 °C. Purified by crystallisation (EtOAc/hexane 10:90). Rf 0.4 
(EtOAc/hexane 10:90). 
1
H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 16.0 Hz, 1H), 7.36 – 
7.32 (m overlapping s at 7.32 ppm, 1H), 7.32 (s, 1H), 7.25 – 7.20 (m, 1H), 7.16 (td, J = 
9.7, 8.3 Hz, 1H), 6.34 (d, J = 16.1 Hz, 1H), 4.47 (t, J = 6.8 Hz, 2H), 4.17 (t, J = 6.7 Hz, 
2H), 3.63 (t, J = 5.83 Hz, 1H), 2.69 (t, J = 7.7 Hz, 1H), 2.14 – 2.08 (m, 2H), 1.70 – 1.63 
(m, 4H), 1.39 – 1.33 (m, 8H). 13C NMR (150 MHz) δ 166.6, 151.8 (dd, J = 131.6, 13.0 
Hz), 150.2 (dd, J = 127.9, 13.1 Hz), 142.2 (br s), 131.7 (dd, J = 5.9, 4.0 Hz), 124.8 (dd, J 
= 6.5, 3.5 Hz), 119.40, 119.39, 116.3, 117.8 (d, J = 17.7 Hz), 116.3 (d, J = 17.6 Hz), 64.8, 
58.7, 46.8, 32.7, 29.4, 29.2, 29.1, 28.6, 25.9, 25.6. 
19
F NMR (376 MHz, CDCl3) -135.35 (d, 
J = 20.9 Hz), -137.71 (d, J = 20.8 Hz). FT-IR (Neat, υmax cm
-1
) 3337, 3063, 2920, 2853, 
1714, 1516, 1272, 1179, 1044, 818. HRMS m/z calculated for C22H29F2N3O3 [M]
+
 
422.2177, found 422.2165. Elemental analysis calculated for C22H29F2N3O3: C 62.69, H 
6.94, N 9.97; found: C 61.89, H 6.83, 9.84. 
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(E)-4-(3-(3-(4-(2-Hydroxyethyl)-1H-1,2,3-triazol-1-yl)propoxy)-3-oxoprop-1-en-1-yl)-
1,2-phenylene diacetate (8h) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, to (E)-4-(3-(3-azidopropoxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (1.0 
g, 2.89 mmol, 1.0 eq.) in (1:1) H2O–tert-BuOH (10 mL) was added 3-butyn-1-ol (242 mg, 
3.5 mmol, 1.2 eq.). Copper(I) iodide (55 mg, 0.289 mmol, 0.1 eq.) was then added. The 
mixture was heated at 125 °C for one hour in a sealed tube. The reaction was then allowed 
to cool to room temperature before dilution with water. The reaction mixture was extracted 
with DCM (3 × 10 mL), dried over MgSO4, and the volatiles removed in vacuo and the 
crude product purified by column chromatography (EtOAc 100%) to give a white solid 
(554 mg, 1.3 mmol, 46%). MP: 78 °C. Rf 0.14 (EtOAc 100%). Recrystallised from EtOAc 
(100%). 
1
H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 16.0 Hz, 1H), 7.44 (s, 1H), 7.40 (dd, J 
= 8.5, 1.9 Hz, 1H), 7.37 (d, J = 1.7 Hz, 1H), 7.22 (d, J = 8.3 Hz, 1H), 6.35 (d, J = 16.0 Hz, 
1H), 4.46 (t, J = 6.9 Hz, 2H), 4.23 (t, J = 5.9 Hz, 2H), 3.92 (t, J = 5.8 Hz, 2H), 2.93 (t, J = 
5.9 Hz, 2H), 2.34-2.31 (m, overlapping s, 2H), 2.30 (s, 3H), 2.29 (s, 3H). 
13
C NMR (100 
MHz, CDCl3) δ 168.2, 168.1, 166.5, 143.8, 143.6, 142.6, 133.1, 126.61, 126.60, 124.1, 
122.9, 122.1, 118.7, 61.7, 61.3, 47.3, 29.6, 28.8, 20.8, 20.7. FT-IR (Neat, υmax cm
-1
) 2933, 
2099, 1770, 1710, 1639, 1505. HRMS m/z calculated for C20H23O6N3 [M+H]
+ 
359.1501, 
found 4359.1495. 
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4-((E)-3-(3-(4-(2-(((E)-3-(3,4-Diacetoxyphenyl)acryloyl)oxy)ethyl)-1H-1,2,3-triazol-1-
yl)propoxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (9) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, to (E)-4-(3-(3-azidopropoxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (347 
mg, 0.6 mmol, 1.0 eq.) in (1:1) H2O–tert-BuOH (8 mL) was added (E)-4-(3-(but-3-yn-1-
yloxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (380 mg, 0.72 mmol, 1.2 eq.). 
Copper (I) iodide (19 mg, 0.06 mmol, 0.1 eq.) was then added. The mixture was heated at 
125 °C for one hour in a sealed tube. The reaction was then allowed to cool to room 
temperature than before dilution with water. The reaction mixture was extracted with DCM 
(3 × 10 mL), dried over MgSO4, and the volatiles removed in vacuo and the crude product 
purified by column chromatography (EtOAc 100%) and recrystallised from 
EtOAc/hexanes (20:80)  to give a white solid  (155 mg, 0.23 mmol, 40%). MP: 125 °C. Rf 
0.27 (EtOAc/petroleum ether 80:20).  
1
H NMR (400 MHz, CDCl3) δ 7.61 (dd, J = 16.0, 2.3 
Hz, 2H), 7.43 (s, 1H), 7.40 (dd, J = 8.4, 2.2 Hz, 2H), 7.37 (s, 2H), 7.23 (d, J = 8.4 Hz, 1H), 
7.21 (d, J = 8.5, 1H), 6.40-6.34 (m, 2H), 4.50-4.47 (m, 4H), 4.25 (t, J = 5.9 Hz, 2H), 3.20 – 
3.10 (m, 2H), 2.37 – 2.33 (m, 2H), 2.31 (s, 3H), 2.30 (s, 3H), 2.29 (s, 3H), 2.29 (s, 3H). 13C 
NMR (100 MHz, CDCl3) δ 168.20, 168.16, 168.08, 168.06, 166.5, 166.4, 144.4, 143.8, 
143.7, 143.6, 143.3, 142.62, 142.59, 133.3, 133.2, 126.6, 124.1, 124.07, 122.95, 122.89, 
121.96, 119.1, 118.7, 63.5, 61.3, 47.3, 29.7, 25.74, 25.66, 20.78, 20.77, 20.74, 20.73. FT-
IR (Neat, υmax cm
-1
) 2962, 1768, 1708, 1638, 1504. HRMS m/z calculated for C33H34O12N3 
[M+H]
+ 
664.2137, found 664.2130  Elemental analysis calculated for C33H33O12N3 requires 
C 59.73%, H 5.01%, N 6.33% found C 59.06%, H 4.97%, N 6.02%. 
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(E)-4-(3-(2-(1-(3-((6-Acetoxy-2,5,7,8-tetramethylchromane-2-carbonyl)oxy)propyl)-
1H-1,2,3-triazol-4-yl)ethoxy)-3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate (10) 
 
According to the general procedure for the copper catalysed 1,3 dipolar cycloaddition 
reaction, to 3-azidopropyl 6-acetoxy-2,5,7,8-tetramethylchromane-2-carboxylate (500 mg, 
1.3 mmol, 1.0 eq.) in H2O–tert-ButOH (10 mL) was added (E)-4-(3-(but-3-yn-1-yloxy)-3-
oxoprop-1-en-1-yl)-1,2-phenylene diacetate (506 mg, 1.6 mmol, 1.2 eq.). Copper(I) iodide 
(25 mg, 0.13 mmol, 0.1 eq.) was then added. The mixture was heated at 125 °C for one 
hour in a sealed tube. The reaction was then allowed to cool to room temperature before 
dilution with water. The reaction mixture was extracted with DCM (3 × 10 mL), dried over 
MgSO4, and the volatiles removed in vacuo and the crude product purified by column 
chromatography (EtOAc/petroleum ether 20:80) to give a white solid (3274 mg, 0.4 mmol 
30%).MP: 56-60 °C. Rf 0.44 (EtOAc/petroleum ether 30:70). Recrystallised hexanes 
(100%). 
1
H NMR (600 MHz, DMSO) δ 7.75 (s, 1H), 7.69-7.65 (m, 1H), 7.64 (d, J = 15.5 
Hz, 2H), 7.31 (d, J = 8.3 Hz, 1H), 6.63 (d, J = 16.0 Hz, 1H), 4.38 (t, J = 6.2 Hz, 2H), 4.22 
– 4.07 (m, 2H), 4.04 – 3.88 (m, 2H), 3.02 (t, J = 6.1 Hz, 2H), 2.67 – 2.33 (m, 4H), 2.28 (d, 
J = 3.6 Hz, 8H), 2.09 (s, 3H), 2.04 (s, 2H) 1.93 (s, 3H), 1.86 (s, 3H), 1.85 – 1.76 (m, 2H), 
1.55 (s, 3H). 
13
C NMR (150 MHz, DMSO) δ 173.0, 169.5, 168.6, 168.5, 166.4, 149.3, 
144.0, 143.6, 143.4, 142.8, 141.4, 133.3, 127.4, 127.1, 125.5, 124.6, 123.6, 123.0, 122.2, 
119.4, 117.7, 77.5, 63.6, 62.2, 46.3, 30.3, 29.2, 25.5, 25.4, 20.8, 20.73, 20.68, 20.64, 13.2, 
12.3, 12.1. FT-IR (Neat, υmax cm
-1
) 2935, 1749, 1712, 1638, 1505. HRMS m/z calculated 
for C36H42O11N3 [M+H]
+ 
692.2814, found 692.2823  Elemental analysis calculated for 
C36H41N3O11 requires C 62.51%, H 5.97%, N 6.07 % found C 61.76%, H 5.90%, N 5.92. 
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11.  Appendix Log P 
The partition coefficient (Log P
129
) describes the ratio of a compounds between two 
immiscible phases, generally n-octanol and water. It gives a measure of the hydrophilicity 
of the molecule. It is important to understand that the Log P value is a valid indicator of the 
hydrophilicity of a molecule for non-dissociated species at neutral pH, if working with 
ionisable species the Log D (pH-dependent lipophilicity descriptor) must be used. It is a 
fundamental parameter in medicinal chemistry and its one of the points of the rule of 5.
130
 
The Lipinsky rule of 5 was initially meant to predict cell permeability and adsorption of 
compounds in the body but has been used for more than twenty years now to predict drug 
likeness. 
The rule of 5 states that potential drugs should follow the parameters listed below, to 
increase their possibility of success: 
1. MW lower than 500†††††,131 
2. Log P less than 5 (–0.4 to +5.6 accepted range) 
3. Number of H-Bond donors (HBD) is less than 5 
4. Number of H-Bond acceptors (HBA) is less than 10 
The rule was based on the 90 percentile values of the physic-chemical properties 
distribution of more than 2000 drug molecules. 
Log P is often considered the most important parameter to judge drug likeness this because 
it affects adsorption, membrane permeability, metabolism, promiscuity, toxicity and 
survival of the drug in the pipeline.
132
 
The reference compounds zileuton for anti-inflammatory activity and fluconazole for 
antimycotic activity possess Log P of 1.77 and 1.81 respectively. In Table 10.5.1Table 
10.5.1 the Log P of the library of compounds herein presented are reported and are all in 
the acceptable range described by Lipinski (exception made for 8e that was anyway 
inactive). 
 
                                                          
†††††
 This cut out has been questioned, and it has been more recently evidenced that the number of rotatable 
bonds and the polar surface area are more useful to discriminate between compounds orally active, in 
particular they should have less than 10 rotatable bonds and polar surface area not higher than 140 Å.
2
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Table 10.5.1 Table of Log P of synthesised compounds calculated with Marvin Sketch 5.4.1.1 method KLOP 
Marvin Sketch software ver. 5.4.1.1.
133,  134 
Compound Log P 
3a 1.99 
3b 2.93 
3c 3.40 
3d 4.80 
3e 1.08 
3f 3.07 
5 1.50 ionic species 
1.63 ionic species 
7 4.16 ionic species 
4.30 non-ionic species 
8a 1.01 
8b 1.77 
8c 2.24 
8d 3.65 
8e 0.10 
8f 2.09 
8h 1.01 
9 3.04 
10 5.70 
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